UNITED STATES
Amendment No. 2
REGISTRATION STATEMENT
TASER INTERNATIONAL, INC.
Delaware
|
3699 | 86-0741227 | ||
(State or other Jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | ||
Incorporation or Organization) | Classification Code Number) | Identification Number) |
7860 E. McClain Drive, Suite 2
Scottsdale, Arizona 85260 (480) 991-0797 (Address and telephone number of principal executive offices and principal place of business) |
Patrick W. Smith,
Chief Executive Officer TASER International, Inc. 7860 E. McClain Drive, Suite 2 Scottsdale, Arizona 85260 (480) 991-0797 (Name, address and telephone number of agent for service) |
Copies to:
Thomas P. Palmer, Esq
Jeffrey S. Cronn, Esq. Tonkon Torp LLP 888 S.W. Fifth Avenue, Suite 1600 Portland, Oregon 97204 (503) 802-2018 |
Mark A. von Bergen, Esq.
Joshua E. Husbands, Esq. Weiss Jensen Ellis & Howard 2300 U.S. Bancorp Tower 111 S.W. Fifth Avenue Portland, Oregon 97204 (503) 243-2300 |
Approximate date of proposed sale to the public:
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box.
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
|
|||||||
|
|||||||
Proposed | |||||||
Maximum Offering | Proposed | ||||||
Amount to be | Price Per | Maximum Aggregate | |||||
Title of Each Class of Securities to be Registered | Registered | Security(1) | Offering Price | ||||
|
|||||||
Units, each consisting of(2)
|
1,265,000 | $11.00 | $13,915,000 | ||||
|
|||||||
(i) one share of common stock, and
|
1,265,000 | | | ||||
|
|||||||
(ii) one warrant to purchase one share of common stock
|
1,265,000 | | | ||||
|
|||||||
Representatives warrants(3)
|
110,000 | ||||||
|
|||||||
Units issuable upon exercise of representatives warrants,
each consisting of
|
110,000 | $13.20 | $1,452,000 | ||||
|
|||||||
(i) one share of common stock, and
|
110,000 | | | ||||
|
|||||||
(ii) one warrant to purchase one share of common stock
|
110,000 | | | ||||
|
|||||||
Common stock issuable upon exercise of warrants, including
warrants underlying representatives warrants(4)
|
1,375,000 | $16.50 | $22,687,500 | ||||
|
|||||||
Total
|
$38,054,500 | ||||||
|
[Additional columns below]
[Continued from above table, first column(s) repeated]
(1) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(g) under the Securities Act of 1933. |
(2) | Includes 165,000 units which Paulson Investment Company, Inc., the representative of the underwriters, has the option to purchase to cover over-allotments, if any. |
(3) | In connection with the sale of the units, TASER International, Inc. will issue to the representative warrants to purchase, in the aggregate, up to 110,000 units. |
(4) | Pursuant to Rule 416 under the Securities Act of 1933, there are also being registered such additional shares and warrants as may be issuable pursuant to the anti-dilution provisions of the public warrants and the representatives warrants. |
(5) | TASER International, Inc. previously paid a registration fee of $8,649 in connection with the February 14, 2001 filing of its Registration Statement on Form SB-2. |
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. |
SUBJECT TO COMPLETION, DATED APRIL 13, 2001
PRELIMINARY PROSPECTUS
1,100,000 Units
This is an initial public offering of units by TASER International, Inc. Each unit consists of one share of common stock and one redeemable public warrant to purchase one share of common stock. We expect that the initial public offering price will be between $9 and $11 per unit. Prior to this offering, there has been no public market for our securities. We have filed an application to list the units, the common stock and the public warrants on The Nasdaq SmallCap Market under the symbols TASRU, TASR and TASRW, respectively.
The common stock and warrants will trade only as a unit for at least 30 days following this offering. The representative of the underwriters will then determine when the units separate, after which the common stock and the public warrants will trade separately.
Investing in these units involves significant risks. See Risk Factors beginning on page 4.
Per Unit | Total | |||||||
|
|
|||||||
Initial public offering price
|
$ | $ | ||||||
Underwriting discount
|
$ | $ | ||||||
Proceeds to TASER International, Inc
|
$ | $ |
The Securities and Exchange Commission and state securities regulators have not approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Paulson Investment Company, Inc. is the representative of the underwriters. We have granted the representative the option for a period of 45 days to purchase up to an additional 165,000 units to cover over-allotments.
PAULSON INVESTMENT COMPANY, INC.
The date of this prospectus is , 2001.
[gatefold cover]
Page 1 of the gatefold: The artwork depicts below the company logo a side view of the ADVANCED TASER M26 with certain parts labeled and a top view of the AIR TASER 34000.
Pages 2 and 3 of the gatefold: The artwork depicts a pictorial diagram illustrating the effective range of the ADVANCED TASER M26 compared to batons and chemical sprays over distances of between zero and twenty feet.
Below the pictorial diagram are smaller photographs of the air cartridges (ammunition), the probes, the dataport on the ADVANCED TASER M26 and the AFID tags.
Below the smaller pictures the following captions appear:
The ADVANCED TASER M26 fires two small metal probes with fine wires attached. When the probes make contact, small barbs adhere to the target. Electrical signals are transmitted through the wires into the body of the subject, impairing his ability to perform coordinated action.
The ADVANCED TASER M26 records the time and date of up to 585 firings. This data can be downloaded to a computer and used to investigate potential misuse of the weapon.
The ADVANCED TASER M26 disperses 20-50 serial numbered identification tags upon firing. These tags can be used to trace the registered owner of the air cartridge used.
PROSPECTUS SUMMARY
The following summary highlights information which is presented in more detail elsewhere in this prospectus and which we believe is material for an investor to read and understand before investing in the units. Before making an investment decision, you should read the entire prospectus carefully, including the Risk Factors section, the financial statements and the notes to the financial statements .
Historical information regarding our securities has been adjusted to reflect a 1-for-6 reverse stock split effected in connection with our reincorporation in Delaware on February 12, 2001. Except as otherwise indicated, all information in this prospectus assumes no exercise of the representatives over-allotment option or the representatives warrants. References to we, us, the company or TASER mean TASER International, Inc., unless otherwise indicated.
Our Company
TASER International, Inc. develops, assembles and markets less-lethal, conducted energy weapons primarily for use in the law enforcement and corrections market. Our ADVANCED TASER weapon offers improved performance over other less-lethal force options used by law enforcement agencies. It can temporarily incapacitate virtually any individual regardless of pain tolerance, drug use, or body size factors that cause other less-lethal options to have decreased effectiveness. The ADVANCED TASER also has a comparable or lower injury rate than other less-lethal weapons and has had no reported long-term, adverse after-effects.
The ADVANCED TASER uses compressed nitrogen to shoot two small probes up to 21 feet. These barbed probes are connected to the weapon by high-voltage insulated wires. When the probes make contact with the target, the ADVANCED TASER transmits powerful electrical pulses along the wires and into the body of the target through up to two inches of clothing. These electrical pulses impair voluntary muscle control so that the subject cannot perform coordinated action.
Nearly all law enforcement agencies authorize the use of less-lethal weapons, including pepper sprays, impact devices, and conducted energy weapons such as TASERs. Effective less-lethal weapons may increase the safety of law enforcement officers, decrease suspect injuries, improve community relations, reduce litigation and police department medical and liability insurance costs, and potentially save lives.
Since December 1999, over 400 police departments in the United States have made initial purchases of our products, and 15 police departments, including San Diego, Sacramento and Albuquerque, have purchased our products for every patrol officer. In addition, at February 1, 2001, more than 200 other police departments were evaluating the use of the ADVANCED TASER.
The key elements of our growth strategy are:
| To expand sales in the law enforcement and corrections market, which we believe to be the opinion leader for all other markets for less-lethal weapons; | |
| To expand into the related private security and military markets; | |
| To expand into the consumer market; | |
| To develop enhanced less-lethal weapons and technologies, such as longer-range TASERs and TASERs with multiple shot capabilities; and | |
| To acquire related businesses that enhance our strategic position. |
Our corporate headquarters is located at 7860 East McClain Drive, Suite 2, Scottsdale, Arizona 85260 and our telephone number is (480) 991-0797. Our website address is www.eTASER.com. Information contained on our website or any other website does not constitute a part of this prospectus.
1
This Offering
The number of shares of common stock outstanding after this
offering is based on 1,510,754 shares outstanding as of
March 15, 2001. The number of shares of common stock
outstanding after this offering assumes no exercise of the
representatives over-allotment option and does not include
an aggregate of 1,807,049 shares of common stock that may become
outstanding as follows:
2
Securities offered
1,100,000 units. Each unit consists of one share of common stock
and one public warrant to purchase an additional share of common
stock. See Description of Securities.
The common stock and public warrants will trade only as a unit
for at least 30 days following this offering. The
representative of the underwriters will then determine when the
units separate, after which the common stock and the public
warrants will trade separately.
Public warrants
The public warrants included in the units will be exercisable
commencing 30 days after this offering. The exercise price of a
public warrant is 150% of the initial public offering price of
the units. The public warrants expire on the fifth anniversary
of the closing of this offering.
We have the right, commencing three months after the closing of
this offering, to redeem the public warrants issued in this
offering at a redemption price of $0.25 per public warrant,
after providing 30 days prior written notice to the public
warrant holders, if the average closing bid price of the common
stock equals or exceeds 200% of the initial public offering
price of the units for ten consecutive trading days ending prior
to the date of the notice of redemption.
Common stock outstanding after this offering
2,610,754 shares
Use of proceeds
Sales and marketing, purchases of inventory, repayment of
stockholder and other debt, working capital, research and
development, and production tooling. See Use of
Proceeds.
Proposed Nasdaq SmallCap Market symbols
Common stock
TASR
Units offered in
this
offering TASRU
Public warrants
included
in the units
TASRW
434,322 shares of common stock issuable upon exercise of stock
options outstanding as of March 15, 2001, with a weighted
average exercise price of $5.96;
52,727 shares of common stock issuable upon exercise of warrants
outstanding as of March 15, 2001, with a weighted average
exercise price of $4.71;
1,100,000 shares of common stock issuable upon exercise of the
public warrants; and
110,000 shares of common stock issuable upon exercise of the
representatives warrants and 110,000 shares of common
stock issuable upon exercise of the public warrants underlying
the representatives warrants.
SUMMARY FINANCIAL INFORMATION
The as adjusted balance sheet data reflects:
We have rights to the following registered trademarks:
TASER
®
and AIR TASER
®
. We also have the
following unregistered trademarks: TASER Wave
,
T-Wave
, AUTO TASER
, ADVANCED
TASER
and AFID
. Each other trademark,
trade name or service mark appearing in this prospectus belongs
to its respective holder.
3
Years Ended December 31,
1999
2000
$
2,208,488
$
3,412,620
120,002
1,574,231
(1,386,838
)
(46,885
)
(1,666,733
)
(406,220
)
$
(0.54
)
$
(0.16
)
3,076,410
2,482,976
December 31, 2000
Actual
As adjusted
$
(1,069,344
)
$
7,260,656
274,273
1,024,273
1,039,066
9,417,212
2,822,144
2,822,144
$
(3,617,215
)
$
5,462,785
the receipt of approximately $9,080,000 as the estimated net
proceeds from the sale of 1,100,000 units offered by us in this
offering at an assumed public offering price of $10.00 per unit,
after deducting the underwriting discount, expense allowance and
estimated offering expenses; and
our planned use of the net proceeds of this offering.
RISK FACTORS
This offering involves a high degree of risk. You should
carefully consider the following risk factors and all other
information contained in this prospectus before purchasing any
units. Any of the following risks could materially harm our
business, operating results and financial condition, and could
result in a decrease in the trading price of our units, common
stock or public warrants, or in a complete loss of your
investment
.
Risks Related to Our Business
We have no history of profitable operations and may incur
future losses.
Since our inception in 1993, we have incurred significant
losses. Our net losses for the years ended December 31,
1999 and 2000 were $1.7 million and $406,000, respectively. We
may never achieve or sustain profitability. At December 31,
2000, we had an accumulated deficit of approximately $6.7
million and negative stockholders equity of $3.6 million.
We also had a net working capital deficit of $2.4 million and
$1.1 million at December 31, 1999 and 2000, respectively.
In addition, we expect our operating expenses to increase
significantly as we expand our sales and marketing efforts and
otherwise support our expected growth. Given these planned
expenditures, we may incur additional losses in the near future.
Our business is difficult to evaluate because we have a
limited operating history in the law enforcement and corrections
market and have been focused on our current business strategy
for only approximately one and one-half years.
We revised our business strategy in late 1999 to concentrate on
the law enforcement and corrections market. Accordingly, we have
a limited operating history based on which you can evaluate our
present business and future prospects. We face risks and
uncertainties relating to our ability to implement our business
plan successfully. Our prospects must be considered in light of
the risks, expenses and difficulties frequently encountered by
newly-public companies that have recently changed their business
strategies. If we are unsuccessful in addressing these risks and
uncertainties, our business, results of operations, financial
condition and prospects will be materially harmed.
We are materially dependent on acceptance of our products
by the law enforcement and corrections market, but cannot
predict the rate at which law enforcement and corrections
agencies will accept our products.
Although we have recently devoted significant resources to sales
opportunities in the law enforcement and corrections market, a
substantial number of law enforcement and corrections agencies
may not purchase our conducted energy, less-lethal weapons. In
addition, if our products are not widely accepted by the law
enforcement and corrections market, we may not be able to expand
sales of our products into other markets. Despite the absence of
reported long-term, adverse after-effects from the use of our
products, law enforcement and corrections agencies may be
influenced by claims or perceptions that conducted energy
weapons are unsafe or may be used in an abusive manner. In
addition, earlier generation conducted energy weapons may have
been perceived as ineffective. Sales of our products to these
agencies may also be delayed or limited by these claims or
perceptions.
We substantially depend on sales of the ADVANCED TASER,
and if this product is not widely accepted, our growth prospects
will be diminished.
In 2000, we derived the majority of our revenues from sales of
ADVANCED TASERs and related cartridges, and expect to depend on
sales of this product for the foreseeable future. A decrease in
the prices of or demand for this product line, or its failure to
achieve broad market acceptance, would significantly harm our
growth prospects, operating results and financial condition.
4
If we are unable to manage our projected growth, our
growth prospects may be limited and our future profitability may
be adversely affected.
We intend to expand our sales and marketing programs and our
manufacturing capability. Rapid expansion may strain our
managerial, financial and other resources. If we are unable to
manage our growth, our business, operating results and financial
condition could be adversely affected. Our systems, procedures,
controls and management resources also may not be adequate to
support our future operations. We will need to continually
improve our operational, financial and other internal systems to
manage our growth effectively, and any failure to do so may lead
to inefficiencies and redundancies, and result in reduced growth
prospects and profitability.
We may face personal injury and other liability claims
that harm our reputation and adversely affect our operating
results and financial condition.
Our products are often used in aggressive confrontations that
may result in serious, permanent bodily injury to those
involved. Although there have been no reported long-term,
adverse after-effects from the use of our products, our products
may cause or be associated with these injuries. A person injured
in a confrontation or otherwise in connection with the use of
our products may bring legal action against us to recover
damages on the basis of theories including personal injury,
wrongful death, negligent design, dangerous product or
inadequate warning. We may also be subject to lawsuits involving
allegations of misuse of our products. If successful, personal
injury, misuse and other claims could have a material adverse
effect on our operating results and financial condition.
Although we carry product liability insurance, significant
litigation could also result in a diversion of managements
attention and resources, negative publicity and an award of
monetary damages in excess of our insurance coverage.
We recently relocated our product assembly operations from
Mexico to the United States, which may adversely affect product
availability.
We have terminated assembly operations with our turnkey supplier
in Guaymas, Mexico and are in process of relocating some
production equipment from Mexico to the United States. We have
also installed a new production line in our facility in
Scottsdale, Arizona. If we encounter delays or unforeseen
problems in completing the termination of our relationship with
our prior supplier or relocating our equipment, they may
significantly adversely affect our ability to produce and ship
product and generate short-term sales and cash flow.
Our future success is dependent on our ability to expand
sales through distributors.
Our distribution strategy is to pursue sales through multiple
channels with an emphasis on independent distributors. Our
inability to recruit and retain police equipment distributors
who can successfully sell our products would adversely affect
our business. In addition, our arrangements with our
distributors are generally short-term. If we do not
competitively price our products, meet the requirements of our
distributors or end-users, provide adequate marketing support,
or comply with the terms of our distribution arrangements, our
distributors may fail to aggressively market our products or may
terminate their relationships with us. These developments would
likely have a material adverse effect on our sales. Our reliance
on the sales of our products by others also makes it more
difficult to predict our revenues, cash flow and operating
results.
We expend significant resources in anticipation of a sale
due to our lengthy sales cycle and may receive no revenue in
return.
Generally, law enforcement and corrections agencies consider a
wide range of issues before committing to purchase our products,
including product benefits, training costs, the cost to use our
products in addition to or in place of other less-lethal
products, product reliability and budget constraints. The length
of our sales cycle may range from 60 days to a year or
more. We may incur substantial selling costs and expend
significant effort in connection with the evaluation of our
products by potential customers
5
Most of our end-users are subject to budgetary and
political constraints which may delay or prevent sales.
Most of our end-user customers are government agencies. These
agencies often do not set their own budgets and therefore have
little control over the amount of money they can spend. In
addition, these agencies experience political pressure that may
dictate the manner in which they spend money. As a result, even
if an agency wants to acquire our products, it may be unable to
purchase them due to budgetary or political constraints. Some
government agency orders may also be canceled or substantially
delayed due to budgetary, political or other scheduling delays
which frequently occur in connection with the acquisition of
products by such agencies.
Government regulation of our products may adversely affect
sales.
Federal regulation of sales in the United States.
Our
weapons are not firearms regulated by the Bureau of Alcohol,
Tobacco and Firearms, but are consumer products regulated by the
United States Consumer Product Safety Commission. Although there
are currently no federal laws restricting sales of our weapons
in the United States, future federal regulation could adversely
affect sales of our products.
Federal regulation of international sales.
Our weapons
are controlled as a crime control implement by the
United States Department of Commerce, or DOC, for export
directly from the United States. Consequently, we must obtain an
export license from the DOC for the export of our weapons from
the United States other than to Canada. While we have a history
of timely obtaining DOC export licenses for sales of our weapons
to the majority of our international customers, unforeseen
changes in U.S. export regulations could significantly and
adversely affect our international sales.
State and local regulation.
Our weapons are currently
controlled, restricted or their use prohibited by several state
and local governments. Our weapons are banned from consumer sale
or use in seven states: New York, New Jersey, Rhode Island,
Michigan, Wisconsin, Massachusetts and Hawaii. Law enforcement
use of our products is also restricted in Michigan, New Jersey,
Rhode Island and Hawaii. Some municipalities, including Omaha,
Nebraska and Washington, D.C., also prohibit consumer use
of our products. Other jurisdictions may ban or restrict the
sale of our products, and our product sales may be significantly
affected by additional state, county and city governmental
regulation.
Foreign regulation.
Certain foreign jurisdictions,
including Japan, the United Kingdom, Australia, Italy and Hong
Kong, prohibit the sale of conducted energy weapons, limiting
our international sales opportunities.
If we are unable to protect our intellectual property, we
may lose a competitive advantage or incur substantial litigation
costs to protect our rights.
Our future success depends in part upon our proprietary
technology. Our protective measures, including a patent,
trademarks and trade secret laws, may prove inadequate to
protect our proprietary rights. Our United States patent on the
construction of the gas cylinder used to store the compressed
nitrogen in our cartridges expires in 2015. The holder of the
patent on the process by which compressed gases launch the
probes in our cartridges has licensed the technology covered by
the patent for use in electronic weapons only to us and to two
other companies. This patent expires in 2009. The scope of any
patent to which we have or may obtain rights may not prevent
others from developing and selling competing products. The
validity and breadth of claims covered in technology patents
involve complex legal and factual questions, and the resolution
of such claims may be highly uncertain, lengthy, and expensive.
In addition, our patents may be held invalid upon challenge,
others may claim rights in or ownership of our patents.
6
If we become subject to intellectual property infringement
claims, we may incur litigation costs and divert management
attention from our business.
Any intellectual property infringement claims against us, with
or without merit, could be costly and time-consuming to defend
and divert our managements attention from our business. If
our products were found to infringe a third partys
proprietary rights, we could be required to enter into royalty
or licensing agreements in order to be able to sell our
products. Royalty and licensing agreements, if required, may not
be available on terms acceptable to us or at all.
In late February 2001, Taser received notice from a patent
licensee with regard to alleged infringement of a patent by us
related to the firing mechanism for our weapons. Although we
believe we do not infringe this patent, we have discussed
resolution of this claim with the licensee and may elect to
arbitrate the dispute. An outcome that is adverse to us, costs
associated with defending any lawsuit that may result, and the
diversion of managements time and our resources as a
result of this claim could harm our business and our financial
condition.
Competition in the law enforcement and corrections market
could reduce our sales and prevent us from achieving
profitability.
The law enforcement and corrections market is highly
competitive. We face competition from numerous larger, better
capitalized and more widely known companies that make other
less-lethal weapons and products, as well as from a small
company that also sells conducted energy less-lethal weapons.
Increased competition may result in greater pricing pressure,
lower gross margins and reduced sales, and prevent us from
achieving profitability.
Defects in our products could reduce demand for our
products and result in a loss of sales, delay in market
acceptance and injury to our reputation.
Complex components and assemblies used in our products may
contain undetected defects that are subsequently discovered at
any point in the life of the product. In 2000, we recalled a
series of ADVANCED TASERs due to a defective component in
connection with which we incurred expenses of approximately
$9,000 and recorded an additional charge of approximately
$41,000 to account for related future expenses. Defects in our
products may result in a loss of sales, delay in market
acceptance, injury to our reputation and increased warranty
costs.
Our revenues and operating results may fluctuate
unexpectedly from quarter to quarter, which may cause our stock
price to decline.
Our revenues and operating results have varied significantly in
the past and may vary significantly in the future due to various
factors, including changes in our operating expenses, market
acceptance of our products and services, regulatory changes that
may affect the marketability of our products, and budgetary
cycles of municipal, state and federal law enforcement and
corrections agencies. As a result of these and other factors, we
believe that period-to-period comparisons of our operating
results may not be meaningful in the near term and that you
should not rely upon our performance in a particular period as
indicative of our performance in any future period.
Our dependence on third-party suppliers for key components
of our weapons could materially harm our business.
We depend on certain domestic and foreign suppliers for the
delivery of components used in the assembly of our products. Our
reliance on third-party suppliers creates risks related to our
potential inability to obtain an adequate supply of components
or subassemblies and reduced control over pricing and timing of
delivery of components and subassemblies. Specifically, we
depend on suppliers of sub-assemblies, machined parts, injection
molded plastic parts, printed circuit boards, custom wire
fabrications and other miscellaneous custom parts for our
products. The final assembly of the cartridges used in the
firing of our weapons was prevented for four weeks beginning in
November 2000 by a suppliers receipt of
7
Foreign currency fluctuations may reduce our
competitiveness and sales in foreign markets.
Although our policy of entering into dollar-denominated sales
contracts eliminates our risk of foreign exchange losses, the
relative change in currency values creates fluctuations in
product pricing for potential international customers. These
changes in foreign end-user costs may result in lost orders and
reduce the competitiveness of our products in certain foreign
markets. These changes may also negatively affect the financial
condition of some foreign customers and reduce or eliminate
their future orders of our products.
A lawsuit involving the rights of a former distributor of
our products may subject us to significant litigation costs and
divert management attention from our business.
A former distributor of our products has filed a lawsuit in the
state of New York asserting certain rights of exclusive sales
representation with respect to our products. The former
distributor claims that he has the exclusive right to market and
sell our products to an extensive list of our current and
potential customers throughout the United States. The suit was
dismissed in February 2001 for lack of personal
jurisdiction of the New York court. In March 2001, the
former distributor appealed the dismissal. An outcome that is
adverse to us, costs associated with defending the lawsuit and
the diversion of our managements time and our resources as
a result of the claim could harm our business or financial
condition.
Risks Related to This Offering
We may use the proceeds of this offering in ways that do
not improve our operating results or the market value of our
securities.
We intend to use the net proceeds from this offering for
increased sales and marketing efforts, purchases of inventory,
repayment of a portion of our stockholder and other debt,
general corporate purposes, research and development, and
purchases of production tooling and equipment. Repayment of our
debt will not directly improve our operating results. Our
management will retain broad discretion and significant
flexibility in applying the net proceeds from this offering. If
our management does not apply the proceeds effectively, our
business will be harmed.
You will suffer immediate and substantial dilution of your
investment.
We anticipate that the initial public offering price of the
units will be substantially higher than the net tangible book
value per share of our common stock after this offering. As a
result, you will incur immediate dilution of approximately
$7.91, or 79%, in net tangible book value for each share of our
common stock included in the units you purchase.
There has been no prior market for our securities and a
public market for our securities may not develop or be
sustained.
Prior to this offering, you could not buy or sell our securities
publicly. If an active public market for our securities does not
develop after this offering, the market price of our securities
may fall below their initial public offering price, and the
liquidity of your investment may be significantly limited.
The initial public offering price of our units may not
accurately reflect their future market performance.
The initial public offering price of the units has been
determined based on negotiations between the underwriters
representative and us. The initial public offering price may not
be indicative of future market
8
The price of our securities may be volatile, which may
lead to losses by investors.
The stock market has recently experienced significant price and
volume fluctuations. You may not be able to resell our
securities at or above the initial public offering price. The
price of our securities may fluctuate significantly in response
to a number of factors, including:
Volatility in the market price of our securities could lead to
claims against us. Defending these claims could result in
significant litigation costs and a diversion of our
managements attention and resources.
Future sales of our common stock by our existing
stockholders could decrease the trading price of our common
stock.
Sales of a large number of shares of our common stock in the
public markets after this offering, or the potential for such
sales, could decrease the trading price of our common stock and
could impair our ability to raise capital through future sales
of our common stock. Upon completion of this offering, there
will be 2,610,754 shares of our common stock outstanding. The
1,100,000 shares of common stock sold in this offering and the
1,100,000 shares of common stock reserved for issuance upon
exercise of the public warrants sold in this offering will be
freely tradeable without restriction or further registration
under the Securities Act of 1933, unless such shares are
purchased by our affiliates, as that term is defined
in such act. An additional 1,807,049 shares of common stock,
including shares issuable upon exercise of the
representatives warrants, may become outstanding upon
exercise or conversion of options or warrants currently
outstanding or sold in this offering, subject to various lock-up
agreements prohibiting the sale of such shares for one year
following completion of this offering.
The exercise of previously issued options and warrants may
dilute your investment in our shares and impair our ability to
obtain equity financing.
As of March 15, 2001, in addition to the 1,510,754 shares
outstanding, there were currently outstanding options to
purchase 434,322 shares of our common stock, 119,055 of which
were currently exercisable. We have reserved an additional
259,000 shares of our common stock for issuance pursuant to
options that may be granted in the future to key employees, and
others, under our 2001 Stock Option Plan. In addition, we have
issued warrants to acquire up to 52,727 shares of our common
stock. While such options and warrants are outstanding, the
holders of such securities have the opportunity to profit from a
rise in the value or market price of our common stock, and the
exercise of these options and warrants could dilute the then
book value per share of our common stock. The existence of these
options and warrants could adversely affect the terms at which
we could obtain additional equity financing. Moreover, the
holders of the options and warrants may be expected to exercise
them at a time when we could obtain equity capital on terms more
favorable than those provided by the options and warrants.
We will need to comply with federal and state securities
laws to maintain the tradeability of our securities.
We must maintain in effect the registration statement filed with
the Securities and Exchange Commission with respect to the units
and must also comply with the securities laws of a state for the
units, common stock and public warrants to be tradeable in that
state. If we do not comply with federal or
9
Certain of our directors or investors will personally
benefit from the use of the proceeds of this offering.
We will use the proceeds from this offering to repay
approximately $100,000 of unreimbursed business expenses to our
chairman and to retire the interest accrued through
March 1, 2001 on our outstanding stockholder notes. In
addition, if the over-allotment option granted to the
representative of the underwriters is exercised in full,
approximately $1.3 million in stockholder notes, including a
note issued to our chairman, will be retired. This debt matures
July 1, 2002, unless extended.
Our directors and executive officers will continue to
control us after this offering, which may lead to conflicts with
stockholders over corporate governance.
Following completion of this offering, our directors and
executive officers will beneficially own approximately 55% of
our outstanding common stock. These stockholders, acting
together, would be able to significantly influence all matters
requiring approval by our stockholders, including the election
of directors and significant corporate transactions, such as
mergers or other business combination transactions. This control
may have the effect of delaying or preventing a third party from
acquiring or merging with us. In addition, prior to the
appointment of disinterested, independent directors to our board
of directors in January 2001, certain past transactions,
including issuances of stock and options to and borrowings from
officers and directors, were not approved by two disinterested,
independent directors at the time of the transaction.
We do not intend to pay cash dividends in the foreseeable
future.
Any investors who have or anticipate any need for immediate
income from their investment should not purchase any of the
units offered hereby.
Provisions of our charter documents and Delaware law may
have anti-takeover effects that could hinder a change in our
corporate control.
Provisions of our certificate of incorporation and bylaws may
discourage, delay or prevent a merger or acquisition that a
stockholder may consider favorable. These provisions include:
Provisions of Delaware law, including provisions that prohibit
business combinations with entities holding greater than a
threshold amount of voting stock, also may discourage, delay or
prevent someone from acquiring or merging with us, which may
cause the market price of our securities to decline.
You should not rely upon our forward-looking
statements.
Some of the statements made in this prospectus discuss future
events and developments, including our future business strategy
and our ability to generate revenue, income and cash flow. In
some cases, you can identify forward-looking statements by words
or phrases such as may, will,
should, expects, plans,
anticipates, believes,
estimates, predicts,
potential, continue, our future
success depends, seek to continue, or the
negative of these words or phrases, or comparable words or
phrases. These statements are only predictions. Actual events or
results may differ materially. In evaluating these statements,
you should specifically consider various facts, including the
risks outlined under Risk Factors. These factors may
cause our actual results to differ materially from any
forward-looking statement. Although we believe that the
expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, levels of
activity, performance or achievements. We are under no duty to
update any of the forward-looking statements after the date of
this prospectus to conform these statements to actual results.
10
Our quarterly operating results;
Changes in earnings estimates by analysts and whether our
earnings meet or exceed such estimates;
Announcements of technological innovations by us or our
competitors;
Additions or departures of key personnel; and
Other events or factors that may be beyond our control.
authorizing our board of directors to issue preferred stock
without stockholder approval;
providing for a classified board of directors with staggered,
three-year terms; and
allowing written stockholder actions only by unanimous consent.
USE OF PROCEEDS
We estimate that the net proceeds from the sale of the 1,100,000
units that we are selling in this offering will be approximately
$9,080,000, or $10,532,000 if the representative exercises its
over-allotment option in full, based on an assumed public
offering price of $10.00 per unit, and after deducting the
underwriting discount, expense allowance, and estimated offering
expenses of $650,000 payable by us.
We expect to allocate the net proceeds of this offering as
follows:
The debt we intend to repay includes:
Further, if the representative exercises its over-allotment
option in full, we will repay the principal on other outstanding
stockholder notes of approximately $1.3 million which currently
mature in July 2002.
We may use the portion of the net proceeds of this offering
currently allocated to other working capital/general corporate
purposes to take advantage of early payment discounts which may
be available from our suppliers, prepay some of our capital
leases or reduce our current liabilities other than amounts
owing to related parties. Although we currently have no
agreements or commitments to do so, we may also use a portion of
the net proceeds to license or acquire new products,
technologies or intellectual property or to acquire or invest in
businesses complimentary to ours. We have no current plans or
proposals pending for any such acquisitions or investments.
Pending application of the net proceeds, we intend to invest the
net proceeds in interest-bearing, investment grade securities.
The foregoing discussion is merely an estimate based on our
current business plan. Our actual expenditures may vary
depending upon circumstances not yet known, such as the time
actually required to reach a positive cash flow or to
successfully expand the market for our products.
DIVIDEND POLICY
We have never declared or paid any cash dividends on our shares
of common stock and do not anticipate paying any cash dividends
in the foreseeable future. Currently, we intend to retain any
future earnings for use in the operation and expansion of our
business. Any future decision to pay cash dividends
11
12
Approximate
Approximate
Amount
Percentage
$
100,000
1
%
300,000
3
612,000
7
190,000
2
2,200,000
24
3,000,000
33
750,000
8
750,000
8
1,178,000
14
$
9,080,000
100
%
a $99,794 note at an interest rate of 10% payable to Phillips
Smith, our chairman and a stockholder, for unreimbursed business
expenses;
$300,400 of accrued interest on notes payable to Bruce Culver, a
director and stockholder, and Phillips Smith;
$611,500 of notes and accrued interest at interest rates ranging
from 11% to 18%, payable to an unrelated private lender; and
a $189,980 note at an interest rate of 10% payable to a
third-party vendor.
CAPITALIZATION
The following table sets forth our capitalization at
December 31, 2000 on an actual basis and on a pro forma
basis, after giving effect to our reincorporation in Delaware,
our related 1-for-6 reverse stock split, and the sale of
1,100,000 units offered hereby at an estimated price of $10.00
per unit and the proposed application of the estimated net
proceeds therefrom. This table should be read in conjunction
with, and is qualified by, the financial statements and notes
thereto included elsewhere in this prospectus.
13
December 31, 2000
Actual
Pro Forma
(dollars in thousands)
$
100
$
125
300
190
268
$
983
$
$
2,822
$
2,822
3,190
5,543
(80
)
(80
)
(6,727
)
(3,617
)
5,463
$
(795
)
$
8,285
(1)
Subsequent to December 31, 2000, an unrelated private
lender loaned us $500,000, which is due to be repaid, with
accrued interest, from proceeds from this offering upon its
closing or by July 1, 2002, whichever is earlier.
(2)
Does not include (i) 434,322 shares of common stock
issuable upon exercise of stock options issued pursuant to our
stock option plans, which have a weighted average exercise price
of $5.96 per share, (ii) an additional 52,727 shares of
common stock issuable upon exercise of warrants outstanding,
which have a weighted average exercise price of $4.71,
(iii) the shares of common stock exercisable upon exercise
of the public warrants, and (iv) the shares of common stock
underlying the units issuable upon exercise of the
representatives over-allotment option or the
representatives warrants.
(3)
Our accumulated deficit, which was $6.7 million at
December 31, 2000, was reclassified into additional paid-in
capital upon the termination of our S-corporation tax status in
the first quarter of 2001.
DILUTION
If you invest in our units, your interest will be diluted to the
extent of the difference between the public offering price per
share of our common stock and the as adjusted net tangible book
value per share of our common stock after this offering. For
purposes of the dilution computation and the following tables,
we have allocated the full purchase price of a unit to the share
of common stock included in the unit and nothing to the warrant
included in the unit. As of December 31, 2000, our net
tangible book value was a negative $3,617,215, or a deficiency
of $2.39 per share of common stock. Net tangible book value per
share represents the amount of our total tangible assets reduced
by the amount of our total liabilities, divided by the total
number of shares of common stock outstanding. Dilution in net
tangible book value per share represents the difference between
the amount per share paid by the purchasers of our units in this
offering and the net tangible book value per share of our common
stock immediately afterwards. Without taking into effect any
changes in the net tangible book value after December 31,
2000, other than to give effect to the sale of 1,100,000 units
in this offering at the assumed initial public offering price of
$10.00 per unit and the application of the net proceeds of this
offering, the net tangible book value of TASER as of
December 31, 2000 would have been $5,462,785, or $2.09 per
share. This represents an immediate increase of $4.48 per share
of common stock to existing stockholders and an immediate
dilution of $7.91 per share of common stock to the new investors
who purchase units in this offering. The following table
illustrates this per share dilution:
The following table summarizes as of December 31, 2000 the
differences between the existing stockholders and the new
investors with respect to the number of shares of common stock
purchased, the total consideration paid, and the average price
per share paid:
The above computations assume no exercise of outstanding options
or warrants to purchase common stock, the representatives
over-allotment option, the public warrants included in units
sold in this offering or the representatives warrants. If
the representatives over-allotment option is exercised in
full, dilution per share to new investors would be $7.51 per
share of common stock.
14
$
10.00
$
(2.39
)
$
4.48
$
2.09
$
7.91
Shares Purchased
Total Consideration
Average Price
Number
Percent
Amount
Percent
Per Share
1,510,754
58
%
$
3,189,548
22
%
$
2.11
1,100,000
42
%
11,000,000
78
%
$
10.00
2,610,754
100
%
$
14,189,548
100
%
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION
The following discussion of our financial condition and
results of operations should be read in conjunction with the
financial statements and related notes to the financial
statements included elsewhere in this prospectus. This
discussion contains forward-looking statements that relate to
future events or our future financial performance. These
statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of
activity, performance or achievements to be materially different
from any future results, levels of activity, performance or
achievements expressed or implied by these forward-looking
statements. These risks and other factors include, among others,
those listed under Risk Factors and those included
elsewhere in this prospectus.
Overview
We began operations in Arizona in 1993 for the purpose of
developing and manufacturing less-lethal self-defense devices.
From inception until the introduction of our first product, the
AIR TASER, in 1994, we were in the development stage and focused
our efforts on product development, raising capital, hiring key
employees and developing marketing materials to promote our
product line.
In 1995 and 1996, we focused our efforts on promoting retail
sales and establishing distribution channels for the AIR TASER
product line. However, our marketing efforts were limited by a
non-compete agreement prohibiting the company from marketing or
selling our products to the U.S. law enforcement and military
markets. Accordingly, initial sales of the AIR TASER were
limited to the consumer market. While early sales in this market
were promising, by the end of 1996 we were unable to establish
consistent sales channels in the consumer marketplace and sales
declined. In late 1996, we relocated our production facilities
to Mexico to reduce production costs.
In 1997, we introduced our second product line, the AUTO TASER.
The initial market response to the AUTO TASER suggested the
demand for this product would more than compensate for the
declining AIR TASER sales. Because of strong pressure from
pre-production orders, we accelerated the development of the
AUTO TASER. As a result of this acceleration, production costs
of the AUTO TASER far exceeded initial projections, and we
experienced a substantial amount of AUTO TASER returns due to
product defects.
The non-compete agreement that had precluded sales to the law
enforcement and military markets expired in 1998. During this
year, we focused our development efforts on the ADVANCED TASER
product line, a redesigned and enhanced version of the AIR
TASER, targeted primarily to the U.S. law enforcement and
corrections market. During 1998, in addition to $66,000 paid to
outside research and development consultants, we also incurred
substantial internal unallocated expenses associated with the
development of the ADVANCED TASER. Further, end-user sales of
the AUTO TASER continued to decline, and product returns
remained higher than expectations.
In August 1999, the AUTO TASER product line was
discontinued and we closed our production facility in Mexico. We
sold all remaining finished goods associated with the AUTO TASER
product line by the end of the first quarter of 2000. Following
closure of our Mexican facility, we outsourced the production of
the AIR TASER and certain non-proprietary assemblies to a
third-party assembler. We shifted our focus to completion of the
ADVANCED TASER development project and introduced the first
ADVANCED TASER units for sale to law enforcement customers in
December 1999. As a result of these activities and product
development expenses, we had accumulated a deficit of $6.3
million by December 31, 1999.
The first full year of the ADVANCED TASER product line sales was
2000. We spent the year focusing on building the distribution
channel for marketing the product line and developing a
nationwide training campaign to introduce the product line to
law enforcement agencies, primarily in North America.
In the first quarter of 2001, we discontinued the outsourcing of
the final assembly of our products and moved such final assembly
to our facility in Scottsdale, Arizona. As a result of this
change, we anticipate
15
Results of Operations
Years ended December 31, 1999 and
2000
The following table shows the percentage of total revenues
represented by selected items included in our statements of
operations:
Net sales.
Net sales increased $1.2 million, or 54.5%,
from $2.2 million for the year ended December 31, 1999 to
$3.4 million for the year ended December 31, 2000. The
increase was due almost entirely to the first full year of sales
of the ADVANCED TASER, primarily to law enforcement agencies.
The increase in sales was partially offset by the decline in
AUTO TASER sales due to the discontinuation of this product line
and somewhat lower sales of the AIR TASER to consumers.
For the years ended December 31, 1999 and 2000, sales by
product line were as follows:
Cost of products sold.
Cost of products sold decreased
from $2.1 million in 1999, or 94.5% of net sales, to $1.8
million in 2000, or 53.9% of net sales. The decrease in cost of
products sold as a percentage of net sales was due primarily to
the lower direct production costs associated with the AIR and
ADVANCED TASERs, which averaged 29.8% of gross sales as compared
to 59.8% of gross sales for the AUTO TASER, and a one-time
charge related to the phase out of the AUTO TASER product line
of approximately $355,000 in 1999 included in indirect
manufacturing expense. In 2001, we anticipate our cost of
products sold will decrease as a percentage of net sales due to
lower labor costs, greater labor productivity, lower materials
cost and greater operating control, all in connection with the
transfer of our product assembly operations from Mexico to the
United States.
For the two years ended December 31, 2000, our principal
product costs included the following:
16
In 2001, our product cost structure will be significantly
different than in 1999 and 2000 primarily due to the
discontinuation of our use of our contract assembler.
Specifically, our cost of direct materials will include only the
cost of components and supplies required to manufacture our
finished goods. Our direct labor and manufacturing costs will
continue to be allocated to cost of products sold, but should be
lower than in 2000 due to the consolidation of our product
manufacturing and assembly operations at our new facility in
Scottsdale, Arizona.
Gross margin.
Gross margin increased $1.5 million, or
1211.8%, from $120,000 in 1999 to $1.6 million in 2000. Our
gross profit margin was 5.4% of net sales in 1999 compared to
46.1% in 2000 due to increased sales of higher margin ADVANCED
TASER products and the one-time write off of $355,000 taken in
1999 as a result of the phase out of the AUTO TASER. We
anticipate our gross margin will increase to approximately 60%
of net sales in 2001 primarily due to increased sales of higher
margin ADVANCED TASER products, partially offset by relocation
costs associated with the transfer of our product assembly
operations from Mexico to the United States.
Sales, general and administrative expenses.
Sales,
general and administrative expenses increased by $171,000, or
11.9%, from $1.4 million in 1999 to $1.6 million in 2000. Sales,
general and administrative expenses were 65.3% of net sales in
1999 compared to 47.3% of net sales in 2000. These costs
increased to support the sales of the ADVANCED TASER and include
sales commissions and product demonstration costs. However,
sales, general and administrative expenses declined as a
percentage of sales in 2000 due to the fixed nature of certain
of these costs and increased gross margins attributable to the
ADVANCED TASER product line.
Interest expense.
Interest expense increased by $79,000,
or 28.4%, from $280,000 in 1999 to $359,000 in 2000. The
increase reflects the cost of the higher level of related party
debt in 2000 over 1999, primarily used to fund working capital.
In addition, we issued warrants and options in 2000 valued at
$26,880 to certain stockholders in return for providing loans to
us.
Corporate tax status.
Prior to our reincorporation in
Delaware in February 2001, we were an S-corporation, which
allowed all the tax attributes to flow through to the
stockholders. In February 2001, we changed our tax
reporting status to that of a C-corporation. When we changed our
reporting status, our accumulated shareholder deficit was
converted to additional paid-in capital. As a result, there are
also no net operating loss carry forwards available to us.
Net loss.
Our net loss decreased $1.3 million, or 75.6%,
from $1.7 million in 1999 to $406,000 in 2000. Basic and diluted
net loss per common share was $0.54 in 1999 compared to $0.16 in
2000. The reduced net loss in 2000 resulted primarily from
increased sales volume and increased gross margins attributable
to sales of the ADVANCED TASER line.
17
Liquidity and Capital Resources
We have sustained significant operating losses since our
inception. In 1999 and 2000, we financed our operations through
advances from and investments by major stockholders, and bank
financing guaranteed by major stockholders.
Liquidity.
We had a working capital deficiency of $2.4
million at December 31, 1999 and $1.0 million at
December 31, 2000. The improvement in working capital from
1999 to 2000 was largely due to the extension of short-term
related party debt in 1999 to long-term debt in 2000. In both
1999 and 2000, cash was used primarily to fund operating losses
and for investment in property and equipment.
In 2000 we generated cash from operations of $75,000, primarily
as a result of a significant customer deposit of $440,000
received in December 2000. In 1999, operations consumed
$704,000 in cash. We have not historically generated sufficient
cash from operations to fund future growth or to repay our
long-term debt that principally comes due July 1, 2002.
However, we anticipate that our cash flow from operations will
be at least break-even in 2001 because we expect our sales will
increase and our cost of products sold will decrease as a
percentage of our total revenues, generating both positive cash
flow and net income. We believe that, with anticipated cash flow
from operations for 2001 and the completion of this offering,
our cash resources will be adequate to meet our expected future
liquidity needs for approximately the next two years.
Capital resources.
We have funded our operating deficits
primarily through loans from two major stockholders, Phillips
Smith and Bruce Culver. Our indebtedness to these stockholders
totaled $2.9 million at December 31, 2000. The majority of
this debt matures in July 2002 and bears interest at a rate
of 10%.
In the event this offering is not completed, we have an
agreement with Messrs. Smith and Culver whereby we may
extend the maturity date of their outstanding notes for a period
not to exceed 24 months. We also may retire the debt at any
time without penalty. In addition, Mr. Culver has
established a non-revocable letter of credit in the amount of
$500,000 on our behalf through December 31, 2001 that we
can use to fund any shortfalls in our monthly capital
requirements until we can make other financing arrangements.
Subsequent to December 31, 2000, an unrelated private
lender loaned us $500,000 to fund working capital. The related
promissory note carries interest at 18% and matures at the
earlier of the completion of this offering or July 2002. In
return for his loan, we granted him 5,000 ten-year warrants with
an exercise price of $10 per share. The fair value of these
warrants is approximately $9,600.
Capital commitments.
At December 31, 2000, we had no
material commitments for capital expenditures. Other commitments
include rental payments under operating leases for office space
and equipment, and commitments under employment contracts with
our chief executive officer, president, and chief financial
officer.
18
Year Ended
December 31,
1999
2000
100
%
100
%
45.3
%
39.6
%
49.2
%
14.3
%
94.5
%
53.9
%
5.4
%
46.1
%
65.3
%
47.3
%
2.9.
%
0.2
%
(62.8
)%
(1.4
)%
12.7
%
10.5
%
(75.5
)%
(11.9
)%
Product Line
1999
%
2000
%
$
80,000
4
%
$
2,099,000
62
%
1,311,000
59
%
1,241,000
36
%
601,000
27
%
24,000
1
%
216,000
10
%
49,000
1
%
$
2,208,000
100
%
$
3,413,000
100
%
Direct materials: For the first eight months of 1999, direct
materials included raw materials as well as supplies used in
production. From September 1999 through February 2001,
direct materials
included our purchase price of finished goods from our contract
manufacturer and raw materials. Direct materials represented the
majority of our direct manufacturing expense.
Direct labor: Direct labor represented the expenses incurred in
our Scottsdale, Arizona facility for the assembly and packaging
of sub-assemblies. Once finished, these sub-assemblies were
transferred to our contract manufacturer for insertion into our
finished products. In the first eight months of 1999, direct
labor included wages paid to employees in our Mexican production
facility.
Shipping expense: Shipping expense included those costs
associated with shipping finished products to our customers.
These costs included freight paid to ship orders, special
handling charges and related transaction fees.
Indirect manufacturing expense: Indirect manufacturing expense
included the indirect costs associated with producing our
products, such as rent on production facilities, depreciation on
production equipment and tooling, engineering and support
salaries and other indirect manufacturing costs.
BUSINESS
Company overview
We develop, assemble and market less-lethal, conducted energy
weapons primarily for use in the law enforcement and corrections
market. Over 400 police departments in the United States have
made initial purchases of our products and 15 police
departments, including San Diego, Sacramento, and Albuquerque,
have purchased our products for every patrol officer. As of
February 1, 2001, more than 200 additional police
departments were evaluating our newest product, the ADVANCED
TASER.
We sell two principal products. We introduced the AIR TASER in
1994 and targeted it primarily at the consumer market. We
designed the AIR TASER to look like a cellular telephone or
other consumer electronic item, rather than a weapon. The terms
of an agreement we signed with Electronic Medical Laboratories,
Inc., doing business as Tasertron, the original licensee of a
patent on certain technology used in our weapons, precluded us
from selling our products to United States law enforcement,
corrections and military agencies until February 1998.
After expiration of this agreement, we introduced the ADVANCED
TASER, an upgraded and redesigned version of the AIR TASER, to
appeal to the law enforcement and corrections market. It uses
the same basic operating principle as the AIR TASER but produces
four times the AIR TASERs power output. It is also
pistol-shaped to make it easier for police officers to use. The
ADVANCED TASER can be sold with an integrated laser sight and a
built-in memory option to record the time and date of up to 585
firings. We believe the ADVANCED TASER will also appeal to the
private security, military and consumer markets, and intend to
pursue sales in these markets after further penetrating the law
enforcement and corrections market.
Industry background
The market for less-lethal weapons includes law enforcement
agencies, correctional facilities, military agencies, private
security guard companies and retail consumers. We believe law
enforcement officials are the opinion leaders regarding market
acceptance of new security products. In recent years, successful
new security products such as the GLOCK handgun and
the Mag-Lite flashlight were first marketed to and
accepted by police departments. We therefore focus on the law
enforcement agency segment of the market for less-lethal weapons.
Generally, each police force has a use-of-force policy that
dictates the level of force its officers can use to respond to
various situations. A police officer is trained to use only the
minimum force necessary to overcome the threat of injury or
violence posed by a suspect. For example, under most policies,
an officer may not use lethal force unless a subject poses a
threat of significant bodily injury or fatality to the officer
or other persons.
In fact, most police officers never deploy lethal force in the
course of their careers. While the vast majority of law
enforcement officers around the world are armed with firearms,
only a small percentage will actually ever use them. Many police
officers, however, must use less-lethal force on a regular
basis. Less-lethal force can range from a control hold to the
use of a baton, chemical spray, or other means to control a
subject that is actively resisting the officer.
Police officers are often injured while trying to subdue a
suspect with less-lethal force. Traditional tactics such as
using a baton or fist to control a suspect result not only in a
significant risk of injury to the suspect, but also a
significant risk that the officer will be injured. If an officer
can subdue a suspect from a safe distance using effective
less-lethal weapons, he greatly reduces the probability that he
or the suspect, as well as bystanders, will be injured during a
confrontation.
A variety of new less-lethal weapons have been developed to
address the need to temporarily incapacitate an attacker without
causing permanent injury or fatality. These weapons vary in
approach, but generally include stun guns, batons and clubs,
chemical sprays, rubber bullets, pepper balls and other impact
munitions. Each weapon has distinct advantages and
disadvantages, and law enforcement agencies
19
The ADVANCED TASER solution
All our products are designed to perform well in terms of the
above characteristics. We believe the ADVANCED TASER, however,
offers the best combination of these characteristics currently
available in a less-lethal weapon. This superior performance
could make the ADVANCED TASER the less-lethal weapon of choice
in many situations for law enforcement agencies and other
security services.
Most less-lethal weapons rely upon a pain response for effect. A
less-lethal weapon that inflicts only pain may not stop the most
dangerous and aggressive suspects. The ADVANCED TASER is
designed to cause complete yet temporary physical
incapacitation, not just discomfort or distraction. In police
testing and field use, the ADVANCED TASER has incapacitated even
highly focused individuals who have demonstrated the ability to
fight through other less-lethal weapons that rely only on pain.
Batons and chemical sprays can only be used from close
distances, usually less than five feet. Rubber bullets, beanbag
rounds, and similar less-lethal impact weapons must be used at
distances greater than 30 feet to minimize suspects
injuries. Therefore, we believe that other less-lethal weapons
as a group are generally ineffective between five and thirty
feet. The ADVANCED TASER is designed to operate within this
range. Since it is equally effective at very close range, we
believe the ADVANCED TASER represents a more versatile
less-lethal weapon for encounters taking place within 21 feet.
In tests involving over 1,000 human volunteers and in hundreds
of field applications, the ADVANCED TASER has had no reported
long-term, adverse after-effects. In field uses, our technology
has been found to have a comparable or lower risk of injury to
officers and suspects than other less-lethal technologies.
Further, the recovery time from an application of the ADVANCED
TASER is generally less than one minute. In contrast, recovery
time from the application of chemical sprays can range from ten
minutes to one hour. Recovery time from the effect of impact
rounds can vary from hours to weeks, depending on bruising and
bone breakage.
The ADVANCED TASER is shaped and designed to function like a
standard handgun. Accordingly, it is easy for law enforcement
officers to use during stressful situations, since their
firearms training familiarizes them with the muscle movements
required for its operation. It can be reloaded and fired again
as quickly as a spent cartridge can be removed and a replacement
cartridge inserted, typically in less than five seconds.
Further, the weapon requires no maintenance other than a
periodic battery check. The ADVANCED TASER also does not leave
contaminating residues, unlike chemical sprays that may
contaminate buildings, vehicles or other closed facilities or
officer uniforms.
20
The ADVANCED TASER operates effectively under a variety of
unfavorable conditions, such as wind and rain, that render
chemical sprays less effective. The ADVANCED TASER housing is
constructed of high tensile-strength polycarbonate to withstand
the rigors of typical police use.
The ADVANCED TASER incorporates features designed to reduce
inappropriate use. Our cartridges contain numerous confetti-like
Anti-Felon Identification tags, or AFIDs, which are scattered
when the unit is fired. AFID tags recovered from usage sites can
thus help identify the owner of the cartridge used. The ADVANCED
TASER we market to law enforcement and corrections agencies also
comes with a data port that records the exact time, date and
duration of up to 585 firings.
The ADVANCED TASER is sold to law enforcement agencies for
approximately $400 per unit. The air cartridge ammunition is
priced under $18 per shot. These prices are competitive with
impact munitions and most other specialized less-lethal weapons,
with the exception of the least expensive chemical sprays.
However, the indirect costs of decontaminating buildings,
vehicles, and uniforms resulting from the use of chemical sprays
can place the ADVANCED TASER at an overall cost advantage per
use.
In addition, litigation costs for law enforcement agencies can
be significant. Reducing the number of injuries and fatalities
caused by law enforcement officers may reduce the number of
suits filed against agencies for excessive use of force,
wrongful death and injury. Further, reducing officer injuries
minimizes medical claims and lost time for work-related injuries.
As with other less-lethal weapons, these characteristics,
particularly safety, may also have the benefit of increasing
goodwill between law enforcement agencies and their communities.
Community relations considerations can be particularly important
at a time when almost any interaction with police can be
videotaped and scrutinized by the media and the public.
Our strategy
Key elements of our strategy for growth include the following:
Our goal is to make the ADVANCED TASER the dominant less-lethal
weapon for use by law enforcement and corrections agencies. Law
enforcement officials are often viewed as experts with regard to
weapons and other security products. As a result, we believe
that widespread acceptance of the ADVANCED TASER in this market
will enhance its credibility and represent a necessary first
step toward expanding sales of our products in additional
markets.
After increasing our presence in the law enforcement and
corrections market, we intend to expand our penetration in the
private security, military and consumer self-defense markets. We
believe the same performance characteristics that will enable
our products to succeed in the law enforcement and corrections
market will also appeal to potential customers in these
additional markets.
We intend to improve our less-lethal weapons technology to
provide further growth and market opportunities. Among other
things, we intend to develop multiple shot capability and
greater effective range. These innovations may increase our
revenues by allowing us to sell upgraded less-lethal weapons and
accessories, both to existing and potential new customers.
21
We may acquire businesses that will complement our growth
strategy and enhance our competitive position in our markets.
However, we have no current plans for such acquisitions.
Markets
Law enforcement and corrections
Federal, state and local law enforcement agencies in the United
States currently represent the primary target market for the
ADVANCED TASER. According to United States Bureau of Justice
statistics, there were nearly 19,000 of these agencies in the
United States in 1996 that employed about 740,000 full-time,
sworn law enforcement officers. In 1995, industry analysts
estimated that the total number of non-administrative
correctional officers in the United States was approximately
450,000.
Acceptance of the ADVANCED TASER by United States police
departments has been fairly rapid since its introduction in
December 1999. We believe it could prove equally suitable
for use in correctional facilities. The ADVANCED TASER is
particularly useful in these confined and crowded settings since
it provides a means of bringing virtually any individual under
control without requiring the use of lethal force. We anticipate
that some correctional officers will be armed with ADVANCED
TASERs, particularly as its performance attributes become more
familiar to the wider law enforcement community.
In the law enforcement market, over 400 police departments have
made initial purchases of the ADVANCED TASER for testing or
deployment. In addition, 15 police departments, including San
Diego, Sacramento, and Albuquerque, purchased enough of our
weapons to issue one to each of their patrol officers.
Private security firms and guard
services
A report of the Security Industry Association for 1999-2000
estimated that there were over 1.7 million privately employed
security guards or personnel in the United States. They
represent a broad range of individuals, including bodyguards,
commercial and government building security guards, commercial
money carrier employees, and many others. We believe that
security personnel armed with ADVANCED TASERs could be as
effective in many circumstances as those armed with conventional
firearms. At the same time, arming guards with ADVANCED TASERs
may reduce the potential liability of private security companies
and personnel.
A number of environments can prove problematic for the use of
conventional firearms. The use of conventional firearms in
airplanes, for example, poses a significant threat to the
integrity of the aircraft and the safety of the passengers.
Conventional firearms may also be inappropriate in subways,
buses, transit systems, banks and casinos. In many of these
crowded environments, the contamination associated with the use
of chemical sprays could also pose significant problems.
One large private security force overseas has ordered over 1,000
ADVANCED TASERs for delivery in Spring 2001. We are in the early
stage of pursuing additional opportunities for sales of the
ADVANCED TASER in private security markets, and have made only
limited sales to date.
Consumer/personal protection
In the late 1990s, industry sources estimated that 30-35 million
Americans owned handguns. We believe these handgun owners
represent one segment of a potentially large consumer market for
our products.
As a result of our shift in focus, the share of our sales made
to consumer markets fell sharply from 1999 to 2000. In 1999,
sales to consumers represented 88% of total sales while these
sales dropped to only 32% of total sales in 2000. We expect the
relative share of sales to consumer markets to remain small in
the next few years. Given the size of the potential consumer
market, however, we believe consumer sales
22
Military
Military police forces may use the ADVANCED TASER for purposes
similar to those of civilian police units. Military
peace-keeping forces also perform policing functions, and the
ADVANCED TASER may prove an effective tool for these operations.
The ADVANCED TASER may also be used by armed forces to reduce
the possibility of civilian casualties resulting from combat
operations on battlefields consisting of both civilians and
combatants. We have yet to pursue sales opportunities in the
military market.
Products
Our weapons use compressed nitrogen to shoot two small
electrified probes up to a maximum distance of 21 feet. The
probes and compressed nitrogen are stored in a replaceable
cartridge attached to the base of the weapon. Our proprietary
replacement cartridges are sold separately.
After firing, the probes discharged from our cartridges remain
connected to the weapon by high-voltage insulated wires that
transmit electrical pulses into the target. These electrical
pulses, which we call TASER-Waves or T-Waves, are transmitted
through the bodys nerves in a manner similar to the
transmission of signals used by the brain to communicate with
the body. The T-Waves temporarily overwhelm the normal
electrical signals within the bodys nerve fibers,
impairing subjects ability to control their bodies or
perform coordinated actions. T-Waves can penetrate up to two
inches of clothing and up to a class 3 bullet resistant
vest. The initial effect lasts up to five seconds and the charge
can be repeated for up to approximately ten minutes by
repeatedly firing the weapon.
Since all our weapons use the same cartridges, we can support
multiple platforms and still achieve economies of scale in
cartridge production. Our cartridges contain numerous colored,
confetti-like tags bearing the cartridges serial number.
These tags, referred to as Anti-Felon Identification tags, or
AFIDs, are scattered when one of our weapons is fired. We
require sellers of our products to participate in the AFID
program by registering buyers of our cartridges. In many cases,
we can use AFIDs to identify the registered owner of cartridges
fired.
We introduced our initial product, the AIR TASER, in 1994. We
designed the AIR TASER to look like a cellular telephone rather
than a weapon to target the consumer electronics market.
Currently, the AIR TASER product line consists of the AIR TASER,
a cartridge that shoots two small electrified probes up to
15 feet, an optional laser sight, and a number of
holstering accessories. We continue to target the AIR TASER line
to the consumer market.
We developed the ADVANCED TASER product line, launched in
December 1999, primarily for the law enforcement and
corrections market. The ADVANCED TASER M26 is our primary
product in this market and is sold exclusively to law
enforcement and corrections agencies. The ADVANCED
TASER M26 offers the following improvements over the AIR
TASER:
Our products are sold primarily through our network of
distributors at a wide range of prices. Our most inexpensive
consumer product is the entry-level consumer AIR TASER, with a
retail price of $99.
23
In addition to weapons and cartridges, we sell holsters,
attachments, cases and other accessories that complement our
core products. Although to date these accessories have generated
limited sales, they offer additional revenue opportunities and
attractive margins.
We offer a lifetime warranty on the AIR TASER. Under this
warranty, we will replace any AIR TASER that fails to operate
properly for a $25 fee. The AIR TASER is designed to disable an
attacker for up to 30 seconds, and we encourage users to leave
the unit and flee after firing it. As a result, we also provide
free replacement units to consumers who follow this suggested
procedure. To qualify for the replacement unit, users must file
a police report that describes the incident and confirms the use
of the AIR TASER. Historically, approximately 2% of the AIR
TASERs sold by us have been returned by end users in connection
with a warranty claim. Warranty costs under the AIR TASER
replacement policy have been minimal to date.
We offer a no-questions-asked lifetime replacement policy on the
ADVANCED TASER. If the weapon fails to operate properly for any
reason, we will replace it for a fee of $25. The fee is intended
to help defray the handling and repair costs associated with
product returns. This policy is attractive to our law
enforcement and corrections agency customers. In particular, it
avoids disputes regarding the source or cause of any defect. Due
to our recent introduction of the ADVANCED TASER, we have
created a reserve for product returns based on a 7% return rate.
In 2000, we recalled a series of ADVANCED TASERs due to a
defective component in connection with which we incurred
expenses of approximately $9,000 and recorded an additional
charge of approximately $41,000 to account for related future
expenses.
Sales and marketing
Law enforcement and corrections agencies represent our primary
target market. In this market, the decision to purchase the
ADVANCED TASER is normally made by a group of people including
the agency head, his training staff, and weapons experts. The
decision sometimes involves political decision-makers such as
city council members. The decision-making process can take as
little as a few weeks or as long as several years.
United States distribution.
With the exception of several
accounts to which we sell directly, the vast majority of our law
enforcement agency sales in the United States occur through our
network of more than 25 independent regional police equipment
distributors. To service these distributors and assist us in
expanding sales to new ones, we retain two manufacturers
representatives that call on potential distributors. We
compensate our manufacturers representatives solely on a
commission basis, calculated as a percentage of the sales they
complete. Sales in the consumer market are made through
different independent distributors, dealers, and retailers. We
provide our distributors with performance-based incentive
programs.
International distribution.
As a result of our shift in
focus to the United States law enforcement and corrections
market, our international sales efforts are currently limited to
presentations and training seminars conducted by TASER
personnel. We recently began introducing the ADVANCED TASER in
Europe and parts of the Middle East, South America and Asia, but
have yet to devote significant resources to these markets. Sales
outside the United States and Canada accounted for 48% and 18%
of total revenues in 1999 and 2000, respectively. In 2001, we
expect international sales to account for approximately 10% of
our total sales.
We have worked in the past with more than 20 foreign
distributors. These foreign distributors purchase products from
us and resell them to sub-distributors, retail dealers or end
users. We continue to provide most foreign distributors with
short-term exclusive contracts to sell our products in a
designated region. Although many of these relationships are
inactive, we continue to ship products as ordered.
24
Training Programs.
Most law enforcement and corrections
agencies will not purchase new weapons until a training program
is in place to certify all officers in their proper use. We
offer an eight-hour class that certifies law enforcement and
corrections agency trainers as instructors in the use of the
ADVANCED TASER. We have certified over 2,500 law enforcement
training officers as ADVANCED TASER instructors. Our
certification program is designed to make it easier for
departments to comply with these training requirements.
Fifty of our certified instructors have undergone further
training and become certified as master instructors. We
authorize these individuals to train other law enforcement and
corrections agency trainers, not just end-users within these
organizations. Twenty-five of our master instructors have agreed
to conduct ADVANCED TASER training classes on a regular basis.
These instructors independently organize and promote their own
training sessions, and we provide them with logistical support.
They are independent professional trainers, serve as local area
TASER experts, and assist our distributors in conducting TASER
demonstrations at other police departments within their regions.
Through the end of 2000, we did not charge for attendance at
these classes but now charge $195 per attendee. We pay master
instructors a per-session training fee and a share of the
attendance fees collected at each session that they conduct.
These training sessions have led directly to the sale of
ADVANCED TASERs to a number of police departments.
Communications.
In addition to our training programs, we
regularly participate in a variety of trade shows and
conferences. Our marketing efforts also benefit from significant
free news coverage. Other marketing communications include video
e-mails, press releases, and conventional print advertising in
law enforcement trade publications. Our website also contains
similar marketing information.
Manufacturing
After a review of our operating costs and changes in regulations
pertaining to the export of the technology used to produce our
weapons, we elected to move our final assembly operations from
our subcontractor in Guaymas, Mexico to our new facility in
Scottsdale, Arizona. We own all of the production equipment used
for the final assembly of our products in the Guaymas facility,
and expect to reinstall it in Scottsdale no later than
April 2001. We currently assemble the compressed nitrogen
containers used inside our air cartridges in our Scottsdale
facility.
Our Scottsdale facility has approximately 6,000 square feet of
assembly and warehouse space. We plan to employ between 15 and
25 assembly personnel by the end of 2001. After the move, our
production capabilities will support the assembly of 2,000
ADVANCED TASERs, 1,000 AIR TASERs, and 24,000 cartridges per
month on a single shift. We can expand our production
capabilities by adding additional personnel and a second shift
with negligible new investment in tooling and equipment. We
expect our Scottsdale facility and tooling to be sufficient to
support our current growth projections at least through 2003.
We currently purchase finished circuit boards and
injection-molded plastic components from third-party suppliers
located in Phoenix. Although we currently obtain these
components from single source suppliers, we own the
injection-molded component tooling used in their production. As
a result, we believe we could obtain alternative suppliers
without incurring significant production delays. We acquire most
of our components on a purchase order basis and do not have
long-term contracts with suppliers. We believe that our
relations with our suppliers are good.
Competition
In the law enforcement and corrections market, the ADVANCED
TASER competes directly with the conducted energy weapon sold by
Electronic Medical Research Laboratories, Inc., doing business
as Tasertron. Tasertron is the sole remaining manufacturer of
the original TASER weapon introduced in the 1970s. The ADVANCED
TASER also competes indirectly with a variety of other less
lethal alternatives. In the consumer market, the AIR TASER
competes directly with a conducted energy weapon introduced by
Bestex, Inc. in 1996, called the Dual-Defense, and indirectly
with other less-lethal alternatives.
25
Law enforcement and corrections market.
Tasertron had an
exclusive license to sell TASER products in the North American
law enforcement and corrections market until February 1998.
Compared to the Tasertron unit, our ADVANCED TASER offers
reduced size, additional power, and a more convenient
pistol-shaped design. We believe agencies choosing to employ a
conducted energy weapon will prefer to adopt a single weapon
system. Since its introduction, the ADVANCED TASER has competed
successfully against the Tasertron unit, even in agencies that
had previously purchased Tasertron units.
Other less-lethal weapons, sold by companies such as Armor
Holdings, Inc. and Jaycor, Inc., compete with our ADVANCED TASER
indirectly. Many law enforcement and corrections personnel
consider less-lethal weapons to be distinct tools, each
best-suited to a particular set of circumstances. Consistent
with this tool kit approach, purchasing any given tool does not
preclude the purchase of one or several more. In other cases,
budgetary considerations and limited space on officers
belts dictate that only a limited number of less-lethal weapons
will be purchased and carried. We believe the ADVANCED
TASERs versatility, effectiveness, and low injury rate
enable it to compete effectively against other less-lethal
alternatives.
Consumer market.
Conducted energy weapons have gained
limited acceptance in the consumer market for less-lethal
weapons. These weapons compete with other less-lethal weapons
such as stun guns, batons and clubs, and chemical sprays. The
primary competitive factors in the consumer market include a
weapons cost, its effectiveness, and its ease of use. The
widespread adoption of the ADVANCED TASER by law enforcement
agencies may help us overcome a perceived historic lack of
consumer confidence in conducted energy weapons.
Regulation
United States regulation.
The AIR TASER and ADVANCED
TASER are subject to the same regulations. Neither weapon is
considered a firearm by the Bureau of Alcohol,
Tobacco, and Firearms. Therefore, no firearms-related
regulations apply to the sale and distribution of our weapons
within the United States. In the 1980s, however, many states
introduced regulations restricting the sale and use of stun
guns, inexpensive hand-held shock devices. We believe existing
stun gun regulations also apply to our weapon systems.
In many cases, the law enforcement and corrections market is
subject to different regulations than the consumer market. Where
different regulations exist, we assume the regulations affecting
the consumer market also apply to the private security market
except as the applicable regulations otherwise specifically
provide. Based on a review of current regulations, we have
determined the following states regulate the sale and use of our
weapon systems:
26
The following cities and counties also regulate our weapon
systems:
United States export regulation.
Our weapon systems are
considered a crime control product by the United States
Department of Commerce. Accordingly, the export of our weapon
systems is regulated under export administration regulations. As
a result, we must obtain export licenses from the Department of
Commerce for all shipments to foreign countries other than
Canada. Most of our requests for export licenses have been
granted, and the need to obtain these licenses has not caused a
material delay in our shipments. The need to obtain licenses,
however, has limited or impeded our ability to ship to certain
foreign markets. In addition, export regulations prohibit the
further shipment of our products from foreign markets in which
we hold an export license for the products to foreign markets in
which we do not hold an export license for the products.
In addition, in the fall of 2000, the Department of Commerce
introduced new regulations restricting the export of the
technology used in our weapon systems. These regulations apply
to both the technology incorporated in our weapon systems and in
the processes used to produce them. The technology export
regulations do not apply to production that takes place within
the United States. After moving our final assembly to our
Scottsdale facility, these technology export regulations will no
longer apply to us but will still apply to certain of our
suppliers located outside of the United States.
Foreign regulation.
Foreign regulations are numerous and
often unclear. We prefer to work with an exclusive distributor
who is familiar with applicable regulations in each of our
foreign markets. Experience with foreign distributors in the
past indicates that restrictions may prohibit certain sales of
our products in a number of countries. The countries in which we
are aware of restrictions include Belgium, Denmark, Hong Kong,
Italy, Japan, New Zealand, Norway, Sweden, Switzerland, and the
United Kingdom. In Australia, Canada, and India, we are also
aware that sales of our products are permitted to law
enforcement and corrections agencies but prohibited to consumers.
Intellectual property
We protect our intellectual property with a variety of patents
and trademarks. In addition, we use confidentiality agreements
with employees and some suppliers to ensure the safety of our
trade secrets. We hold a United States patent on the
construction of the gas cylinder used to store the compressed
nitrogen in our cartridges. This patent expires in 2015. We and
two other companies are the only licensees for use in electronic
weapons of the technology described in a United States patent
held by John H. Cover, Jr. The licenses held by the other
licensees may not be transferred and their rights under the
licenses may not be expanded or modified without our approval.
Mr. Covers patent covers the process by which
compressed gases launch the probes in our cartridges and expires
in 2009. Using this compressed gas technology instead of
gunpowder prevents our products from being classified as
firearms by the Bureau of Alcohol, Tobacco and Firearms. We also
have a broad-based patent application pending covering the
energy wave form we developed for the ADVANCED TASER.
We own the AIR TASER and TASER registered trademarks. We also
have several unregistered trademarks.
27
In late February 2001, we received notice from a patent
licensee with regard to alleged infringement of a patent by us
related to the firing mechanism for our weapons. Although we
believe we do not infringe this patent, we have discussed
resolution of this claim with the licensee and may elect to
arbitrate the dispute. The licensee has not specified the
damages it seeks in connection with the claim.
Research and development
Our research and development initiatives are led by our internal
personnel and make use of specialized consultants when
necessary. These initiatives include bio-medical research as
well as electrical and mechanical engineering design. Future
development projects will focus on reducing the size, extending
the range, and improving the functionality of our weapons. Total
research and development expenditures were $64,000 in 1999 and
$7,100 in 2000.
Employees
As of December 31, 2000, we had 16 full-time employees. Six
employees were involved in sales, marketing and training. Two
were employed in research, development and engineering. We also
employed four administrative personnel and four in production
support. Our employees are not covered by any collective
bargaining agreement, and we have never experienced a work
stoppage. We believe that our relations with our employees are
good.
Facilities
We conduct our operations from a modern 11,800-square-foot
facility located in Scottsdale, Arizona. The monthly rent for
this facility is approximately $11,000. Our lease expires on
January 1, 2006. We believe this facility will meet our
needs for the next three years and that additional space will be
available on reasonable terms upon the expiration of our current
lease or if we require additional space.
Legal proceedings
In February 2000, a distributor of our products from late
1997 through early 2000 sued us in the United States District
Court, Southern District of New York. The former distributor
claims the exclusive right to sell our products to many of the
largest law enforcement, corrections, and military agencies in
the United States. He seeks monetary damages in the aggregate
amount of $400 million against us and certain of our officers
allegedly arising in connection with his service to us as a
distributor on theories of our failure to pay commissions,
breach of contract, interference with contract, and on related
theories. We signed no contracts with this former distributor.
We also believe that he has no reasonable basis for claims to
informal or implied contractual rights. As a result, we believe
his claims are without merit, and the litigation will have no
material adverse affect on our business, operating results or
financial condition. The former distributors suit was
dismissed in February 2001 for lack of personal
jurisdiction of the New York court. In March 2001, he
appealed the dismissal.
Corporate information
We were incorporated in Arizona in September 1993 as ICER
Corporation. We changed our name to AIR TASER, Inc. in
December 1993, and to TASER International, Incorporated in
April 1998. In February 2001, we reincorporated in
Delaware as TASER International, Inc.
28
Effectiveness: temporary incapacitation of aggressive
suspects;
Range: variable distance over which the weapon is
effective;
Safety: low risk of injury or death;
Ease of use: simple operation, low maintenance and no
contamination;
Dependability: reliability in many environments, product
durability;
Accountability: tracking to reduce misuse of the weapon;
and
Cost: low cost per use and possible reduction of litigation
expense.
Effectiveness
Range
Safety
Ease of Use
Dependability
Accountability
Cost
Fully exploit the expanding law enforcement and corrections
market
.
Expand into private security, military, and consumer
markets
.
Develop enhanced less-lethal weapon technologies
.
Acquire businesses that enhance our strategic position
.
Increased effectiveness: the ADVANCED TASER has four times the
power of the AIR TASER and has proven effective in
incapacitating over 99% of volunteers tested.
Better accountability: the ADVANCED TASERs memory system
records the time, date, and duration of up to 585 firings. By
downloading this information periodically, law enforcement and
corrections agencies can track every use of the ADVANCED TASER.
These agencies can use this data to investigate potential misuse.
Ease of use: the ADVANCED TASERs familiar pistol shape and
integrated laser sight minimize the training required for law
enforcement and corrections officers and make it easier to use.
State
Law Enforcement Use
Consumer Use
Legal
Legal, subject to restrictions
Legal
Legal, subject to restrictions
Prohibited
Prohibited
Legal
Legal, subject to restrictions
Legal
Legal, subject to restrictions
Legal
Prohibited
Prohibited (except for evaluation)
Prohibited
Prohibited
Prohibited
Legal
Prohibited
Legal
Legal, subject to restrictions
Legal
Legal, subject to restrictions
Prohibited
Prohibited
Legal
Legal, subject to restrictions
Legal
Prohibited
City
Law Enforcement Use
Consumer Use
Legal
Prohibited
Legal
Prohibited
Legal
Prohibited
Legal
Prohibited
Legal
Legal, subject to restrictions
Legal
Prohibited
Legal
Prohibited
Legal
Prohibited
MANAGEMENT
Directors and executive officers
Our directors and executive officers are as follows:
Phillips W. Smith
is the chairman of our board of
directors. Dr. Smith has served as a director since 1993.
Since January 1999, Dr. Smith has served on the board of
directors of Pentawave, Inc., a developer of cross-media
publishing software. From June 1991 to September 1997,
Dr. Smith served as the president and chief executive
officer of Zycad Corporation, a developer of engineering and
manufacturing applications software. Dr. Smith holds a
B.S.E. degree from West Point, an M.B.A. degree from Michigan
State University, and a Ph.D. in Business Administration from
St. Louis University.
Patrick W. Smith
is the chief executive officer and a
co-founder of TASER. Mr. Smith has served as our chief
executive officer and as a director since 1993. Mr. Smith
holds a B.S. degree in Biology and Neurobiology from Harvard
University, an M.B.A. degree from the University of Chicago, and
a Masters Degree in International Finance from the University of
Leuven in Leuven, Belgium.
Thomas P. Smith
is the president and a co-founder of
TASER. Mr. Smith has served as our president since April
1994 and as a director since 1993. Mr. Smith holds a B.S.
degree in Ecology and Evolutionary Biology from the University
of Arizona and an M.B.A. degree from Northern Arizona University.
Bruce R. Culver
has served as a director of TASER since
January 1994. Mr. Culver co-founded Professional Staff,
P.L.C., a human resource management company, and has served on
its board of directors since April 1990. In March 1993,
Mr. Culver organized and has since remained the chief
executive officer of Culver Distributions, Inc., doing business
as California Distribution Company, providing warehouse and
distribution services to internet companies. Since April 1997,
Mr. Culver has served on the board of Pentawave, Inc.,
becoming its chairman in October 2000.
Matthew R. McBrady
has served as a director of TASER
since January 2001. From August 1998 though July 1999,
Mr. McBrady served as a member of the staff of President
Clintons Council of Economic Advisers. In December 1997,
Mr. McBrady began working as a financial and analytical
consultant for Avenue A, Inc, an internet marketing company, and
served as its vice president of analytics from June 1999 through
October 1999. Mr. McBrady taught corporate finance
courses at the University of Southern California during the
summer terms of 1997 and 1998, at Harvard College from September
1996 through May 1997, and at Harvard Business School during the
spring term of 1998. Mr. McBrady holds a B.S. in Economics
from Harvard University, an M.S. in International Economics from
Oxford University, and expects to receive a Ph.D. in Corporate
and International Finance from Harvard University in June 2001.
Karl F. Walter
has served as a director of TASER since
January 2001. Mr. Walter was a co-founder of Glock, Inc., a
subsidiary of GLOCK GmbH, an Austrian semi-automatic pistols
manufacturer. From January 1994 through February 1997,
Mr. Walter worked as a director of law enforcement sales
for Sturm Ruger Co., a firearms manufacturer. Since March 1997,
Mr. Walter has worked as the program manager for AV
Technology International, LLC, a builder of armored vehicles.
29
Kathleen C. Hanrahan
is our chief financial officer,
serving in that position since November 2000. Ms. Hanrahan
first joined TASER in January 1996 as an internal controls
consultant and became our controller in March 1996.
Our certificate of incorporation provides that we have no less
than three and no more than nine directors divided into three
classes (Class 1, Class 2, and Class 3), with
members of each class serving for staggered three-year terms. As
a result, only one class of directors will be elected at each
annual meeting of our stockholders, with the other classes
continuing for the remainder of their respective three-year
terms. Messrs. Phillips Smith and Bruce Culver have been
designated as Class 1 directors, whose term expires at the
2001 annual meeting; Messrs. Patrick Smith and Karl Walter
have been designated as Class 2 directors, whose term
expires at the 2002 annual meeting; and Messrs. Thomas
Smith and Matthew McBrady have been designated as Class 3
directors, whose term expires at the 2003 annual meeting.
Each officer serves at the discretion of our board of directors.
No officer is subject to an agreement that requires the officer
to serve TASER for a specified number of years. Mr. Thomas
Smith and Mr. Patrick Smith are Dr. Phillips
Smiths sons. No other family relationships exist among our
directors and executive officers.
Director compensation
Prior to 2001, directors were not compensated for their service
on the board. Beginning in 2001, independent directors will
receive $1,250 per quarter. In addition, in December 2000,
Messrs. McBrady and Walter each received options to
purchase 6,667 shares vesting ratably over four years at an
exercise price of $3.30 per share. Directors are also reimbursed
for expenses incurred in connection with attendance at meetings.
Committees of the board of directors
Our board of directors has an Audit Committee consisting of
Mr. McBrady and Mr. Walter, and a Compensation
Committee consisting of Mr. Culver and Mr. Walter. The
Audit Committee meets with management and our independent public
accountants to determine the adequacy of our internal controls
and other financial reporting matters. The Compensation
Committee reviews and recommends to the board of directors the
compensation and benefits of our officers, reviews general
policy matters relating to compensation and benefits of our
employees and administers the issuance of stock options and
discretionary cash bonuses to our officers, employees, directors
and consultants. We intend to appoint only independent directors
to the Audit and Compensation Committees.
Executive compensation
The following table sets forth information regarding
compensation awarded to, earned by or paid to our chief
executive officer for all services rendered to us during 1998,
1999 and 2000. None of our executive officers earned in excess
of $100,000 in 2000.
Summary Compensation Table
Option grants in last fiscal year
We did not grant any options to our chief executive officer
during the year ended December 31, 2000.
30
Fiscal year end option values
The following table sets forth information regarding the number
and value of unexercised options held by our chief executive
officer on December 31, 2000. He did not exercise any
options to purchase common stock during 2000.
Stock option plans
We have two stock option plans: the 1999 stock option plan and
the 2001 stock option plan.
The 1999 stock option plan authorized us to issue options to
purchase up to 833,333 shares of our common stock. Under this
plan, we have issued options to purchase 143,322 shares at $0.22
to $7.20 per share, including 10,000 options to Patrick W.
Smith. We will issue no further options under the plan. The plan
is administered by our board of directors. Subject to the
provisions of this plan, the board determines who will receive
options, the number of options granted, the manner of exercise
and the exercise price of the options. The term of incentive
stock options granted under the plan may not exceed ten years,
or five years for options granted to an optionee owning more
than 10% of our voting stock. The exercise price of an incentive
stock option granted under this plan must be equal to or greater
than the fair market value of the shares of our common stock on
the date the option is granted. The exercise price of a
non-qualified option granted under this plan must be equal to or
greater than 85% of the fair market value of the shares of our
common stock on the date the option is granted. An incentive
stock option granted to an optionee owning more than 10% of our
voting stock must have an exercise price equal to or greater
than 110% of the fair market value of our common stock on the
date the option is granted.
The 2001 stock option plan authorizes us to issue options to
purchase up to 550,000 shares of our common stock. Under this
plan, we have granted options to purchase 291,000 shares at an
exercise price equal or greater than the value of the common
stock portion of the initial per unit public offering price in
this offering, including 60,000 options to Patrick W. Smith. The
plan is administered by our board of directors. Subject to the
provisions of this plan, the board determines who will receive
options, the number of options granted, the manner of exercise
and the exercise price of the options. The term of incentive
stock options granted under the plan may not exceed ten years,
or five years for incentive stock options granted to an optionee
owning more than 10% of our voting stock. The exercise price of
an incentive stock option granted under this plan must be equal
to or greater than the fair market value of the shares of our
common stock on the date the option is granted. The exercise
price of a non-qualified option granted under this plan must be
equal to or greater than 85% of the fair market value of the
shares of our common stock on the date the option is granted. An
incentive stock option granted to an optionee owning more than
10% of our voting stock must have an exercise price equal to or
greater than 110% of the fair market value of our common stock
on the date the option is granted.
Employment agreements
In July 1998, we entered into an employment agreement with
Patrick W. Smith pursuant to which he agreed to serve as our
chief executive officer. The agreement is for an initial
three-year term ending June 30, 2001, and is automatically
renewed for a two-year term on such date and every two years
thereafter unless we give Mr. Smith one-year prior notice
of termination, if the termination is without cause. The
agreement provides for annual base compensation in the amount of
$65,000, which amount may be increased based on performance. In
2000, Mr. Smiths salary was increased to $90,000. We
may terminate this agreement with or without cause. Should we
terminate the agreement without cause, upon a
31
CERTAIN TRANSACTIONS
In 1998, Mr. Bruce R. Culver, a director of TASER, loaned
us $622,525. In March 1998, $150,000 of such amount was
converted into 20,833 shares of our common stock at an estimated
value of $7.20 per share. In December 1998, we issued
Mr. Culver a promissory note for $472,525, the remaining
amount due. The note bears interest at a rate of 10% per year
and matures July 1, 2002.
In 1999, Mr. Culver loaned us $1,500,000. In return, in
April 1999, we issued him a promissory note for $500,000 at an
effective interest rate of 27.1% per year to mature
October 31, 2000, and 1,666,667 shares of our common stock
at a price of $0.60 per share. These shares were subject to a
repurchase agreement between Mr. Culver and us that allowed
us to repurchase the shares if we met certain operating
performance criteria. We met the criteria and repurchased the
shares from Mr. Culver in July 2000 in exchange for a
promissory note in the amount of $1,000,000. We consolidated
this note and the April 1999 note into a new note for $1,500,000
which carries interest at bank prime, which was 9.5% at
December 31, 2000, plus 1%. This note matures July 1,
2002. In March 1999, Mr. Culver loaned us $100,000,
and in July 1999, Mr. Culver loaned us $50,000. The related
notes carry interest at a rate of 10% and mature July 2002. In
May 2000, Mr. Culver loaned us an additional $200,000 at an
interest rate of 10%, due July 1, 2002. We have used all
amounts loaned to us by Mr. Culver to fund our working
capital needs. As of December 31, 2000, the aggregate
principal amount due to Mr. Culver under these notes was
$2,322,525 plus accrued interest of $140,794. Under certain
circumstances, Mr. Culver has agreed to extend the maturity of
these notes.
In September 1999, we sold Mr. Culver 151,515 shares of our
common stock for $3.30 per share for an aggregate purchase price
of $500,000.
In July 2000, we issued Mr. Culver a warrant to purchase
22,727 shares of our common stock at a price of $3.30 per share
in connection with his provision of a $1,500,000 loan to us in
such month. These warrants expire July 31, 2005.
In 1998, Mr. Phillips W. Smith, our chairman, loaned us
$725,691 to fund our working capital needs. In March 1998,
$150,000 was converted into 20,833 shares of common stock at an
estimated fair value of $7.20 per share and $120,000 was repaid.
In December 1998, we issued a promissory note for $455,691, the
remaining amount due. The note bears interest at a rate of 10%
per year and matures July 1, 2002. Further, Mr. Smith
has deferred expenses in the amount of $99,794, which has been
formalized in a note bearing 10% interest, which matured
December 31, 2000. Under certain circumstances,
Mr. Smith has agreed to extend the maturity of these notes.
As of December 31, 2000, the aggregate principal amount due
to Mr. Smith under these notes was $555,485 plus accrued
interest of $119,045.
In the event this offering is not completed, we have an
agreement with Mr. Smith and Mr. Culver whereby we may
extend the maturity date of their outstanding notes for a period
not to exceed 24 months. We may retire the debt at any time
without penalty. In addition, Mr. Culver has established a
non-revocable letter of credit in the amount of $500,000 on our
behalf that we may use to fund any shortfalls in monthly working
capital requirements until we can make other financing
arrangements, and provided us a related letter of support.
In 1999, Mr. Smith worked as a full-time advisor to us and
was compensated solely by a five-year option on 16,667 shares of
our common stock with an exercise price of $0.66 per share.
In July 1999, Malcolm W. Sherman, a stockholder, loaned us
$75,000 to acquire production equipment. The related note
carries interest at 9.18% and matures July 1, 2001. In May
2000, we issued Mr. Sherman an option to purchase 3,333
shares of our common stock at an exercise price of $0.22 per
share in connection with his continuing provision of services to
us following his retirement as a full-time employee and in
consideration of his provision of the loan.
32
Our board of directors has approved all transactions that we
have entered into with related parties. However, until January
2001, we did not have any disinterested, independent directors
serving on our board of directors. Consequently, none of our
related party transactions effected prior to such date were
approved by disinterested, independent directors at the time of
the transaction. Our two disinterested, independent directors
have since determined that our related party transactions that
were entered into prior to such date and continue in effect,
including the outstanding loans from Messrs. Culver and Smith to
us, are on terms no less favorable to us than we could obtain
from unaffiliated parties, and have ratified these transactions.
We derived no revenue from related party transactions during the
fiscal year ended December 31, 2000.
On an ongoing basis, all related party transactions will be
reviewed by our board of directors. It is the policy of our
board of directors that all proposed transactions by us with our
directors, officers, five-percent stockholders and their
affiliates, including forgiveness of any loan from us to any
such person, be entered into or approved only if such
transactions are on terms no less favorable to us than we could
obtain from unaffiliated parties, are reasonably expected to
benefit us and are approved by a majority of the disinterested,
independent members of our Board of Directors. Such independent
directors are authorized to consult with independent legal
counsel at our expense in determining whether to approve any
such transaction.
33
Name
Age
Position
63
30
33
55
30
54
37
Annual Compensation
Long Term Compensation
Securities Underlying Options
Name and Principal Position
Year
Salary
Bonus
(#)
2000
$
65,208
$
2,500
1999
$
49,161
10,000
1998
$
43,205
Number of Securities
Value of Unexercised In-the-
Underlying Options at Fiscal
Money Options at Fiscal
Year End(#)
Year End($)(1)
Name
Exercisable
Unexercisable
Exercisable
Unexercisable
6,672
3,328
$
46,895
$
26,505
(1)
Based on the estimated fair value of our common stock as of
December 31, 2000, determined by our board of directors to
be $8.00 per share.
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information regarding the beneficial ownership of our common stock as of March 15, 2001, and as adjusted to reflect the sale of 1,100,000 units in this offering, by:
| each person or group of affiliated persons known to be the beneficial owner of more than 5% of our outstanding common stock; | |
| each of our directors; | |
| our chief executive officer; and | |
| all of our directors and executive officers as a group. |
As of such date, there were 1,510,754 shares of common stock outstanding before giving effect to the sale of units in this offering. We believe that, except as otherwise described below, each named beneficial owner has sole voting and investment power with respect to the shares listed.
Number of | Percentage | Percentage | ||||||||||
Shares | Beneficially | Beneficially | ||||||||||
Beneficially | Owned Before | Owned After | ||||||||||
Name of Beneficial Owner | Owned | This Offering | This Offering | |||||||||
|
|
|
|
|||||||||
Phillips W. Smith(1)
|
388,943 | 25.4 | % | 14.8 | % | |||||||
Patrick W. Smith(2)
|
363,118 | 23.8 | % | 13.8 | % | |||||||
Bruce R. Culver(3)
|
491,146 | 31.9 | % | 18.6 | % | |||||||
Thomas P. Smith(4)
|
219,208 | 14.4 | % | 8.6 | % | |||||||
Malcolm W. Sherman(5)
|
123,796 | 8.2 | % | 4.7 | % | |||||||
Karl F. Walter(6)
|
417 | * | * | |||||||||
Matthew R. McBrady(7)
|
417 | * | * | |||||||||
All directors and executive officers as a group (7
persons)(8)
|
1,478,921 | 92.1 | % | 54.7 | % |
The address of each person identified in this table is c/o 7860 East McClain Drive, Suite 2, Scottsdale, Arizona 85260.
As of March 15, 2001, we had nine stockholders.
(1) | Includes 21,297 shares subject to options or warrants that are exercisable within 60 days. |
(2) | Includes 12,784 shares subject to options that are exercisable within 60 days. |
(3) | Includes 31,061 shares subject to warrants that are exercisable within 60 days. |
(4) | Includes 12,784 shares subject to options that are exercisable within 60 days. |
(5) | Includes 3,333 shares subject to options that are exercisable within 60 days. |
(6) | Includes 417 shares subject to options that are exercisable within 60 days. |
(7) | Includes 417 shares subject to options that are exercisable within 60 days. |
(8) | Includes 94,432 shares subject to options or warrants that are exercisable within 60 days. |
34
DESCRIPTION OF SECURITIES
Upon completion of the offering, our authorized capital stock
will consist of 50,000,000 shares of common stock, $0.00001 par
value, and 25,000,000 shares of preferred stock, $0.00001 par
value, of which there will be 2,610,754 shares of common stock
and no shares of preferred stock outstanding. Our certificate of
incorporation and bylaws provide further information about our
capital stock.
Units
Each unit consists of one share of common stock and one public
warrant to purchase one additional share of common stock. The
common stock and warrants will trade only as a unit for at least
30 days following this offering. The representative of the
underwriters will then determine when the units separate, after
which the common stock and the public warrants will trade
separately.
Common stock
Holders of our common stock are entitled to one vote for each
share on all matters submitted to a stockholder vote and may not
cumulate their votes. Holders of common stock are entitled to
share in all dividends that the board of directors, in its
discretion, declares from legally available funds. In the event
of our liquidation, dissolution or winding up, each outstanding
share entitles its holder to participate pro rata in all assets
that remain after payment of liabilities and after providing for
each class of stock, if any, having preference over the common
stock.
Holders of our common stock have no conversion, preemptive or
other subscription rights, and there are no redemption
provisions applicable to our common stock. The rights of the
holders of common stock are subject to any rights that may be
fixed for holders of preferred stock. All outstanding shares of
common stock are, and the shares underlying all options and
public warrants will be, duly authorized, validly issued, fully
paid and non-assessable upon our issuance of these shares.
Preferred stock
Our certificate of incorporation provides for the issuance of up
to 25,000,000 shares of preferred stock. As of the date of this
prospectus, there are no outstanding shares of preferred stock.
Subject to certain limitations prescribed by law and the rights
and preferences of the preferred stock, our board of directors
is authorized, without further stockholder approval, from
time-to-time to issue up to an aggregate of 25,000,000 shares of
our preferred stock, in one or more additional series. Each new
series of preferred stock may have different rights and
preferences that may be established by our board of directors. A
majority of our disinterested, independent directors must
approve any issuance by us of our preferred stock.
The rights and preferences of future series of preferred stock
may include:
35
Public warrants
General
Each public warrant entitles the holder to purchase one share of
our common stock at an exercise price per share of 150% of the
initial public offering price of the units. The exercise price
is subject to adjustment upon the occurrence of certain events
as provided in the public warrant certificate and summarized
below. Our public warrants may be exercised at any time during
the period commencing 30 days after this offering and
ending on the fifth anniversary date of the closing of this
offering, which is the expiration date. Those of our public
warrants which have not previously been exercised will expire on
the expiration date. A public warrant holder will not be deemed
to be a holder of the underlying common stock for any purpose
until the public warrant has been properly exercised.
Separate transferability
Our public warrants will trade only as a unit for a period of at
least 30 days following this offering. The representative of the
underwriters will then determine when the units separate, after
which the common stock and the public warrants will trade
separately. The representative intends to separate the units
30 days after this offering absent unforeseen
circumstances. We will announce in advance the separation of the
units by a public press release. Upon separation, unit holders
will receive certificates for the common stock and public
warrants in exchange for their unit certificates.
Redemption
We have the right, commencing three months after the closing of
this offering, to redeem the public warrants issued in this
offering at a redemption price of $0.25 per public warrant after
providing 30 days prior written notice to the public
warrant holders, if the average closing bid price of the common
stock equals or exceeds 200% of the initial public offering
price of the units for ten consecutive trading days ending prior
to the date of the notice of redemption. We will send the
written notice of redemption by first class mail to public
warrant holders at their last known addresses appearing on the
registration records maintained by the transfer agent for our
public warrants. No other form of notice or publication or
otherwise will be required. If we call the public warrants for
redemption, they will be exercisable until the close of business
on the business day next preceding the specified redemption date.
Exercise
A public warrant holder may exercise our public warrants only if
an appropriate registration statement is then in effect with the
Securities and Exchange Commission and if the shares of common
stock underlying our public warrants are qualified for sale
under the securities laws of the state in which the holder
resides.
Our public warrants may be exercised by delivering to our
transfer agent the applicable public warrant certificate on or
prior to the expiration date or the redemption date, as
applicable, with the form on the reverse side of the certificate
executed as indicated, accompanied by payment of the full
exercise price for the number of public warrants being
exercised. Fractional shares will not be issued upon exercise of
our public warrants.
Adjustments of exercise price
The exercise price is subject to adjustment if we declare any
stock dividend to stockholders or effect any split or reverse
split with respect to our common stock. Therefore, if we effect
any stock split or reverse split with respect to our common
stock, the exercise price in effect immediately prior to such
stock split or reverse split will be proportionately reduced or
increased, respectively. Any adjustment of the exercise price
will also result in an adjustment of the number of shares
purchasable upon exercise of a public warrant or, if we elect,
an adjustment of the number of public warrants outstanding.
36
Prior warrants
As of the date of this prospectus, we had issued and outstanding
warrants to purchase 52,727 shares of our common stock at a
weighted average exercise price of $4.71, the forms of which
have been filed as exhibits to the registration statement of
which this prospectus is a part.
Registration rights
All holders of registration rights contained in agreements with
us have waived such rights in connection with this offering. In
connection with this offering, we have granted Paulson
Investment Company, Inc., representative of the underwriters of
this offering, warrants to purchase shares of our common stock.
These representatives warrants, as well as the shares of
common stock and warrants included in the units issuable upon
exercise of the representatives warrants, are being
registered on the registration statement of which this
prospectus is a part. We will cause the registration statement
to remain effective until the earlier of the time that all of
the representatives warrants have been exercised and the
date which is five years after the effective date of this
offering. The common stock and warrants issued to the
representative upon exercise of these warrants will be freely
tradeable. We will bear all expenses incurred in connection with
the registration of the shares of common stock and warrants
included in the units issuable upon the exercise of the
representatives warrants.
Federal income tax considerations
The following discussion sets forth the material federal income
tax consequences, under current law, relating to the purchase
and sale of the units and the underlying common stock and
warrants. The discussion is a summary and does not deal with all
aspects of federal taxation that may be applicable to an
investor. It does not consider specific facts and circumstances
that may be relevant to a particular investors tax
position. Some holders, such as dealers in securities, insurance
companies, tax exempt organizations, foreign persons and those
holding common stock or warrants as part of a straddle or hedge
transaction, may be subject to special rules that are not
addressed in this discussion. This discussion is based only on
current provisions of the Internal Revenue Code of 1986, as
amended, and on administrative and judicial interpretations as
of the date of this prospectus, all of which are subject to
change. You should consult your own tax advisor as to the
specific tax consequences to you of this offering, including the
applicability of federal, state, local and foreign tax laws.
Allocation of Purchase Price
Each unit as a whole will have a tax basis equal to the cost of
the unit. The measure of income or loss from some of the
transactions described below depends on the tax basis in each of
the warrant and the share of common stock comprising the unit.
We have allocated the purchase price between the warrant and the
common stock so that the tax basis for the warrant will be equal
to 20% of the price of the unit and the tax basis for the common
stock will be equal to 80% of the price of the unit. If you
disagree with the allocation, please see your tax advisor for
advice on how to notify the Internal Revenue Service that you
disagree with the allocation and claim a different basis.
Exercise or Sale of Warrants
No gain or loss will be recognized by a holder of a warrant on
the purchase of shares of common stock for cash on an exercise
of a warrant, except that gain will be recognized to the extent
cash is received in the place of fractional shares. The tax
basis of common stock received upon exercise of a warrant will
equal the sum of the tax basis of the exercised warrant and the
exercise price. The holding period of the common stock acquired
will begin on the date the warrant is exercised. It does not
include the period during which the warrant was held.
Gain or loss from the sale or other disposition of a warrant
will be capital gain or loss to its holder if the common stock
to which the warrant relates would have been a capital asset in
the holders hands. This capital gain or loss will be
long-term capital gain or loss if the holder has held the
warrant for more than
37
Sale of Common Stock
A holder who sells common stock other than in connection with a
tax free reorganization of involving us will recognize gain or
loss in an amount equal to the difference between the amount
realized and the holders tax basis in the common stock.
Generally, the holders tax basis in the common stock will
equal the portion of the unit price that was allocable to the
common stock. If the common stock is a capital asset in the
holders hands, gain or loss upon the sale of the common
stock will be a long-term or short-term capital gain or loss,
depending on whether the common stock has been held for more
than one year. Individuals generally have a maximum federal
income tax of 20% on long-term capital gains. The deduction of
capital losses is subject to limitations.
Expiration of Warrants Without Exercise
If a holder of a warrant allows it to expire or lapse without
exercise, the expiration or lapse will be treated as a sale or
exchange of the warrant on the expiration date. The holder will
have a loss equal to the amount of such holders tax basis
in the lapsed warrant. If the warrant is a capital asset in the
hands of the holder, the loss will be a long-term or short-term
capital loss, depending on whether the warrant was held for more
than one year. The deduction of capital losses is subject to
limitations.
Anti-takeover provisions of our charter documents
Our certificate of incorporation and bylaws include a number of
provisions that may have the effect of delaying or preventing a
change of control of TASER:
These provisions may deter hostile takeovers or delay changes in
control of our management, which could depress the market price
of our securities.
Transfer agent and public warrant agent
The transfer agent for our common stock and public warrants is
US Stock Transfer Corporation, Glendale, California.
38
number of shares to be issued;
dividend rights and dividend rates;
right to convert the preferred stock into a different type of
security;
voting rights attributable to the preferred stock;
right to receive preferential payments upon a liquidation of the
company;
right to set aside a certain amount of assets for payments
relating to the preferred stock; and
prices to be paid upon redemption of the preferred stock.
Our board is divided into three classes, with each class serving
a three-year staggered term, so that one-third of the board is
elected each year;
The authorized number of our directors can be changed only by
resolution of the board of directors;
We can issue preferred stock without any vote or further action
by stockholders;
Any action required or permitted to be taken by our stockholders
at an annual or a special meeting is valid only if it is
properly brought before the meeting, and written stockholder
action is valid only if unanimous; and
Our bylaws limit persons who may call a special meeting of our
stockholders.
SHARES ELIGIBLE FOR FUTURE SALE
This offering
Upon completion of this offering, we expect to have 2,610,754
shares of common stock outstanding, assuming no exercise of
outstanding options or warrants, or 2,775,754 shares if the
representatives over-allotment is exercised in full. Of
these shares, the 1,100,000 shares of common stock issued as
part of the units sold in this offering will be freely tradeable
without restrictions or further registration under the
Securities Act of 1933, except that any shares purchased by our
affiliates, as that term is defined under the
Securities Act, may generally only be sold in compliance with
the limitations of Rule 144 under the Securities Act. The
1,100,000 shares of common stock underlying the public warrants
issued as part of the units sold in this offering will also be
freely tradeable after exercise of the warrants, except for
shares held by our affiliates.
Outstanding restricted stock
The 1,510,754 outstanding shares of common stock held by our
existing stockholders are restricted securities within the
meaning of Rule 144 and may not be sold in the absence of
registration under the Securities Act unless an exemption from
registration is available, including the exemption from
registration offered by Rule 144. Holders of all of our
outstanding restricted shares of common stock have agreed not to
sell or otherwise dispose of any of their shares of common stock
for a period of one year after completion of this offering,
without the prior written consent of Paulson Investment Company,
Inc., subject to certain limited exceptions. Prior to the
expiration of this lock-up period, no shares of our outstanding
restricted common stock may be sold in the public market
pursuant to Rule 144. After the expiration of this lock-up
period, or earlier with the prior written consent of Paulson
Investment Company, Inc., all 1,510,754 of these outstanding
restricted shares may be sold in the public market pursuant to
Rule 144.
In general, under Rule 144, as currently in effect,
beginning 90 days after the date of this prospectus, a
person who has beneficially owned restricted shares for at least
one year, including a person who may be deemed to be our
affiliate, may sell within any three-month period a number of
shares of common stock that does not exceed a specified maximum
number of shares. This maximum is equal to the greater of 1% of
the then outstanding shares of our common stock or the average
weekly trading volume in the common stock during the four
calendar weeks immediately preceding the sale. Sales under
Rule 144 are also subject to restrictions relating to
manner of sale, notice and availability of current public
information about us. In addition, under Rule 144(k) of the
Securities Act, a person who is not our affiliate, has not been
an affiliate of ours within three months prior to the sale and
has beneficially owned shares for at least two years would be
entitled to sell such shares immediately without regard to
volume limitations, manner of sale provisions, notice or other
requirements of Rule 144.
Preferred stock
As of March 15, 2001, we had no shares of preferred stock
outstanding.
Options
Beginning 90 days after the date of this prospectus,
certain shares issued or issuable upon the exercise of options
granted by us prior to the date of this prospectus will also be
eligible for sale in the public market pursuant to Rule 701
under the Securities Act, except that
of
these shares are subject to the lock-up agreements discussed
above. Pursuant to Rule 701, persons who purchase shares
upon exercise of options granted under a written compensatory
plan or contract may sell such shares in reliance on
Rule 144 without having to comply with the holding period
requirements of Rule 144, and in the case of
non-affiliates, without having to comply with the public
information, volume limitation or notice provisions of
Rule 144. As of March 15, 2001, we had options
outstanding to purchase 434,322 shares of common
39
We intend to file registration statements on Form S-8 under
the Securities Act to register approximately 434,322 shares of
our common stock issuable under our stock option plans. These
registration statements are expected to be filed within three to
six months after the completion of this offering. Shares of our
common stock issued upon the exercise of stock options after the
effective date of the Form S-8 registration statements will
be eligible for resale in the public market without restriction,
subject to Rule 144 limitations and the lock-up agreements
discussed above.
Warrants
As of March 15, 2001, we had warrants outstanding to
purchase 52,727 shares of common stock which have not been
exercised and which are currently exercisable. Any shares issued
upon the exercise of these warrants will be eligible for sale
pursuant to Rule 144, except that these shares are also
subject to the lock-up agreements discussed above.
Representatives warrants
In connection with this offering, we have agreed to issue to the
representative of the underwriters warrants to purchase 110,000
units. The representatives warrants will be exercisable
into units at any time during the four-year period commencing
one year after the effective date of this offering. We will
cause the registration statement to remain effective until the
earlier of the time that all of the representatives
warrants have been exercised and the date which is five years
after the effective date of this offering. The common stock and
warrants issued to the representative upon exercise of these
warrants will be freely tradeable.
40
UNDERWRITING
Paulson Investment Company, Inc. is acting as the representative
of the underwriters. We and the underwriters named below have
entered into an underwriting agreement with respect to the units
being offered. In connection with this offering and subject to
certain conditions, each of the underwriters named below has
severally agreed to purchase, and we have agreed to sell, the
number of units set forth opposite the name of each underwriter.
The underwriting agreement provides that the underwriters are
obligated to purchase all of the units offered by this
prospectus, other than those covered by the over-allotment
option, if any units are purchased. The underwriting agreement
also provides that the obligations of the several underwriters
to pay for and accept delivery of the units are subject to the
approval of certain legal matters by counsel and certain other
conditions. These conditions include the requirements that no
stop order suspending the effectiveness of the registration
statement be in effect and that no proceedings for such purpose
have been instituted or threatened by the Securities and
Exchange Commission.
The representative has advised us that the underwriters propose
to offer our units to the public initially at the offering price
set forth on the cover page of this prospectus and to selected
dealers at such price less a concession of not more than
$ per unit. The underwriters and
selected dealers may reallow a concession to other dealers,
including the underwriters, of not more than
$ per unit. After completion of the
initial public offering of the units, the offering price, the
concessions to selected dealers and the reallowance to their
dealers may be changed by the underwriters.
The underwriters have informed us that they do not expect to
confirm sales of our units offered by this prospectus to any
accounts over which they exercise discretionary authority.
Over-allotment option
Pursuant to the underwriting agreement, we have granted Paulson
Investment Company, Inc. an option, exercisable for 45 days
from the date of this prospectus, to purchase up to an
additional
units
on the same terms as the units being purchased by the
underwriters from us. Paulson Investment Company, Inc. may
exercise the option solely to cover over-allotments, if any, in
the sale of the units that the underwriters have agreed to
purchase. If the over-allotment option is exercised in full, the
total public offering price, underwriting discounts and
commissions, and proceeds to us before offering expenses will be
$ ,
$ and
$ ,
respectively.
Stabilization
Until the distribution of the units offered by this prospectus
is completed, rules of the Securities and Exchange Commission
may limit the ability of the underwriters to bid for and to
purchase units. As an exception to these rules, the underwriters
may engage in transactions that stabilize the price of the
units. Paulson Investment Company, Inc., on behalf of the
underwriters, may engage in over-allotment sales, stabilizing
transactions, syndicate covering transactions and penalty bids
in accordance with Regulation M under the Securities Exchange
Act of 1934.
41
Short sales involve the sale by the underwriters of a greater
number of shares than they are required to purchase in this
offering. Covered short sales are sales made in an amount not
greater than the representatives over-allotment option to
purchase additional shares in this offering. In determining the
source of shares to close out the covered short position, the
underwriters will consider, among other things, the price of
shares available for purchase in the open market as compared
with the price at which they may purchase shares through the
over-allotment option. Naked short sales are sales in excess of
the over-allotment option. A naked short position is more likely
to be created if the underwriters are concerned that there may
be downward pressure on the price of the shares in the open
market after pricing that could adversely affect investors who
purchase in this offering.
In general, the purchase of a security to stabilize or to reduce
a short position could cause the price of the security to be
higher than it might be otherwise. These transactions may be
effected on The Nasdaq SmallCap Market or otherwise. Neither we
nor the underwriters can predict the direction or magnitude of
any effect that the transactions described above may have on the
price of the units. In addition, neither we nor the underwriters
can represent that the underwriters will engage in these types
of transactions or that these types of transactions, once
commenced, will not be discontinued without notice.
Indemnification
The underwriting agreement provides for indemnification between
us and the underwriters against specified liabilities, including
liabilities under the Securities Act, and for contribution by us
and the underwriters to payments that may be required to be made
with respect to those liabilities. We have been advised that, in
the opinion of the Securities and Exchange Commission,
indemnification for liabilities under the Securities Act is
against public policy as expressed in the Securities Act and is
therefore unenforceable.
Underwriters compensation
We have agreed to sell the units to the underwriters at the
initial offering price of
$ ,
less the % underwriting discount.
The underwriting agreement also provides that upon the closing
of the sale of the units offered, Paulson Investment Company,
Inc. will be paid a nonaccountable expense allowance equal to
2.5 percent of the gross proceeds from the sale of the
units offered by this prospectus, including the over-allotment
option.
We have also agreed to issue warrants to the representative to
purchase from us up to
units
at an exercise price per unit equal to 120% of the offering
price per unit. These warrants are exercisable during the
four-year period beginning one year from the date of
effectiveness of the registration statement. These warrants, and
the securities underlying the warrants, are not transferable for
one year following the effective date of the registration,
except to an individual who is an officer or partner of an
underwriter, by will or by the laws of descent and distribution,
and are not redeemable. These warrants will have registration
rights. We will cause the registration statement to remain
effective until the earlier of the time that all of the
representatives warrants have been exercised and the date
which is five years after the effective date of this offering.
The common stock and warrants issued to the representative upon
exercise of these warrants will be freely tradeable.
The holders of the representatives warrants will have, in
that capacity, no voting, dividend or other stockholder rights.
Any profit realized by the representative on the sale of the
securities issuable upon exercise of the representatives
warrants may be deemed to be additional underwriting
compensation. The securities underlying the
representatives warrants are being registered on the
registration statement. During
42
Lock-up agreements
Our officers, directors and other stockholders have agreed that
for a period of one year from the date this registration
statement becomes effective that they will not sell, contract to
sell, grant any option for the sale or otherwise dispose of any
of our equity securities, or any securities convertible into or
exercisable or exchangeable for our equity securities, other
than through intra-family transfers or transfers to trusts for
estate planning purposes, without the consent of Paulson
Investment Company, Inc., as the representative of the
underwriters, which consent will not be unreasonably withheld.
Paulson Investment Company, Inc. may consent to an early release
from the one-year lock-up period if in its opinion the market
for the common stock would not be adversely impacted by such
sales and in cases of an officer, director or other
stockholders financial emergency.
Determination of offering price
Before this offering, there has been no public market for the
units and the common stock and public warrants contained in the
units. Accordingly, the initial public offering price of the
units offered by this prospectus and the exercise price of the
public warrants were determined by negotiation between us and
the underwriters. Among the factors considered in determining
the initial public offering price of the units and the exercise
price of the public warrants were:
The offering price stated on the cover page of this prospectus
should not be considered an indication of the actual value of
the units. That price is subject to change as a result of market
conditions and other factors, and we cannot assure you that the
units, or the common stock and public warrants contained in the
units, can be resold at or above the initial public offering
price.
LEGAL MATTERS
The validity of the securities being offered hereby will be
passed upon on our behalf by Tonkon Torp LLP, Portland, Oregon.
Certain legal matters will be passed upon for the underwriters
by Weiss Jensen Ellis & Howard, P.C., Portland, Oregon.
EXPERTS
The financial statements as of and for the years ended
December 31, 1999 and 2000 included in this prospectus have
been audited by Arthur Andersen LLP, independent public
accountants, as indicated in their reports with respect thereto,
and are included herein in reliance upon the authority of said
firm as experts in auditing and accounting and in giving said
reports.
43
Underwriters
Number of Units
Over-allotment involves syndicate sales in excess of the
offering size, which creates a syndicate short position.
Stabilizing transactions permit bids to purchase the underlying
security so long as the stabilizing bids do not exceed a
specified maximum.
Syndicate covering transactions involve purchases of the common
stock and public warrants in the open market after the
distribution has been completed in order to cover syndicate
short positions.
The underwriters may also elect to reduce any short position by
exercising all or part of the over-allotment option to purchase
additional units as described above.
Penalty bids permit the representative to reclaim a selling
concession from a syndicate member when the units originally
sold by the syndicate member are purchased in a syndicate
covering transaction to cover syndicate short positions.
our history and our prospects;
the industry in which we operate;
the status and development prospects for our proposed products
and services;
our past and present operating results;
the previous experience of our executive officers; and
the general condition of the securities markets at the time of
this offering.
WHERE YOU CAN FIND MORE INFORMATION
We have filed a registration statement on Form SB-2 under
the Securities Act with the Securities and Exchange Commission
with respect to the units offered hereby. This prospectus filed
as part of the registration statement does not contain all of
the information contained in the registration statement and
exhibits thereto and reference is hereby made to such omitted
information. Statements made in this registration statement are
summaries of the terms of such referenced contracts, agreements
or documents and are not necessarily complete. Reference is made
to each such exhibit for a more complete description of the
matters involved and such statements shall be deemed qualified
in their entirety by such reference. The registration statement
and the exhibits and schedules thereto filed with the Securities
and Exchange Commission may be inspected by you at the
Securities and Exchange Commissions principal office in
Washington, D.C. Copies of all or any part of the
registration statement may be obtained from the Public Reference
Section of the Securities and Exchange Commission,
450 Fifth Street, N.W., Washington, D.C. 20549,
(202) 942-8090, and at the Commissions regional
offices located at Seven World Trade Center, 13th Floor,
New York, New York 10048 and Northwestern Atrium Center,
500 West Madison Street, Suite 11400, Chicago,
Illinois 60661. The Commission also maintains a website at
http://www.sec.gov that contains reports, proxy statements and
information statements and other information regarding
registrants that file electronically with the Commission. For
further information pertaining to us and the units offered by
this prospectus, reference is made to the registration statement.
We intend to furnish our stockholders with annual reports
containing financial statements audited by our independent
public accountants.
44
TASER INTERNATIONAL, INC.
INDEX TO FINANCIAL STATEMENTS
F-1
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
To the Board of Directors of
We have audited the accompanying balance sheets of TASER
International, Inc. (an Arizona corporation) as of
December 31, 1999 and 2000, and the related statements of
operations, stockholders deficit and cash flows for each
of the two years in the period ended December 31, 2000.
These financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with auditing standards
generally accepted in the United States. Those standards require
that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the financial position
of TASER International, Inc. as of December 31, 1999 and
2000, and the results of its operations and its cash flows for
each of the two years in the period ended December 31,
2000, in conformity with accounting principles generally
accepted in the United States.
Phoenix, Arizona
F-2
TASER INTERNATIONAL, INC.
BALANCE SHEETS
The accompanying notes are an integral part of these balance
sheets.
F-3
TASER INTERNATIONAL, INC.
STATEMENTS OF OPERATIONS
The accompanying notes are an integral part of these financial
statements.
F-4
TASER INTERNATIONAL, INC.
STATEMENTS OF STOCKHOLDERS DEFICIT
The accompanying notes are an integral part of these financial
statements.
F-5
TASER INTERNATIONAL, INC.
STATEMENTS OF CASH FLOWS
The accompanying notes are an integral part of these financial
statements.
F-6
TASER INTERNATIONAL, INC.
NOTES TO FINANCIAL STATEMENTS
1. The Company
a. History and Nature of
Organization
TASER International, Inc. (TASER or the Company) was
incorporated and began operations in Arizona in 1993 for the
purpose of developing and manufacturing less-lethal,
self-defense devices. From its inception until the Company
commenced production in December 1994, the Company was in
the development stage. During the period leading up to the start
of production, the Companys activities included raising
capital, hiring key personnel and obtaining the necessary
licenses. All production costs during the period from inception
through December 31, 1995, consisting of research and
development activities and limited product manufacturing, were
expensed as incurred.
Through 1996, the Company was developing its signature product,
the AIR TASER, and establishing the marketing channels to
promote retail sales. Significant nonrecurring expenditures were
incurred, including research and development costs, the
development of marketing and sales materials, the purchase of
the licensing rights to the TASER technology and trademark, and
the relocation of the manufacturing operations to Mexico, which
resulted in significant operating losses.
In 1997, the Company introduced a new product, the AUTO TASER.
As a result of significant expenditures for research and
development, manufacturing difficulties, scrap, engineering
changes and other costs associated with the start up of this
product line, the Company continued to experience operating
losses in 1997, 1998 and 1999. This product line was
discontinued August 1, 1999.
In 1998, the Company formally changed its name from Air Taser,
Inc. to TASER International, Inc. and began development of its
ADVANCED TASER product, which was introduced for sale in
December 1999.
b. Financing
The Company has been financed primarily from advances from and
investments by major stockholders and bank financing guaranteed
by major stockholders. Since inception, the Company has
sustained significant operating losses and has, at
December 31, 2000, a deficit in working capital of
approximately $1,069,000. In addition, new capital will be
required to fund further product development, market
penetration, working capital and future operations. The Company
believes that additional financing will be available under terms
and conditions that are acceptable to it. However, there can be
no assurance that additional financing will be available.
Subsequent to year end, the Company closed a loan for $500,000
from an unrelated private lender, and management believes its
operating cash flow throughout 2001 will be positive. In
addition, in the event the Companys contemplated initial
public offering is not completed, the Company has an agreement
with two major stockholders whereby the Company may, at the
Companys sole option, extend the maturity date of the
stockholders outstanding notes for a period not to exceed
24 months. The Company may also, at the Companys sole
option, retire such debt at any time without penalty. In
addition, a major stockholder has established a non-revocable
letter of credit in the amount of $500,000 on the Companys
behalf that the Company can use to fund any shortfalls in the
Companys monthly capital requirements until it can make
other financing arrangements.
c. Initial Public Offering
The Company is contemplating an initial public
offering (IPO) of 1,100,000 shares of common stock at an
estimated price of $10 per unit, consisting of one share of
common stock and one warrant to purchase one share of common
stock (Note 11).
F-7
NOTES TO FINANCIAL STATEMENTS (Continued)
d. Reincorporation and Restatement
of Shares
In February 2001, the Company reincorporated in the State
of Delaware. In connection with the reincorporation, the Company
completed a 1-for-6 share reverse stock split. The accompanying
financial statements and footnotes have been restated for the
lower number of shares of common stock outstanding for all
periods presented.
2. Summary of Significant Accounting Policies
a. Cash and Cash Equivalents
Cash and cash equivalents include funds on hand and short-term
investments with original maturities of three months or less.
b. Inventory
Inventories are stated at the lower of cost or market; cost is
determined using the most recent acquisition cost method which
approximates the first-in, first-out (FIFO) method.
Inventories consisted of the following at December 31:
Inventory cost in 1999 and 2000 includes primarily the cost paid
to an outsourced manufacturer, which included charges for
material, labor and overhead. Indirect manufacturing charges
incurred by the Company were expensed as period costs since
finished goods levels have not been significant.
c. Property and Equipment
Property and equipment are stated at cost. Additions and
improvements are capitalized while ordinary maintenance and
repair expenditures are charged to expense as incurred.
Depreciation is calculated using the straight-line method over
the estimated useful lives of the assets.
d. Long-Lived Assets
The Company periodically evaluates the carrying value of
long-lived assets in accordance with Statement of Financial
Accounting Standards (SFAS) No. 121,
Accounting for
the Impairment of Long-Lived Assets and for Long-Lived Assets to
be Disposed of
. Under SFAS 121, long-lived assets to be
held and used in operations are reviewed for impairment whenever
events or circumstances indicate that the carrying amount of an
asset may not be fully recoverable. An impairment loss is
recognized if the sum of the expected long-term undiscounted
cash flow is less than the carrying amount of the long-lived
assets being evaluated. The Company has not recognized any
impairment losses during the two year period ended
December 31, 2000.
e. Customer Deposits
The Company requires certain deposits in advance of shipment for
foreign customer sales orders. At December 31, 2000,
customer deposits consisted primarily of one foreign customer
sales order.
F-8
NOTES TO FINANCIAL STATEMENTS (Continued)
f. Cost of Products Sold
During 2000, the Company outsourced the assembly of its finished
goods, but continued to manufacture certain small, proprietary
components internally. Prior to August 1999, all finished
goods were assembled internally. At December 31, 2000, cost
of products sold represents net amounts paid to a vendor to
acquire finished goods sold to customers and the manufacturing
costs, including material, labor and overhead related to the
proprietary components the Company manufactures internally.
Prior to August 1999, costs of products sold included the
manufacturing costs, including materials, labor and overhead
related to finished goods and components. Shipping costs
incurred related to product delivery are also included in cost
of products sold.
At December 31, 1999, included within cost of products sold
is a one-time charge related to the phase-out of the AUTO TASER
product line of approximately $355,000.
g. Revenue Recognition
The Company recognizes revenues when products are shipped and
all sales are final. The Company charges certain of its
customers shipping fees, which are recorded as a component of
net sales.
On December 3, 1999, the Securities and Exchange Commission
issued Staff Accounting Bulletin (SAB) No. 101,
Revenue Recognition in Financial Statements
, which
provides additional guidance in applying generally accepted
accounting principles for revenue recognition in financial
statements. The issuance of SAB No. 101 did not have a
material impact on the revenue recognition method of the Company.
h. Use of Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could
differ from those estimates.
i. Advertising Costs
The Company expenses the production cost of advertising as
incurred or the first time the advertising takes place. The
Company incurred advertising costs of $24,652 and $35,035 in
1999 and 2000, respectively. Advertising costs are included in
sales, general and administrative expenses in the statements of
operations.
j. Warranty Costs
The Company warrants its products from manufacturing defects for
their lives and will replace any defective units with a new one
for a $25 fee. In 2000, the Company recalled a series of
ADVANCED TASERs due to a defective component in connection with
which the Company incurred warranty expense of approximately
$9,000 and recorded an additional charge of $41,000 to cover
estimated future warranty costs based upon the number of units
sold and the estimated defect rate using its prior actual
experience.
k. Research and Development
Expenses
The Company expenses research and development costs as incurred.
The Company incurred product development expense of $64,227 and
$7,137 in 1999 and 2000, respectively.
F-9
NOTES TO FINANCIAL STATEMENTS (Continued)
l. Income Taxes
The Company, since inception, has qualified as an S corporation
under the Internal Revenue Code, and accordingly, is not
directly subject to income taxes. There is no provision or
benefit for income taxes reflected in the accompanying financial
statements, since items of taxable income and losses are
reported in the individual returns of stockholders.
Subsequent to December 31, 2000, the Company reincorporated
in the State of Delaware and elected to be taxed as a
C corporation. Net operating losses (NOLs) prior to
the change to a C corporation accrued to the individual
stockholders. Accordingly, such losses are not available to
reduce future taxes payable by the Company as a
C corporation.
Upon termination of the S status, the Company is required to
implement SFAS No. 109,
Accounting for Income
Taxes
which requires the calculation of existing
temporary differences between the financial statement carrying
amounts of existing assets and liabilities and their respective
tax bases. Management does not expect such implementation to
have a significant impact on the Company.
Had the Company been a C corporation in 1999 and 2000, no
federal or state income tax benefit would have been recorded for
the NOLs discussed above because their realizability could not
be determined as more likely than not. Accordingly, no pro forma
benefit for federal or state income taxes is recorded as if the
Company were taxed as a C corporation for any of the
periods presented. Additionally, the accumulated deficit at the
time of the S election termination will be reclassified to
additional paid-in capital.
m. Concentration of Credit Risk and
Major Customers
Financial instruments that potentially subject the Company to
concentrations of credit risk consist of accounts receivable,
accounts payable and notes payable to related parties. Sales are
typically made on credit and the Company generally does not
require collateral. The Company performs ongoing credit
evaluations of its customers financial condition and
maintains an allowance for estimated potential losses. Accounts
receivable are presented net of an allowance for doubtful
accounts. Provision for bad debts was $32,250 and $72,905 at
December 31, 1999 and 2000, respectively.
For the years ended December 31, 1999 and 2000, sales by
product were as follows:
Sales to customers outside of the United States are denominated
in U.S. dollars.
F-10
NOTES TO FINANCIAL STATEMENTS (Continued)
n. Financial Instruments
The Companys financial instruments include cash, accounts
receivable and accounts payable. Due to the short-term nature of
these instruments, the fair value of these instruments
approximates their recorded value. The Company does not have any
financial instruments with off-balance sheet risk.
The Company has notes payable to stockholders at varying terms
which, based on the short-term nature of the notes and financing
obtained from outside sources, the Company believes are stated
at their estimated fair market value.
o. Segment Information
The Company has adopted SFAS No. 131,
Disclosures About
Segments of an Enterprise and Related Information
. This
statement requires disclosure of certain information about the
Companys operating segments, products, geographic areas in
which it operates and major customers. This statement also
allows a company to aggregate similar segments for reporting
purposes. Management has determined that its operations can be
aggregated into one reportable segment. Therefore, no separate
segment disclosures have been included in the accompanying notes
to the financial statements.
p. Stock-Based Compensation
The Company measures compensation costs related to stock option
plans using the intrinsic value method and provides pro forma
disclosures of net income (loss) and earnings (loss) per common
share as if the fair value based method had been applied in
measuring compensation costs. Accordingly, compensation cost for
stock options is measured as the excess, if any, of the fair
value of the Companys common stock at the date of
measurement over the amount an employee must pay to acquire the
stock and is amortized over the vesting period, generally three
years.
q. Comprehensive Income
The Company has adopted SFAS No. 130,
Reporting
Comprehensive Income
. This statement requires that all
components of comprehensive income be reported in the financial
statements in the period in which they are recognized. During
the years ended December 31, 1999 and 2000, the Company did
not have any components of comprehensive income requiring
separate reporting in the Companys financial statements.
r. Income (Loss) Per Common Share
Income (loss) per common share is computed in accordance
with SFAS No. 128,
Earnings Per Share
. Basic income
(loss) per common share is based upon the weighted average
shares outstanding. Diluted income (loss) per common share is
based on the weighted average shares outstanding and dilutive
common stock equivalents. Approximately 144,875 and 186,049
options and warrants were not included in the computation of
diluted earnings per share for 1999 and 2000, respectively, as
their effect would be anti-dilutive.
s. Recent Accounting
Pronouncements
In June 1998, the Financial Standards Board issued SFAS
No. 133,
Accounting for Derivative Instruments and
Hedging Activities.
Under SFAS 133, all derivatives are
required to be recognized in the balance sheet at fair value.
Gains or losses from changes in fair value would be recognized
in earnings in the period of change unless the derivative is
designated as a hedging instrument. In June 1999, the
Financial Accounting Standards Board issued SFAS No. 137,
which amended SFAS 133, delaying its effective date to
fiscal years beginning after June 15, 2000. The Company
does not currently hold any
F-11
NOTES TO FINANCIAL STATEMENTS (Continued)
derivative instruments nor does it engage in hedging activities.
The Company does not believe the new standard will impact its
financial statements.
3. Property and Equipment
Property and equipment consist of the following at
December 31, 1999 and 2000:
4. Commitments and Contingencies
a. Operating Leases
The Company has entered into operating leases for office space
and equipment. Rent expense under these leases for the years
ended December 31, 1999 and 2000, was $147,655 and $93,241,
respectively. Future minimum lease payments under operating
leases as of December 31, 2000, are as follows:
b. Litigation
From time to time, the Company is involved in certain legal
actions and claims arising in the normal course of business.
Management is of the opinion that it maintains adequate
insurance and that such matters will be resolved without a
material effect on the Companys financial position or
results of operations.
In late February 2001, the Company received informal notice
from a patent licensee alleging infringement of a patent related
to the firing mechanism for our weapons. The Company believes it
has not infringed upon this patent. The Company has discussed
resolution of this claim with the licensee and may elect to
arbitrate the dispute. The Company intends to vigorously contest
the claim and management believes this matter will be resolved
without a material effect on the Companys financial
position or results from operations.
In February 2000, the Company was named a defendant in a
suit with a former distributor in the state of New York. The
suit was dismissed in February 2001 for lack of
jurisdiction of the New York court. In March 2001, the
former distributor appealed the dismissal. Management believes
this matter will be resolved without a material effect on the
Companys financial condition or results of operations.
F-12
NOTES TO FINANCIAL STATEMENTS (Continued)
c. Employment Agreements
The Company has employment agreements with its President, Chief
Executive Officer (CEO) and Chief Financial Officer (CFO).
The Company may terminate the agreements with or without cause.
Should the Company terminate the agreements without cause, upon
a change of control of the Company or death of the employee, the
President, CEO and CFO are entitled to additional compensation.
Under these circumstances, these officers may receive the
remaining amounts under the contract upon termination which
could total $510,000.
5. Income Taxes
Concurrently with the change in tax status as discussed in
Note 2, the Company will adopt the provisions of SFAS
No. 109. Under the asset and liability method of SFAS
No. 109, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases and
operating loss and tax credit carryforwards. Deferred tax assets
and liabilities are measured using enacted tax rates applied to
taxable income in the years in which those temporary differences
are expected to be recovered or settled. The effect on the
deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that includes the enactment
date.
Management believes that the following estimated deferred tax
assets and liabilities would exist at December 31, 2000, if
the date of tax status change was effective on December 31,
2000. The Company would provide a full valuation reserve for the
deferred tax asset because the Company has not sustained taxable
net income in any periods at sufficient levels to assure
realization:
6. Line of Credit
During 1999, the Company had a line of credit with a bank with a
total commitment of up to $1,500,000. The line was used to fund
the Companys working capital needs, and was personally
guaranteed by two stockholders, had an interest rate of 10% and
was secured by virtually all of the assets of the Company. At
December 31, 1998, borrowings under the line were
$1,329,600. The line matured and was paid in full on
February 15, 1999.
7. Inventory Financing Agreement
In 1995, the Company entered into an inventory financing
agreement with its warehouser. Under the agreement, the Company
had the right to sell its product to the warehouser at a stated
price up to quantities totaling the lesser of $500,000 or the
number of units sold in the last two months. The Company
repurchased the product once sold to a third party at the stated
price plus 2% per month (24% annually). In June 1998, the
agreement expired and the Company issued a $189,980 note for the
amount due. The note bears interest at 10% and is paid monthly
and matured March 31, 2000. As of December 31, 2000,
no amounts of principal have been paid on this note and the
balance is recorded as a current payable.
F-13
NOTES TO FINANCIAL STATEMENTS (Continued)
8. Notes Payable
At December 31, 1999 and 2000 debt obligations were as
follows:
At December 31, 2000, aggregate annual maturities of
long-term debt and capital leases were as follows:
During 1998, Mr. Phillips W. Smith, the Companys
chairman, loaned the Company approximately $725,691. In
March 1998, $150,000 was converted into 20,833 shares of
common stock at an estimated fair value of $7.20 per share and
$120,000 was repaid. In December 1998, the Company issued a
promissory note for $455,691, the remaining amounts due. The
note carried interest at 9% (increased to 10% in
January 2001) and its maturity was extended to July 1,
2002.
In addition, during 1998, Mr. Bruce R. Culver, a director
of the Company, loaned the Company approximately $622,525. In
March 1998, $150,000 was converted into 20,833 shares of
common stock at an estimated market value of $7.20 per share. In
December 1998, the Company issued a promissory note for
$472,525, the remaining amounts due. The note carried interest
at 9% (increased to 10% in January 2001) and its maturity
was extended to July 1, 2002.
In January 1999, Mr. Culver loaned the Company
$1,500,000. In return, the Company issued a promissory note for
$500,000 at an effective interest rate of 27.12% to mature
October 31, 2000 and issued 1,666,667 shares of common
stock to Mr. Culver at a fair market value of $0.60 per
share. The stock issued was subject to a repurchase agreement
which allowed the Company to repurchase the shares issued at
cost if certain criteria were met. In July 2000, the
Company repurchased the 1,666,667 shares under the agreement in
exchange for a promissory note for $1,000,000. This $1,000,000
note and the $500,000 note issued in January 1999 were
consolidated into a new note for $1,500,000 which carries
interest at bank prime (9.5% at December 31, 2000) plus 1%
and matures July 1, 2002.
In March 1999, the Company issued a promissory note to
Mr. Culver for $100,000 at an interest rate of 10% which
matures on July 1, 2002.
F-14
NOTES TO FINANCIAL STATEMENTS (Continued)
In March 1999, the Company issued a promissory note to
Mr. Smith for $99,794 at an interest rate of 10% which
matured December 31, 2000.
In July 1999, the Company issued a promissory note to
Mr. Culver for $50,000 to fund working capital needs at an
interest rate of 10% which matures July 1, 2002.
In May 2000, the Company issued a promissory note to
Mr. Culver for $200,000 to fund working capital needs at an
interest rate of 10% which matures on July 1, 2002.
In the event the planned IPO is not completed, the Company has
an agreement with Mr. Smith and Mr. Culver whereby the
Company may at the Companys sole option, extend the
maturity date of the outstanding notes for a period not to
exceed 24 months. The Company, at the Companys sole
option, may retire the debt at any time without penalty.
In July 1999, the Company issued a promissory note to
Mr. Malcolm Sherman, a stockholder, for $75,000 to acquire
production equipment. The note carries interest at 9.18% and
matures July 1, 2001.
In September 1997, the Company issued a promissory note to
an unrelated private lender to fund working capital for $112,000
at an interest rate of 11% which matures June 30, 2002.
In January 2001, the Company issued a promissory note to an
unrelated private lender to fund working capital for $500,000 at
an interest rate of 18% which matures the earlier of the close
of the IPO or July 1, 2002.
9. Stockholders Equity
a. Common Stock
Concurrent with the re-incorporation in Delaware effective
February 2001, the Company adopted a certificate of
incorporation and authorized the issuance of two classes of
stock to be designated common stock and
preferred stock, provided that both common and
preferred stock shall have a par value of $0.00001 per share and
authorized the Company to issue 50 million shares of common
stock and 25 million shares of preferred stock.
Additionally, effective February 2001, the Company declared
a 1-for-6 reverse stock split of common stock. All references to
the number of shares, per share amounts, conversion amounts and
stock option and warrant data of the Companys common stock
have been restated to reflect this reverse stock split for all
periods presented.
b. Preferred Stock
The Company is authorized to issue up to 25 million shares of
preferred stock, $0.00001 par value. The power to issue any
shares of preferred stock of any class or any series of any
class and designations, voting powers, preferences, and relative
participating, optional or other rights, if any, or the
qualifications, limitations, or restrictions thereof, shall be
determined by the Board of Directors.
c. Warrants
At December 31, 2000, the Company has warrants outstanding
to purchase 42,747 shares of common stock at prices ranging from
$0.22 to $21.00 per share with an average exercise price of
$3.48 per share
F-15
NOTES TO FINANCIAL STATEMENTS (Continued)
and a weighted average useful life of 3.58 years. A summary
of warrants outstanding and exercisable at December 31,
2000 is presented in the table below:
In 2000, the Company issued 22,727 warrants to a stockholder as
consideration for his provision of a $1,500,000 loan to the
Company. The warrants are exercisable at $3.30 per share and
expire July 31, 2005. These warrants have been recorded at
their estimated fair value of $16,500 as additional paid-in
capital and the related interest expense in the accompanying
financial statements.
In January 2001, the Company issued 5,000 warrants to an
unrelated private lender as a loan guarantee. These warrants are
exercisable at $10 per share and expire January 1, 2006.
The fair value of these warrants of approximately $9,650 will be
recorded as additional paid-in capital and the related expense
recorded in the year in which the service is provided or ratably
over the life of the debt.
d. Deferred Compensation
During 2000, two non-employee Board of Director members received
their director fees for services relating to 2001 to 2004
through the issuance of, in the aggregate, 13,333 options at an
exercise price of $3.30 per share. These options have been
recorded at their estimated fair value of $79,920 as deferred
compensation in the accompanying balance sheets and will be
amortized into expense over the next four years.
e. Stock Option Plans
The Company has historically issued stock options for various
equity owners and key employees as a means of attracting and
retaining quality personnel. The option holders have the right
to purchase a stated amount of shares at the estimated market
value on the grant date. The options issued under the
Companys 1999 Stock Option Plan (the 1999
Plan) generally vest over a three-year period. The options
issued under the Companys 2001 Stock Option Plan (the
2001 Plan) generally vest over a four-year period.
The directors of the Company adopted the Companys
1998-1999 Stock Option Plan. The 1998-1999 Plan was administered
by the Board of Directors which determined the employees,
directors or consultants which will be granted options and the
terms of the options, including the vesting provision which
typically is over a three-year period.
The 1998-1999 Plan was terminated by the Company and options
granted under it were voluntarily canceled by the recipients or
terminated in connection with termination of the
recipients employment.
The 1999 Plan provides for officers, key employees and
consultants to receive nontransferable stock options to purchase
up to 833,333 shares of the Companys common stock. The
term of the options may not exceed ten years although most
options granted had an initial expiration period of between five
and seven years. In 1998, the Company had a similar plan which
was cancelled in 1999.
F-16
NOTES TO FINANCIAL STATEMENTS (Continued)
In 1999, the Company issued 16,667 five-year options to
Mr. Phillips W. Smith at an exercise price of $0.66
per share for consulting services, and 3,958 ten-year options to
an unrelated private lender at an exercise price of $7.20 per
share as consideration for his financing the Companys
purchase of inventory. In 2000, the Company issued 4,697
ten-year options to a non-employee at an exercise price of $3.30
per share for consulting services, and 3,333 five-year options
to a stockholder at an exercise price of $0.22 per share in
connection with his provision of services and a loan to the
Company. These options have been recorded at fair value as
additional paid-in capital and the related expense recorded in
the year in which the service is provided in the accompanying
financial statements.
A summary of the Companys stock options at
December 31, 1999 and 2000 and for the years then ended is
presented in the table below:
Stock options outstanding and exercisable at December 31,
2000 are as follows:
The Company measures the compensation cost of its stock option
plan using the intrinsic value based method of accounting
prescribed in Accounting Principles Board Opinion 25,
Accounting for Stock Issued to Employees
. Accordingly, no
compensation cost has been recognized for its stock option plan.
The weighted average remaining contractual life of those options
is approximately 6.64 years. Had the Companys
compensation cost been determined using the fair value of
approximately $8,000 in 1999 and $8,300 in 2000, based on the
method of accounting prescribed by SFAS No. 123,
Accounting for Stock-
F-17
NOTES TO FINANCIAL STATEMENTS (Continued)
Based Compensation
, the Companys net loss and net
loss per common share would have been adjusted to the following
pro forma amounts (amounts in thousands except per common share
amounts):
In January 2001, the Company adopted the 2001 Plan which
provides for officers, key employees and consultants to receive
nontransferable stock options to purchase up to 550,000 shares
of the Companys common stock. In February 2001, the
Company granted 291,000 ten-year options to employees,
stockholders and one consultant at exercise prices equal or
greater than the value of the common stock portion of the
initial per unit public offering price in the Companys
contemplated IPO. Total compensation cost associated with the
option granted to the consultant is approximately $3,143.
10. Loss per Share
Basic net loss per share is based upon the weighted average
number of common shares outstanding during the period.
In periods of losses, diluted net loss per share is based upon
the weighted average number of common shares outstanding during
the period. As the Company had a net loss for the years ended
December 31, 1999 and 2000, the Companys common stock
options and warrants were anti-dilutive.
Loss per share is calculated as follows for the year ended
December 31:
11. Subsequent Event
The Company intends to file an SB-2 registration statement
offering 1,100,000 units at an estimated initial offering price
of $10 per unit consisting of one share of common stock and one
warrant to purchase one share of common stock. Also, the Company
intends to issue to the representative of the IPOs
underwriters warrants which enable the representative to acquire
110,000 units for 150% of the IPO unit offering price.
F-18
You should rely only on the
information contained in this prospectus. We have not authorized
anyone to provide you with information different from the
information contained in this prospectus. We are offering to
sell, and seeking offers to buy, units only in jurisdictions in
which offers and sales are permitted.
Until
,
2001 (25 days after the date of this prospectus), all
broker-dealers that effect the transactions in these securities,
whether or not participating in this offering, may be required
to deliver a prospectus. This is in addition to the
dealers obligation to deliver a prospectus when acting as
underwriters and with respect to their unsold allotments or
subscriptions.
1,100,000 UNITS
PAULSON INVESTMENT
,
2001
Page
F-2
F-3
F-4
F-5
F-6
F-7
ARTHUR ANDERSEN LLP
1999
2000
Assets
$
54,905
$
206,408
in 2000
121,921
312,681
158,167
221,169
14,043
24,535
349,036
764,793
256,110
274,273
$
605,146
$
1,039,066
Liabilities and Stockholders Deficit
$
112,000
$
100,000
1,664,774
124,574
19,176
22,171
574,989
589,949
62,317
539,329
189,980
189,980
138,942
268,134
2,762,178
1,834,137
74,781
2,778,219
19,979
43,925
2,856,938
4,656,281
32
15
4,068,814
3,189,548
(79,920
)
(6,320,638
)
(6,726,858
)
(2,251,792
)
(3,617,215
)
$
605,146
$
1,039,066
1999
2000
$
2,208,488
$
3,412,620
1,001,082
1,350,175
1,087,404
488,214
120,002
1,574,231
1,442,613
1,613,979
64,227
7,137
(1,386,838
)
(46,885
)
279,895
359,335
$
(1,666,733
)
$
(406,220
)
$
(0.54
)
$
(0.16
)
(0.54
)
(0.16
)
3,076,410
2,482,976
3,076,410
2,482,976
?Common Stock?
Additional
Total
Paid-in
Deferred
Accumulated
Stockholders
Shares
Amount
Capital
Compensation
Deficit
Deficit
1,359,239
$
14
$
2,567,432
$
$
(4,653,905
)
$
(2,086,459
)
1,666,667
17
999,983
1,000,000
151,515
1
499,999
500,000
1,400
(1,666,733
)
(1,666,733
)
3,177,421
32
4,068,814
(6,320,638
)
(2,251,792
)
(1,666,667
)
(17
)
(999,983
)
(1,000,000
)
79,920
(79,920
)
13,917
13,917
26,880
(406,220
)
(406,220
)
1,510,754
$
15
$
3,189,548
$
(79,920
)
$
(6,726,858
)
$
(3,617,215
)
1999
2000
$
(1,666,733
)
$
(406,220
)
179,453
124,803
90,474
(190,760
)
607,165
(63,002
)
16,598
(10,492
)
(95,150
)
14,960
62,317
477,012
101,650
129,192
(704,226
)
75,493
(133,760
)
(99,759
)
(19,195
)
(16,266
)
(12,000
)
728,344
163,238
(1,329,635
)
1,500,000
(79,920
)
1,400
120,717
880,914
175,769
42,928
151,503
11,977
54,905
$
54,905
$
206,408
$
179,171
$
239,552
$
33,635
$
43,207
$
$
1,000,000
$
1,400
$
13,917
$
0
$
26,880
$
0
$
79,920
1999
2000
$
131,007
$
153,506
27,160
67,663
$
158,167
$
221,169
1999
2000
(000s omitted)
$
1,311
$
1,241
601
24
80
2,099
216
49
$
2,208
$
3,413
52
%
82
%
48
18
100
%
100
%
Estimated
Useful Lives
1999
2000
5 years
$
$
5,000
5 years
335,050
380,326
5 years
31,535
31,535
3-5 years
332,460
383,492
5-7 years
22,767
57,542
721,812
857,895
(465,702
)
(583,622
)
$
256,110
$
274,273
$
144,481
142,643
146,362
150,193
154,139
143,156
$
880,974
$
42,171
26,646
(68,817
)
$
$
246,745
2,809,359
5,308
3,589
3,888
$
3,068,889
Outstanding
Weighted
Average
Exercise
Expiration
Price
Warrants
Date
$
21.00
3,333
7/31/05
0.22
8,334
1/1/03
0.22
8,333
1/1/03
3.30
22,727
7/31/05
$
3.48
42,727
1999
2000
Weighted
Weighted
Average
Average
Exercise
Exercise
Options
Price
Options
Price
65,334
$
6.37
124,875
$
0.82
121,458
0.83
21,863
2.83
(61,917
)
6.71
(3,416
)
0.22
124,875
$
0.82
143,322
$
1.14
42,352
$
1.20
84,979
$
1.02
Outstanding
Exercisable
Average
Exercise
Average
Price
Options
Life(a)
Options
$
0.22
3,333
4.50
3,333
0.60
80,834
7.52
50,718
0.66
36,667
3.00
23,426
7.20
3,958
9.74
3,958
3.30
18,530
8.42
3,544
$
1.02
143,322
6.60
84,979
(a)
Average contractual life remaining in years.
Year Ended December 31,
1999
2000
$
(1,667
)
$
(406
)
(1,675
)
(414
)
$
(0.54
)
$
(0.16
)
(0.54
)
(0.17
)
1999
2000
$
(1,666,733
)
$
(406,220
)
3,076,410
2,482,976
$
(0.54
)
$
(0.16
)
$
(1,666,733
)
$
(406,220
)
3,076,410
2,482,976
0
0
3,076,410
2,482,976
$
(0.54
)
$
(0.16
)
Page
1
4
11
11
13
14
15
19
29
32
34
35
39
41
43
43
44
F-1
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 24.
Indemnification of Directors and
Officers.
Our certificate of incorporation allows and our bylaws require
that we indemnify our directors and officers who are or were a
party to, or are threatened to be made a party to, any
proceeding (including a derivative action if the director or
officer is not found liable to us), against all expenses
reasonably incurred by a director or officer in connection with
such a proceeding (including expenses, judgments, fines and
amounts paid in settlement), if the director or officer acted in
good faith, in a manner he or she believed was not opposed to
our best interests, and, with respect to a criminal proceeding,
had no reason to believe that his or her conduct was unlawful.
We have entered into separate indemnification agreements with
each of our directors and officers. The agreements provide for
mandatory indemnification for and limit the liability of our
directors and officers in serving us to the fullest extent
permitted by the Delaware General Corporation Law. Specifically,
under the agreements, our directors and officers will not be
personally liable for monetary damages for their errors or
omissions, except for liability for the breach of a
directors or officers duty of loyalty to us or our
stockholders, for intentional misconduct or acts not in good
faith, for making any unlawful distribution, for any transaction
from which the director or officer derived an improper benefit,
or for violating section 16(b) of the Securities Exchange Act of
1934, as amended, or similar laws.
Our bylaws and indemnification agreements generally require that
we advance to our directors and officers expenses incurred by
them in defending a proceeding in advance of its final
disposition, provided that the director or officer agrees to
reimburse us for such advances if it is ultimately found that
the director or officer is not entitled to indemnification. In
addition, our bylaws permit us to purchase insurance on behalf
of our directors and officers against any liability asserted
against them in such capacity. We intend to obtain such
insurance.
Item 25.
Other Expenses of Issuance and
Distribution.
The following table sets forth an itemization of SEC
Registration, NASD filing and Nasdaq listing fees, and all other
estimated expenses, all of which we will pay, in connection with
the issuance and distribution of the securities being registered:
Item 26.
Recent Sales of Unregistered
Securities.
We have issued the following securities within the last three
years. The following information regarding our securities has
been adjusted to reflect a 1-for-6 reverse stock split effected
in connection with our redomestication in Delaware on
February 12, 2001.
II-1
(1) In March 1998, pursuant to an exemption under
Section 4(2) of the Securities Act, we sold shares of our
common stock as follows: 20,833 shares at $7.20 per share for an
aggregate purchase price of $150,000 to Bruce R. Culver; and
20,833 shares at $7.20 per share for an aggregate purchase price
of $150,000 to Phillips W. Smith.
(2) In January 1999, pursuant to an exemption under
Section 4(2) of the Securities Act, we sold shares of our
common stock as follows: 1,666,667 shares at $0.60 per share for
an aggregate purchase price of $1,000,000 to Bruce R. Culver.
These shares were subject to a repurchase option that was
exercised by us in July 2000 at the same price ($0.60 per
share) for an aggregate purchase price of $1,000,000.
(3) In September 1999, pursuant to an exemption under
Section 4(2) of the Securities Act, we sold shares of our
common stock as follows: 151,515 shares at $3.30 per share for
an aggregate purchase price of $500,000 to Bruce R. Culver.
Messrs. Culver and Smith are accredited investors and
sophisticated in our business. Mr. Smith has served as a
director of TASER since 1993, Mr. Culver since 1994. Each
have had access to information with respect to us necessary to
make an informed investment decision in connection with the
sales referenced above.
Item 27.
Exhibits.
II-2
Item 28.
Undertakings.
Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to our directors, officers and
controlling persons pursuant to the foregoing provisions, or
otherwise, we have been advised that in the opinion of the
Securities and Exchange Commission such indemnification is
against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment
by us of expenses incurred or paid by a director, officer or
controlling person of us in the successful defense of any
action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities
being registered, we will, unless in the opinion of our counsel
the matter has been settled by controlling precedent, submit to
a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final
adjudication of such issue.
We hereby undertake to:
II-3
In addition, we hereby undertake to provide to the underwriters
at the closing specified in the underwriting agreement,
certificates in such denominations and registered in such names
as required by the underwriters to permit prompt delivery to
each purchaser.
II-4
Nature of Expense
Amount
$
9,514
3,960
8,000
125,000
125,000
150,000
145,000
65,000
1,250
17,276
$
650,000
Exhibit
No.
Description
1.1
Form of Underwriting Agreement*
3.1
Registrants Certificate of Incorporation*
3.2
Registrants Bylaws*
4.1
Reference is made to pages 1-4 of Exhibit 3.1 and
pages 1-5 and 12-14 of Exhibit 3.2
4.2
Form of Common Stock Certificate
4.3
Form of Public Warrant*
4.4
Form of Unit Certificate
4.5
Form of Warrant and Unit Agreement
4.6
Form of Representatives Warrant*
5.1
Opinion of Tonkon Torp LLP**
10.1
Employment Agreement with Patrick W. Smith, dated July 1,
1998*
10.2
Employment Agreement with Thomas P. Smith, dated
November 15, 2000*
10.3
Employment Agreement with Kathleen C. Hanrahan, dated
November 15, 2000*
10.4
Form of Indemnification Agreement between the Registrant and its
directors*
10.5
Form of Indemnification Agreement between the Registrant and its
officers*
10.6
1999 Employee Stock Option Plan*
10.7
2001 Stock Option Plan*
10.8
Form of Warrant issued to Bruce Culver and Phil Smith*
10.9
Licensing Agreement with respect to intellectual property dated
October 15, 1993, as amended, by and between the Registrant
and John H. Cover, Jr., and related documents*
10.10
Promissory Note, dated January 23, 2001, payable to Phillip
Purer in the amount of $500,000 and related security documents*
10.11
Promissory Note, dated December 31, 1998, payable to B
& M Distributing, Inc., in the amount of $189,980 and
related guarantee and security documents*
10.12
Promissory Note, dated October 24, 2000, payable to Bank of
America in the amount of $60,000 and related guarantee and
security documents*
10.13
Form of Promissory Notes issued to stockholders*
Exhibit
No.
Description
10.14
Lease between the Registrant and Norton P. Remes and Joan A.
Remes Revocable Trust, dated November 17, 2000*
10.15
Promissory Note, dated July 1, 1999, payable to
Malcolm W. Sherman in the amount of $75,000
10.16
Letter Agreement with respect to services, dated May 26,
2000, by and between the Registrant and Malcolm W. Sherman
10.17
Standby Letter of Credit dated April 13, 2001 in the amount
of $500,000 established on behalf of the Registrant, and related
Letter of Support
10.18
Form of Amendment to Promissory Notes issued to stockholders
23.1
Consent of Tonkon, Torp LLP (included in Exhibit 5.1)
23.2
Consent of Arthur Andersen LLP, independent public accountants
24
Power of Attorney. Reference is made to the signature page.
*
Previously filed
**
To be filed by amendment.
(1) File, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement to:
(i) Include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933, as amended
(the Securities Act);
(ii) Reflect in the prospectus any facts or events which,
individually or together, represent a fundamental change in the
information in the registration statement; and notwithstanding
the foregoing, any increase or decrease in volume of securities
offered (if the dollar value of the securities offered would not
exceed that which was registered) and any deviation from the low
or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission
pursuant to Rule 424(b) under the Securities Act if, in the
aggregate, the changes in volume and price represent no more
than a 20% change in the maximum aggregate offering price set
forth in the Calculation of Registration Fee table
in the effective registration statement; and
(iii) Include any additional or changed material
information on the plan of distribution.
(2) For determining liability under the Securities Act,
treat each post-effective amendment as a new registration
statement of the securities offered, and the offering of the
securities at that time to be the initial bona fide offering.
(3) File a post-effective amendment to remove from
registration any of the securities that remain unsold at the end
of the offering.
(4) For purposes of determining any liability under the
Securities Act, treat the information omitted from the form of
prospectus filed as part of this registration statement in
reliance upon Rule 430A and contained in a form of
prospectus filed by the registrant pursuant to
Rule 424(b)(1) or (4) or 497(h) under the Securities Act as
part of this registration statement as of the time it was
declared effective.
(5) For determining any liability under the Securities
Act, treat each post-effective amendment that contains a form of
prospectus as a new registration statement for the securities
offered in the registration statement, and that offering of the
securities at that time as the initial bona fide offering of
those securities.
SIGNATURES
In accordance with the requirements of the Securities Act of
1933, the registrant has duly caused this Amendment No. 2
to the Registration Statement to be signed on its behalf by the
undersigned, in the City of Scottsdale, Arizona on
April 13, 2001.
In accordance with the requirements of the Securities Act of
1933, this Amendment No. 2 to the Registration Statement
was signed by the following persons in the capacities and on the
dates stated.
II-5
TASER INTERNATIONAL, INC.
BY:
/s/PATRICK W. SMITH
Patrick W. Smith,
Chief Executive Officer
Signature
Title
Date
/s/ PATRICK W. SMITH
Patrick W. Smith
April 13, 2001
/s/ THOMAS P. SMITH*
Thomas P. Smith
April 13, 2001
/s/ KATHLEEN C. HANRAHAN*
Kathleen C. Hanrahan
April 13, 2001
/s/ PHILLIPS W. SMITH
Phillips W. Smith
April 13, 2001
/s/ BRUCE R. CULVER*
Bruce R. Culver
April 13, 2001
/s/ KARL F. WALTER*
Karl F. Walter
April 13, 2001
/s/ MATTHEW R. MCBRADY*
Matthew R. McBrady
April 13, 2001
*By
/s/ PATRICK W. SMITH
EXHIBIT INDEX
Exhibit
No.
Description
1.1
Form of Underwriting Agreement*
3.1
Registrants Certificate of Incorporation*
3.2
Registrants Bylaws*
4.1
Reference is made to pages 1-4 of Exhibit 3.1 and
pages 1-5 and 12-14 of Exhibit 3.2
4.2
Form of Common Stock Certificate
4.3
Form of Public Warrant*
4.4
Form of Unit Certificate
4.5
Form of Warrant and Unit Agreement
4.6
Form of Representatives Warrant*
5.1
Opinion of Tonkon Torp LLP**
10.1
Employment Agreement with Patrick W. Smith, dated
July 1, 1998*
10.2
Employment Agreement with Thomas P. Smith, dated
November 15, 2000*
10.3
Employment Agreement with Kathleen C. Hanrahan, dated
November 15, 2000*
10.4
Form of Indemnification Agreement between the Registrant and its
directors*
10.5
Form of Indemnification Agreement between the Registrant and its
officers*
10.6
1999 Employee Stock Option Plan*
10.7
2001 Stock Option Plan*
10.8
Form of Warrant issued to Bruce Culver and Phil Smith*
10.9
Licensing Agreement with respect to intellectual property dated
October 15, 1993, as amended, by and between the Registrant
and John H. Cover, Jr., and related documents*
10.10
Promissory Note, dated January 23, 2001, payable to Phillip
Purer in the amount of $500,000 and related security documents*
10.11
Promissory Note, dated December 31, 1998, payable to
B & M Distributing, Inc., in the amount of
$189,980 and related guarantee and security documents*
10.12
Promissory Note, dated October 24, 2000, payable to Bank of
America in the amount of $60,000 and related guarantee and
security documents*
10.13
Form of Promissory Notes issued to stockholders*
10.14
Lease between the Registrant and Norton P. Remes and
Joan A. Remes Revocable Trust, dated November 17,
2000*
10.15
Promissory Note, dated July 1, 1999, payable to
Malcolm W. Sherman in the amount of $75,000
10.16
Letter Agreement with respect to services, dated May 26,
2000, by and between the Registrant and Malcolm W. Sherman
10.17
Standby Letter of Credit dated April 13, 2001 in the amount
of $500,000 established on behalf of the Registrant, and related
Letter of Support
10.18
Form of Amendment to Promissory Notes issued to Stockholders
23.1
Consent of Tonkon, Torp LLP (included in Exhibit 5.1)
23.2
Consent of Arthur Andersen LLP, independent public accountants
24
Power of Attorney. Reference is made to the signature page.
*
Previously filed
**
To be filed by amendment.
EXHIBIT 4.2
NUMBER SHARES
TSR
INCORPORATED UNDER THE LAWS SEE REVERSE FOR CERTAIN DEFINITIONS
OF THE STATE OF DELAWARE CUSIP 87651B 10 4
TASER INTERNATIONAL, INC.
This certifies that ____________________________________________________________
is the record holder of ________________________________________________________
FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK,
$0.00001 PAR VALUE PER SHARE, OF
TASER INTERNATIONAL, INC.
transferable on the books of the corporation by the holder hereof in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This certificate is not valid until countersigned and registered by the Transfer Agent and Registrar.
WITNESS the facsimile signatures of its duly authorized officers.
Dated: _________________________ __________________________ SECRETARY PRESIDENT |
TASER INTERNATIONAL, INC.
The Corporation will furnish without charge to each stockholder who so requests a statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock of the Corporation or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. Such requests shall be made to the Corporation's Secretary at the principal office of the Corporation.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations.
TEN COM - as tenants in common TEN ENT - as tenants by the entireties JT TEN - as joint tenants with rights of survivorship and not as tenants in common UNIF GIFT MIN ACT - _________________Custodian______________ (Cust) (minor) under Uniform Gifts to Minors Act ________________________________________ |
(State) UNIF TRF MIN ACT - _________________Custodian______________ (Cust) (minor) under Uniform Gifts to Minors Act ________________________________________ (State) |
Additional abbreviations may also be used though not in the above list
For value received, ______________________________________ hereby sell(s), assign(s), and transfer(s) unto
(PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE)
Dated:__________________, ________
X _____________________________________
X _____________________________________
NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER.
Signature(s) Guaranteed:
THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS,
STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN
AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE
17AD-15.
EXHIBIT 4.4
UNIT CERTIFICATE
U-_____ _________Units
TASER INTERNATIONAL, INC.
ORGANIZED UNDER THE LAWS OF THE STATE OF DELAWARE
EACH UNIT CONSISTING OF ONE SHARE
OF COMMON STOCK, PAR VALUE $0.00001
PER SHARE, AND ONE COMMON STOCK
PURCHASE WARRANT
CUSIP 87651B 20 3
THIS CERTIFIES THAT
or registered assigns (the "Registered Holder") is the owner of the number of Units specified above, each of which consists of one share of common stock, par value $0.00001 per share, of TASER International, Inc. (the "Common Stock") and one common stock purchase warrant to purchase one share of Common Stock (the "Warrant"). On or prior to the Separation Time (as defined herein), the securities evidenced by this certificate may be combined, exchanged or transferred only as Units, and the Common Stock and Warrants evidenced by this Certificate may not be split up, exchanged or traded separately. The Units may separate into shares of Common Stock and Warrants as of the close of business on ______________________, 2001 [thirty days after the consummation of the initial public offering of Units], or at any time after that date, in the discretion of Paulson Investment Company, Inc. (the "Separation Time"). The shares of Common Stock and Warrants comprising the Units shall be separately tradeable commencing on the first day after the Separation Time on which The Nasdaq SmallCap Market is open for trading. The Warrants comprising part of the Units are issued under and pursuant to a certain Warrant and Unit Agreement dated as of ______________, 2001 (the "Warrant Agreement"), between the Company and US Stock Transfer Corporation, as Transfer Agent (the "Transfer Agent"), and are subject to the terms and provisions contained therein and on the face of the certificates covered thereby, to all of which terms and provisions the holder of this Unit Certificate consents by acceptance hereof. The Warrant Agreement provides for adjustment in the number of shares of Common Stock to be delivered upon the exercise of Warrants evidenced hereby and to the exercise price of such Warrants in certain events therein set forth. Subject to the foregoing, the number of Warrants and the number of shares of Common Stock comprising the Units are equal.
Copies of the Warrant Agreement are available for inspection at the stock transfer office of the Transfer Agent and Registrar or may be obtained upon written request addressed to TASER International, Inc. at 7860 E. McClain Drive, Suite 2, Scottsdale, Arizona 85260, Attention: Chief Financial Officer.
This Unit Certificate is not valid unless countersigned by the Transfer Agent and Registrar of the Company.
IN WITNESS WHEREOF, TASER International, Inc. has caused this Unit Certificate to be duly executed manually or in facsimile by two of its officers thereunto duly authorized.
Dated:_____________________________
TASER INTERNATIONAL, INC.
By: ________________________________ President
Attest: ______________________________ Secretary
Countersigned
US Stock Transfer Corporation
1745 Gardena Avenue
Glendale, California 91204
By: ________________________________
Authorized Signature
TASER INTERNATIONAL, INC.
The Registered Holder hereby is entitled, at any time after the Separation Time (as defined on the face hereof) to exchange the Units represented by this Unit Certificate for Common Stock Certificate(s) representing one share of Common Stock, for each Unit represented by this Unit Certificate, and Warrant Certificate(s) representing one Warrant, for each unit represented by this Unit Certificate, upon surrender of this Unit Certificate to the Transfer Agent and Registrar together with any documentation required by such agent.
REFERENCE IS MADE TO THE WARRANT AGREEMENT REFERRED TO ON THE FACE HEREOF, AND THE PROVISIONS OF SUCH WARRANT AGREEMENT SHALL FOR ALL PURPOSES HAVE THE SAME EFFECT AS THOUGH FULLY SET FORTH ON THE FACE OF THIS CERTIFICATE. COPIES OF THE WARRANT AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST FROM THE TRANSFER AGENT AND REGISTRAR, US STOCK TRANSFER CORPORATION.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations.
TEN COM - as tenants in common TEN ENT - as tenants by the entireties JT TEN - as joint tenants with rights of survivorship and not as tenants in common COM PROP - as community property UNIF GIFT MIN ACT - _________________Custodian________________ (Cust) (minor) under Uniform Gifts to Minors Act __________________________________________ (State) UNIF TRF MIN ACT - _________________Custodian________________ (Cust) (minor) under Uniform Gifts to Minors Act |
__________________________________________ (State) |
FORM OF ASSIGNMENT
(TO BE SIGNED ONLY UPON ASSIGNMENT)
FOR VALUE RECEIVED, the undersigned Registered Holder ( )
hereby sells, assigns and transfers unto
Units evidenced by the within Unit Certificate, and irrevocably constitutes and
appoints
______________________________________________________________________attorney
to transfer this Unit Certificate on the books of TASER International, Inc. with
the full power of substitution in the premises.
Dated:__________________, ________
Signature:
(Signature must conform in all respects to the name of Registered Holder as specified on the face of this Unit Certificate in every particular, without alteration or any change whatsoever, and the signature must be guaranteed in the usual manner.)
Signatures Guaranteed:
The signatures should be guaranteed by an eligible institution (banks, stockbrokers, savings and loan association and credit unions with membership in an approved signature medallion program), pursuant to S.E.C. Rule 17Ad-15.
Exhibit 4.5
WARRANT AND UNIT AGREEMENT
TASER International, Inc., 7860 E. McClain Drive, Suite 2, Scottsdale, Arizona 85260, a Delaware corporation ("Company"), and US Stock Transfer Corporation, _________________________, Glendale, California, a _________ corporation ("Transfer Agent"), agree as follows:
1. PURPOSE. The Company proposes to publicly offer and issue in an initial public offering (the "Offering") ____________ units ("Units"). Each Unit will entitle the registered holder of a Unit ("Unit Holder") to (i) one (1) share of the Company's $0.00001 par value common stock ("Share") and (ii) one (1) warrant permitting the purchase of one (1) Share ("Warrant").
2. WARRANTS. Each Warrant will entitle the registered holder of a Warrant ("Warrant Holder") to purchase from the Company one (1) Share at one hundred fifty percent (150%) of the Initial Public Offering price of the Units ("Exercise Price"). A Warrant Holder may exercise all or any number of Warrants resulting in the purchase of a whole number of Shares.
3. EXERCISE PERIOD. The Warrants may be exercised at any time during the period commencing thirty (30) days after the effective date ("Offering Date") of the Offering ("Exercise Date") and ending at 3:00 p.m., Denver Colorado time on the fifth (5th) anniversary date of the closing of the Offering ("Expiration Date") except as changed by Section 15 of this Agreement.
4. NON-DETACHABILITY. A Warrant Certificate (as defined below) may not be detached from a Share certificate contained in a Unit for at least thirty (30) days following the Offering Date. Until such time, a Warrant Certificate may be split up, combined, exchanged or transferred on the books of the Transfer Agent only together with a Share certificate. Paulson Investment Company, Inc. will then determine when the Units separate, after which the Shares and Warrants will trade separately.
5. CERTIFICATES. The Warrant certificates shall be in registered form only and shall be substantially in the form set forth in Exhibit A attached to this Agreement ("Warrant Certificate"). The Unit certificates shall be in registered form only and shall be substantially in the form set forth in Exhibit B attached to this Agreement ("Unit Certificate"). Warrant and Unit Certificates shall be signed by, or shall bear the facsimile signature of, the Chief Executive Officer, President or a Vice President of the Company and the Secretary or an Assistant Secretary of the Company. If any person, whose facsimile signature has been placed upon any Warrant or Unit Certificate or the signature of an officer of the Company, shall have ceased to be such officer before such Warrant or Unit Certificate is countersigned, issued and delivered, such Warrant or Unit Certificate shall be countersigned, issued and delivered with the same effect as if such person had not ceased to be such officer. Any Warrant or Unit Certificate may be signed by, or made to bear the facsimile signature of, any person who at the actual date of the preparation of such Warrant or Unit Certificate shall be a proper officer of the Company to sign such Warrant or Unit Certificate, even though such person was not such an officer upon the date of this Agreement.
6. ISSUANCE OF NEW CERTIFICATES. Notwithstanding any of the provisions of his Agreement or the several Warrant or Unit Certificates to the contrary, the Company may, at its
1-WARRANT AND UNIT AGREEMENT
option, issue new Warrant or Unit Certificates in such form as may be approved by its Board of Directors to reflect any adjustment or change in the Exercise Price or the number or kind of shares purchasable under the several Warrant or Unit Certificates made in accordance with the provisions of this Agreement.
7. COUNTERSIGNING. Warrant and Unit Certificates shall be manually countersigned by the Transfer Agent and shall not be valid for any purpose unless so countersigned. The Transfer Agent hereby is authorized to countersign and deliver to, or in accordance with the instructions of, any Warrant or Unit Holder any Warrant or Unit Certificate, respectively, which is properly issued.
8. REGISTRATION OF TRANSFER AND EXCHANGES. The Transfer Agent will keep or cause to be kept books for registration of ownership or transfer of Warrant and Unit Certificates issued hereunder. Such registers shall show the names and addresses of the respective holders of the Warrant and Unit Certificates and the number of Warrants and Units evidenced by each such Warrant or Unit Certificate. Subject to the provisions of Section 4, the Transfer Agent shall from time to time register the transfer of any outstanding Warrant or Unit Certificate upon records maintained by the Transfer Agent for such purpose upon surrender of such Warrant or Unit Certificate to the Transfer Agent for transfer, accompanied by appropriate instruments of transfer in form satisfactory to the Company and the Transfer Agent and duly executed by the Warrant or Unit Holder or a duly authorized attorney. Upon any such registration of transfer, a new Warrant or Unit Certificate shall be issued in the name of and to the transferee and the surrendered Warrant or Unit Certificate shall be cancelled.
9. EXERCISE OF WARRANTS.
a. Any one Warrant or any multiple of one Warrant evidenced by any Warrant Certificate may be exercised on or after the Exercise Date and on or before the Expiration Date. A Warrant shall be exercised by the Warrant Holder by surrendering to the Transfer Agent the Warrant Certificate evidencing such Warrant with the exercise form on the reverse of such Warrant Certificate duly completed and executed and delivering to the Transfer Agent, by good check or bank draft payable to the order of the Company, the Exercise Price for each Share to be purchased.
b. Upon receipt of a Warrant Certificate with the exercise form thereon duly executed together with payment in full of the Exercise Price (and an amount equal to any applicable taxes or government charges) for the Shares for which Warrants are then being exercised, the Transfer Agent shall requisition from any transfer agent for the Shares, and upon receipt shall make delivery of, certificates evidencing the total number of whole Shares for which Warrants are then being exercised in such names and denominations as are required for delivery to, or in accordance with the instructions of, the Warrant Holder. Such certificates for the Shares shall be deemed to be issued, and the person to whom such Shares are issued of record shall be deemed to have become a holder of record of such Shares, as of the date of the surrender of such Warrant Certificate and payment of the Exercise Price (and an amount equal to any applicable taxes or government charges), whichever shall last occur, provided that if the books of the Company with respect to the Shares shall be deemed to be closed, the person to whom such Shares are issued of record shall be deemed to have become a record holder of such Shares as of the date on which such books shall next be open (whether before, on or after the Expiration Date). The Company covenants and agrees
2-WARRANT AND UNIT AGREEMENT
that it shall not cause its stock transfer books to be closed for a period of more than twenty (20) consecutive business days except upon consolidation, merger, sale of all of its assets, dissolution or liquidation or as otherwise provided by law.
c. In addition, if it is required by law and upon instruction by the Company, the Transfer Agent will deliver to each Warrant Holder a prospectus that complies with the provisions of Section 5 of the Securities Act, as amended, and the Company agrees to supply the Transfer Agent with a sufficient number of prospectuses to effectuate that purpose.
d. Any Warrant Certificate or Certificates may be exchanged at the option of the holder thereof for another Warrant Certificate or Certificates of different denominations, of like tenor and representing in the aggregate the same number of Warrants, upon surrender of such Warrant Certificate or Certificates, with the Form of Assignment duly filled in and executed, to the Transfer Agent, at any time or from time-to-time after the close of business on the date hereof and prior to the close of business on the Expiration Date. The Transfer Agent shall promptly cancel the surrendered Warrant Certificate or Certificates and deliver the new Warrant Certificate or Certificates pursuant to the provisions of this Section.
e. If less than all the Warrants evidenced by a Warrant Certificate are exercised upon a single occasion, a new Warrant Certificate for the balance of the Warrants not so exercised shall be issued and delivered to, or in accordance with, transfer instructions properly given by the Warrant Holder until the Expiration Date.
f. All Warrant Certificates surrendered upon exercise of the Warrants shall be cancelled.
g. Upon the exercise, or conversion of any Warrant, the Transfer Agent shall account promptly to the Company with respect to Warrants exercised and concurrently pay to the Company all moneys received by the Transfer Agent for the purchase of securities or other property through the exercise of such Warrants.
h. Expenses incurred by the Transfer Agent while acting in the capacity as Transfer Agent, in accordance with this Agreement, will be paid by the Company. A detailed accounting statement relating to the number of shares exercised, names of registered Warrant Holder(s) and the net amount of exercise funds remitted will be given to the Company with the payment of each exercise amount.
10. REDEMPTION. Following three (3) months after the closing of the Offering, the Warrants outstanding at the time of a redemption may be redeemed at the option of the Company, in whole or in part on a pro-rata basis, at any time if, at the time notice of such redemption is given by the Company as provided in subsection a., below, the Daily Price has exceeded two hundred percent (200%) of the Initial Public Offering Price for the ten (10) consecutive trading days immediately preceding the date of such notice, at a price of $0.25 per Warrant (the "Redemption Price"). For the purpose of the foregoing sentence, the term "Daily Price" shall mean, for any relevant day, the closing bid price on that day as reported by the principal exchange or quotation system on which prices for the Common Stock are reported. On the redemption date (the "Redemption Date"), the
3-WARRANT AND UNIT AGREEMENT
holders of record of redeemed Warrants shall be entitled to payment of the Redemption Price upon surrender of such redeemed Warrants to the Company at the principal office of the Transfer Agent in Glendale, California.
a. Notice of redemption of Warrants shall be given at least thirty (30) days prior to the Redemption Date by mailing, by registered or certified mail, return receipt requested, a copy of such notice to the Transfer Agent and by first class mail to all of the holders of record of Warrants at their respective addresses appearing on the books or transfer records of the Company or such other address designated in writing by the holder of record to the Transfer Agent not less than forty (40) days prior to the Redemption Date.
b. From and after the Redemption Date, all rights of the Warrant Holders (except the right to receive the Redemption Price) shall terminate, but only if (i) no later than one day prior to the Redemption Date the Company shall have irrevocably deposited with the Transfer Agent as paying agent a sufficient amount to pay on the Redemption Date the Redemption Price for all Warrants called for redemption and (ii) the notice of redemption shall have stated the name and address of the Transfer Agent and the intention of the Company to deposit such amount with the Transfer Agent no later than one day prior to the Redemption Date.
c. The Transfer Agent shall pay to the holders of record of redeemed Warrants all monies received by the Transfer Agent for the redemption of Warrants to which the holders of record of such redeemed Warrants who shall have surrendered their Warrants are entitled.
d. Any amounts deposited with the Transfer Agent that shall be unclaimed after six (6) months after the Redemption Date may be withdrawn by the Company, and thereafter the holders of the Warrants called for redemption for which such funds were deposited shall look solely to the Company for payment. The Company shall be entitled to the interest, if any, on funds deposited with the Transfer Agent and the holders of redeemed Warrants shall have no right to any such interest.
e. If the Company fails to make a sufficient deposit with the Transfer
Agent as provided above, the holder of any Warrants called for redemption may at
the option of the holder (i) by notice to the Company declare the notice of
redemption a nullity as to such holder, or (ii) maintain an action against the
Company for the Redemption Price. If the holder brings such an action, the
Company will pay reasonable attorneys' fees of the holder. If the holder fails
to bring an action against the Company for the Redemption Price within sixty
(60) days after the Redemption Date, the holder shall be deemed to have elected
to declare the notice of redemption to be a nullity as to such holder and such
notice shall be without any force or effect as to such holder. Except as
otherwise specifically provided in this subsection e., a notice of redemption,
once mailed by the Company, as provided in subsection a., shall be irrevocable.
11. TAXES. The Company will pay all taxes attributable to the initial issuance of Shares upon exercise of Warrants. The Company shall not, however, be required to pay any tax which may be payable in respect of any transfer involved in any issue of Warrant or Unit Certificates or in the issue of any certificates of Shares in the name other than that of the Warrant or Unit Holder upon the exercise of any Warrant or Unit, as the case may be.
4-WARRANT AND UNIT AGREEMENT
12. MUTILATED OR MISSING CERTIFICATES. If any Warrant or Unit Certificate is mutilated, lost, stolen or destroyed, the Company and the Transfer Agent may, on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant or Unit Certificate, include the surrender thereof), and upon receipt of evidence satisfactory to the Company and the Transfer Agent of such mutilation, loss, theft or destruction, issue a substitute Warrant or Unit Certificate, respectively, of like denomination or tenor as the Warrant or Unit Certificate so mutilated, lost, stolen or destroyed. Applicants for substitute Warrant or Unit Certificates shall comply with such other reasonable regulations and pay any reasonable charges as the Company or the Transfer Agent may prescribe.
13. SUBSEQUENT ISSUE OF CERTIFICATES. Subsequent to their original
issuance, no Warrant or Unit Certificates shall be reissued except (i) such
Certificates issued upon transfer thereof in accordance with Section 8 hereof,
(ii) such Certificates issued upon any combination, split-up or exchange of
Warrant or Unit Certificates pursuant to Section 8 hereof, (iii) such
Certificates issued in replacement of mutilated, destroyed, lost or stolen
Warrant or Unit Certificates pursuant to Section 12 hereof, (iv) Warrant
Certificates issued upon the partial exercise of Warrant Certificates pursuant
to Section 9 hereof, and (v) Warrant Certificates issued to reflect any
adjustment or change in the Exercise Price or the number or kind of shares
purchasable thereunder pursuant to Section 6 hereof. The Transfer Agent is
hereby irrevocably authorized to countersign and deliver, in accordance with the
provisions of said Sections 6, 8, 9 and 12, the new Warrant or Unit
Certificates, as the case may be, required for purposes thereof, and the
Company, whenever required by the Transfer Agent, will supply the Transfer Agent
with Warrant and Unit Certificates duly executed on behalf of the Company for
such purposes.
14. RESERVATION OF SHARES. For the purpose of enabling the Company to satisfy all obligations to issue Shares upon exercise of Warrants, the Company will at all times reserve and keep available free from preemptive rights, out of the aggregate of its authorized but unissued shares, the full number of Shares which may be issued upon the exercise of the Warrants. The Company covenants all shares which shall be so issuable, will upon issue be fully paid and nonassessable by the Company and free from all taxes, liens, charges and security interests with respect to the issue thereof. In the case of a Warrant exercisable solely for securities listed on a securities exchange or for which there are at least two (2) independent market makers, the Company may elect to redeem Warrants submitted to the Transfer Agent for exercise for a price equal to the difference between the aggregate low asked price, or closing price, as the case may be, of the securities for which such Warrant is exercisable on the date of such submission and the Exercise Price of such Warrants; in the event of such redemption, the Company will pay to the holder of such Warrants the above-described redemption price in cash within ten (10) business days after receipt of notice from the Transfer Agent that such Warrants have been submitted for exercise.
15. GOVERNMENTAL RESTRICTIONS. If any Shares issuable upon the exercise of Warrants require registration or approval of any governmental authority, the Company will use commercially reasonable efforts to secure such registration or approval and, to the extent practicable, take action in anticipation of and prior to the exercise of the Warrants necessary to permit a public offering of the securities underlying the Warrants during the term of this Agreement; provided that in no event shall such Shares be issued, and the Company shall have the
5-WARRANT AND UNIT AGREEMENT
authority to suspend the exercise of all Warrants, until such registration or approval shall have been obtained; but all Warrants, the exercise of which is requested during any such suspension, shall be exercisable at the Exercise Price. If any such period of suspension continues past the Expiration Date, all Warrants, the exercise of which have been requested on or prior to the Expiration Date, shall be exercisable upon the removal of such suspension until the close of business on the business day immediately following the expiration of such suspension.
16. ADJUSTMENTS OF NUMBER AND KIND OF SHARES PURCHASABLE AND EXERCISE PRICE. The number and kind of securities or other property purchasable upon exercise of a Warrant shall be subject to adjustment from time to time upon the occurrence, after the date hereof, of any of the following events:
a. In case the Company shall (i) pay a dividend in, or make a distribution of, shares of capital stock on its outstanding Common Stock, (ii) subdivide its outstanding shares of Common Stock into a greater number of such shares or (iii) combine its outstanding shares of Common Stock into a smaller number of such shares, the total number of shares of Common Stock purchasable upon the exercise of each Warrant outstanding immediately prior thereto shall be adjusted so that the holder of any Warrant Certificate thereafter surrendered for exercise shall be entitled to receive at the same aggregate Exercise Price the number of shares of capital stock (of one or more classes) which such holder would have owned or have been entitled to receive immediately following the happening of any of the events described above had such Warrant been exercised in full immediately prior to the record date with respect to such event. Any adjustment made pursuant to this subsection shall, in the case of a stock dividend or distribution, become effective as of the record date therefor and, in the case of a subdivision or combination, be made as of the effective date thereof. If, as a result of an adjustment made pursuant to this subsection, the holder of any Warrant Certificate thereafter surrendered for exercise shall become entitled to receive shares of two or more classes of capital stock of the Company, the Board of Directors of the Company, (whose determination shall be conclusive and shall be evidenced by a Board resolution filed with the Transfer Agent) shall determine the allocation of the adjusted Exercise Price between or among shares of such classes of capital stock.
b. In the event of a capital reorganization or a reclassification of the Common Stock (except as provided in subsection a. above or subsection e. below), any Warrant Holder, upon exercise of Warrants, shall be entitled to receive, in substitution for the Common Stock to which he would have become entitled upon exercise immediately prior to such reorganization or reclassification, the shares (of any class or classes) or other securities or property of the Company (or cash) that he would have been entitled to receive at the same aggregate Exercise Price upon such reorganization or reclassification if such Warrants had been exercised immediately prior to the record date with respect to such event; and in any such case, appropriate provision (as determined by the Board of Directors of the Company, whose determination shall be conclusive and shall be evidenced by a certified Board resolution filed with the Transfer Agent) shall be made for the application of this Section with respect to the rights and interests thereafter of the Warrant Holders (including but not limited to the allocation of the Exercise Price between or among shares of classes of capital stock), to the end that this Section (including the adjustments of the number of shares of Common Stock or other securities purchasable and the Exercise Price thereof) shall thereafter be reflected, as nearly as reasonably practicable, in all subsequent exercises of the Warrants for any
6-WARRANT AND UNIT AGREEMENT
shares or securities or other property (or cash) thereafter deliverable upon the exercise of the Warrants.
c. Whenever the number of shares of Common Stock or other securities purchasable upon exercise of a Warrant is adjusted as provided in this Section, the Company will promptly file with the Transfer Agent a certificate signed by a Chairman of the Board or the Chief Executive Officer, the President or a Vice President of the Company and by the Secretary or an Assistant Secretary of the Company setting forth the number and kind of securities or other property purchasable upon exercise of a Warrant, as so adjusted, stating that such adjustments in the number or kind of shares or other securities or property conform to the requirements of this Section, and setting forth a brief statement of the facts accounting for such adjustments. Promptly after receipt of such certificate, the Company, or the Transfer Agent at the Company's request, will deliver, by first-class, postage prepaid mail, a brief summary thereof (to be supplied by the Company) to the registered holders of the outstanding Warrant Certificates; provided, however, that failure to file or to give any notice required under this subsection, or any defect therein, shall not affect the legality or validity of any such adjustments under this Section; and provided, further, that, where appropriate, such notice may be given in advance and included as part of the notice required to be given pursuant to Section 18 hereof.
d. In case of any consolidation of the Company with, or merger of the Company into, another corporation (other than a consolidation or merger which does not result in any reclassification or change of the outstanding Common Stock), or in case of any sale or conveyance to another corporation of the property of the Company as an entirety or substantially as an entirety, the corporation formed by such consolidation or merger or the corporation which shall have acquired such assets, as the case may be, shall execute and deliver to the Transfer Agent a supplemental warrant agreement providing that the holder of each Warrant then outstanding shall have the right thereafter (until the expiration of such Warrant) to receive, upon exercise of such Warrant, solely the kind and amount of shares of stock and other securities and property (or cash) receivable upon such consolidation, merger, sale or transfer by a holder of the number of shares of Common Stock of the Company for which such Warrant might have been exercised immediately prior to such consolidation, merger, sale or transfer. Such supplemental warrant agreement shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided in this Section. The above provision of this subsection shall similarly apply to successive consolidations, mergers, sales or transfers.
The Transfer Agent shall not have any responsibility to determine the correctness of any provision contained in any such supplemental warrant agreement relating to either the kind or amount of shares of stock or securities or property (or cash) purchasable by holders of Warrant Certificates upon the exercise of their Warrants after any such consolidation, merger, sale or transfer or of any adjustment to be made with respect thereto, but subject to the provisions of Section 23 hereof, may accept as conclusive evidence of the correctness of any such provisions, and shall be protected in relying upon, a certificate of a firm of independent certified public accountants (who may be the accountants regularly employed by the Company) with respect thereto.
e. Irrespective of any adjustments in the number or kind of shares issuable upon exercise of Warrants, Warrant Certificates theretofore or thereafter issued may continue to express
7-WARRANT AND UNIT AGREEMENT
the same price and number and kind of shares as are stated in the similar Warrant Certificates initially issuable pursuant to this Agreement.
f. The Company may retain a firm of independent public accountants of recognized standing, which may be the firm regularly retained by the Company, selected by the Board of Directors of the Company or the Executive Committee of said Board, and not disapproved by the Transfer Agent, to make any computation required under this Section, and a certificate signed by such firm shall, in the absence of fraud or gross negligence, be conclusive evidence of the correctness of any computation made under this Section.
g. For the purpose of this Section, the term "Common Stock" shall mean
(i) the Common Stock or (ii) any other class of stock resulting from successive
changes or reclassifications of such Common Stock consisting solely of changes
in par value, or from par value to no par value, or from no par value to par
value. In the event that at any time as a result of an adjustment made pursuant
to this Section, the holder of any Warrant thereafter surrendered for exercise
shall become entitled to receive any shares of capital stock of the Company
other than shares of Common Stock, thereafter the number of such other shares so
receivable upon exercise of any Warrant shall be subject to adjustment from time
to time in a manner and on terms as nearly equivalent as practicable to the
provisions with respect to the Common Stock contained in this Section, and all
other provisions of this Agreement, with respect to the Common Stock, shall
apply on like terms to any such other shares.
h. The Company may, from time to time and to the extent permitted by law, reduce the exercise price of the Warrants by any amount for a period of not less than twenty (20) days. If the Company so reduces the exercise price of the Warrants, it will give not less than fifteen (15) days' notice of such decrease, which notice may be in the form of a press release, and shall take such other steps as may be required under applicable law in connection with any offers or sales of securities at the reduced price.
17. REDUCTION OF EXERCISE PRICE BELOW PAR VALUE. Before taking any action that would cause an adjustment pursuant to Section 16 hereof reducing the portion of the Exercise Price required to purchase one share of capital stock below the then par value (if any) of a share of such capital stock, the Company will use its best efforts to take any corporate action which, in the opinion of its counsel, may be necessary in order that the Company may validly and legally issue fully paid and non-assessable shares of such capital stock.
18. NOTICE TO WARRANT HOLDERS. In case the Company after the date hereof shall propose (i) to offer to the holders of Common Stock, generally, rights to subscribe to or purchase any additional shares of any class of its capital stock, any evidences of its indebtedness or assets, or any other rights or options or (ii) to effect any reclassification of Common Stock (other than a reclassification involving merely the subdivision or combination of outstanding shares of Common Stock) or any capital reorganization, or any consolidation or merger to which the Company is a party and for which approval of any stockholders of the Company is required, or any sale, transfer or other disposition of its property and assets substantially as an entirety, or the liquidation, voluntary or involuntary dissolution or winding-up of the Company, then, in each such case, the Company shall file with the Transfer Agent and the Company, or the Transfer Agent on its behalf,
8-WARRANT AND UNIT AGREEMENT
shall mail (by first-class, postage prepaid mail) to all registered holders of the Warrant Certificates notice of such proposed action, which notice shall specify the date on which the books of the Company shall close or a record be taken for such offer of rights or options, or the date on which such reclassification, reorganization, consolidation, merger, sale, transfer, other disposition, liquidation, voluntary or involuntary dissolution or winding-up shall take place or commence, as the case may be, and which shall also specify any record date for determination of holders of Common Stock entitled to vote thereon or participate therein and shall set forth such facts with respect thereto as shall be reasonably necessary to indicate any adjustments in the Exercise Price and the number or kind of shares or other securities purchasable upon exercise of Warrants which will be required as a result of such action. Such notice shall be filed and mailed in the case of any action covered by clause (i) above, at least ten (10) days prior to the record date for determining holders of the Common Stock for purposes of such action or, if a record is not to be taken, the date as of which the holders of shares of Common Stock of record are to be entitled to such offering; and, in the case of any action covered by clause (ii) above, at least twenty (20) days prior to the earlier of the date on which such reclassification, reorganization, consolidation, merger, sale, transfer, other disposition, liquidation, voluntary or involuntary dissolution or winding-up is expected to become effective and the date on which it is expected that holders of shares of Common Stock of record on such date shall be entitled to exchange their shares for securities or other property deliverable upon such reclassification, reorganization, consolidation, merger, sale, transfer, other disposition, liquidation, voluntary or involuntary dissolution or winding-up. Failure to give any such notice or any defect therein shall not affect the legality or validity of any transaction listed in this Section.
19. NO FRACTIONAL WARRANTS, UNITS OR SHARES. The Company shall not be required to issue fractions of Warrants or Units upon the reissue of Warrants or Units, any adjustments as described in Section 16 or otherwise; but the Company in lieu of issuing any such fractional interest, shall adjust the fractional interest by payment to the Warrant or Unit Holder an amount, in cash, equal to the current market value of any such fraction or interest. If the total Warrants or Units surrendered by exercise would result in the issuance of a fractional Share, the Company shall not be required to issue a fractional Share but rather the resulting fractional interest shall be adjusted by payment in an amount, in cash, equal to the current market value of such fractional interest.
20. RIGHTS OF WARRANT HOLDERS. No Warrant Holder, as such, shall have any rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant Holders, as such, are limited to those rights expressly provided in this Agreement or in the Warrant Certificates. The Company and the Transfer Agent may treat the registered Warrant Holder in respect of any Warrant Certificates as the absolute owner thereof for all purposes notwithstanding any notice to the contrary.
21. RIGHT OF ACTION. All rights of action in respect to this Agreement are vested in the respective registered holders of the Warrant and Unit Certificates; and any registered holder of any Warrant or Unit Certificate, without the consent of the Transfer Agent or of any other holder of a Warrant or Unit Certificate, may, in his own behalf for his own benefit, enforce, and may institute and maintain any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect of, his right to exercise the Warrants evidenced by such Warrant Certificate, for the
9-WARRANT AND UNIT AGREEMENT
purchase of shares of the Common Stock in the manner provided in the Warrant Certificate and in this Agreement.
22. AGREEMENT OF WARRANT AND UNIT HOLDERS. Every holder of a Warrant or Unit Certificate by accepting the same consents and agrees with the Company, the Transfer Agent and with every other holder of a Warrant or Unit Certificate, respectively, that:
a. The Warrant and Unit Certificates are transferable on the registry books of the Transfer Agent only upon the terms and conditions set forth in this Agreement; and
b. The Company and the Transfer Agent may deem and treat the person in whose name the Warrant or Unit Certificate is registered as the absolute owner of the Warrant or Unit, as the case may be, (notwithstanding any notation of ownership or other writing thereon made by anyone other than the Company or the Transfer Agent) for all purposes whatever and neither the Company nor the Transfer Agent shall be affected by any notice to the contrary.
23. TRANSFER AGENT. The Company hereby appoints the Transfer Agent to act as the agent of the Company and the Transfer Agent hereby accepts such appointment upon the following terms and conditions by all of which the Company and every Warrant and Unit Holder, by acceptance of his Warrants or Units, shall be bound:
a. Statements contained in this Agreement and in the Warrant and Unit Certificates shall be taken as statements of the Company. The Transfer Agent assumes no responsibility for the correctness of any of the same except such as describes the Transfer Agent or for action taken or to be taken by the Transfer Agent.
b. The Transfer Agent shall not be responsible for any failure of the Company to comply with any of the Company's covenants contained in this Agreement or in the Warrant or Unit Certificates.
c. The Transfer Agent may consult at any time with counsel satisfactory to it (who may be counsel for the Company) and the Transfer Agent shall incur no liability or responsibility to the Company or to any Warrant or Unit Holder in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with the opinion or the advice of such counsel, provided the Transfer Agent shall have exercised reasonable care in the selection and continued employment of such counsel.
d. The Transfer Agent shall incur no liability or responsibility to the Company or to any Warrant or Unit Holder for any action taken in reliance upon any notice, resolution, waiver, consent, order, certificate or other paper, document or instrument believed by it to be genuine and to have been signed, sent or presented by the proper party or parties.
e. The Company agrees to pay to the Transfer Agent reasonable compensation for all services rendered by the Transfer Agent in the execution of this Agreement, to reimburse the Transfer Agent for all expenses, taxes and governmental charges and all other charges of any kind or nature incurred by the Transfer Agent in the execution of this Agreement and to indemnify the
10-WARRANT AND UNIT AGREEMENT
Transfer Agent and save it harmless against any and all liabilities, including judgments, costs and counsel fees, arising from the Transfer Agent's engagement under this Agreement except as a result of the Transfer Agent's negligence, bad faith or willful misconduct.
f. The Transfer Agent shall be under no obligation to institute any action, suit or legal proceeding or to take any other action likely to involve expense unless the Company or one or more Warrant or Unit Holders shall furnish the Transfer Agent with reasonable security and indemnity for any costs and expenses which may be incurred in connection with such action, suit or legal proceeding, but this provision shall not affect the power of the Transfer Agent to take such action as the Transfer Agent may consider proper, whether with or without any such security or indemnity. All rights of action under this Agreement or under any of the Warrants or Units may be enforced by the Transfer Agent without the possession of any of the Warrant or Unit Certificates or the production thereof at any trial or other proceeding relative thereto, and any such action, suit or proceeding instituted by the Transfer Agent shall be brought in its name as Transfer Agent, and any recovery of judgement shall be for the ratable benefit of the Warrant or Unit Holders as their respective rights or interest may appear.
g. The Transfer Agent and any shareholder, director, officer or employee of the Transfer Agent may buy, sell or deal in any of the Warrants, Units or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not Transfer Agent under this Agreement. Nothing herein shall preclude the Transfer Agent from acting in any other capacity for the Company or for any other legal entity.
24. SUCCESSOR TRANSFER AGENT. Any legal entity into which the Transfer Agent may be merged or converted or with which it may be consolidated, or any legal entity resulting from any merger, conversion or consolidation to which the Transfer Agent shall be a party, or any legal entity succeeding to the corporate trust business of the Transfer Agent, shall be the successor to the Transfer Agent hereunder without the execution or filing of any paper or any further act of a party or the parties hereto provided such legal entity is eligible to be appointed under Section 25 below. In any such event or if the name of the Transfer Agent is changed, the Transfer Agent or such successor may adopt the countersignature of the original Transfer Agent and may countersign such Warrant or Unit Certificates either in the name of the predecessor Transfer Agent or in the name of the successor Transfer Agent.
25. CHANGE OF TRANSFER AGENT. The Transfer Agent may resign or be discharged by the Company from its duties under this Agreement by the Transfer Agent or the Company, as the case may be, giving notice in writing to the other, and by giving a date when such resignation or discharge shall take effect, which notice shall be sent at least thirty (30) days prior to the date so specified. If the Transfer Agent shall resign, be discharged or shall otherwise become incapable of acting, the Company shall appoint a successor to the Transfer Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Transfer Agent or by any Warrant or Unit Holder or after discharging the Transfer Agent, then the Company agrees to perform the duties of the Transfer Agent hereunder until a successor Transfer Agent is appointed. Any successor Transfer Agent shall be a bank or a trust company, in good standing, organized under the
11-WARRANT AND UNIT AGREEMENT
laws of any state of the United States of America, having a combined capital and surplus of at least $4,000,000 at the time of its appointment as Transfer Agent. After appointment, the successor Transfer Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Transfer Agent without further act or deed, and the former Transfer Agent shall deliver and transfer to the successor Transfer Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for effecting the delivery or transfer. Failure to give any notice provided for in this Section, however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Transfer Agent or the appointment of the successor Transfer Agent, as the case may be.
26. NOTICES. Any notice or demand authorized by this Agreement to be given or made by the Transfer Agent or by any Warrant or Unit Holder to or on the Company shall be sufficiently given or made if sent by mail, first class, certified or registered, postage prepaid, addressed (until another address is filed in writing by the Company with the Transfer Agent), as follows:
TASER International, Inc. 7860 E. McClain Drive, Suite 2 Scottsdale, Arizona 85260
Any notice or demand authorized by this Agreement to be given or made by any Warrant or Unit Holder or by the Company to or on the Transfer Agent shall be sufficiently given or made if sent by mail, first class, certified or registered, postage prepaid, addressed (until another address is filed in writing by the Transfer Agent with the Company), as follows:
US Stock Transfer Corporation
Any distribution, notice or demand required or authorized by this Agreement to be given or made by the Company or the Transfer Agent to or on the Warrant or Unit Holders shall be sufficiently given or made if sent by mail, first class, certified or registered, postage prepaid, addressed to the Warrant or Unit Holders at their last known addresses as they shall appear on the registration books for the Warrant or Unit Certificates maintained by the Transfer Agent.
27. SUPPLEMENTS AND AMENDMENTS. The Company and the Transfer Agent may from time to time supplement or amend this Agreement without the approval of any Warrant or Unit Holders in order to cure any ambiguity or to correct or supplement any provision contained herein which may be defective or inconsistent with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder which the Company and the Transfer Agent may deem necessary or desirable.
28. SUCCESSORS. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Transfer Agent shall bind and inure to the benefit of their respective successors and assigns hereunder.
12-WARRANT AND UNIT AGREEMENT
29. TERMINATION. This Agreement shall terminate at the close of business on the Expiration Date or such earlier date upon which all Warrants have been exercised; provided, however, that if exercise of the Warrants is suspended pursuant to Section 15 and such suspension continues past the Expiration Date, this Agreement shall terminate at the close of business on the business day immediately following expiration of such suspension. The provisions of Section 23 shall survive such termination.
30. GOVERNING LAW. This Agreement and each Warrant and Unit Certificate issued hereunder shall be deemed to be a contract made under the laws of the State of [California] and for all purposes shall be construed in accordance with the laws of said State.
31. BENEFITS OF THIS AGREEMENT. Nothing in this Agreement shall be construed to give any person or corporation other than the Company, the Transfer Agent and the Warrant and Unit Holders any legal or equitable right, remedy or claim under this Agreement, and this Agreement shall be for the sole and exclusive benefit of the Company, the Transfer Agent and the Warrant and Unit Holders.
32. COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of such counterparts shall for all purposes be deemed to be an original and all such counterparts shall together constitute but one and the same instrument.
33. INTEGRATION. As of the date hereof, this Agreement contains the entire and only agreement, understanding, representation, condition, warranty or covenant between the parties hereto with respect to the matters herein, supersedes any and all other agreements between the parties hereto relating to such matters, and may be modified or amended only by a written agreement signed by both parties hereto pursuant to the authority granted by Section 27.
34. DESCRIPTIVE HEADINGS. The descriptive headings of the Sections of this Agreement are inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof.
Date: , 2001 --------------- TASER International, Inc., a Delaware corporation By: ----------------------------------------- Its Chief Executive Officer |
SEAL
ATTEST:
13-WARRANT AND UNIT AGREEMENT
US Stock Transfer Corporation, a corporation ------------ By: -------------------------------- Its Vice President |
SEAL
ATTEST:
14-WARRANT AND UNIT AGREEMENT
EXHIBIT A
[WARRANT CERTIFICATE]
15-WARRANT AND UNIT AGREEMENT
EXHIBIT B
[UNIT CERTIFICATE]
16-WARRANT AND UNIT AGREEMENT
Exhibit 10.15
[TASER INTERNATIONAL LETTERHEAD]
PROMISSORY NOTE
Amount of Note ($): $75,000 Cash
City: Scottsdale, State: Arizona
Date: July 1, 1999
FOR VALUE RECEIVED the undersigned jointly and severally promise(s) to pay
to the order of:
Malcolm Sherman, currently residing in Scottsdale, Arizona
the principal sum of:
Seventy-Five thousand & no/100 ($75,000.00) dollars together with interest
thereon from date at the rate of:
9.18% Per Annum
until maturity, said principal and interest shall be paid in 24 equal monthly
payments of $3,757.37, beginning on August 15, 1999 with the last payment
submitted on July 15, 2001. (Please see attached Loan Amortization).
Each maker and endorser severally waives demand, protest and notice of maturity, non-payment or protest and all requirements necessary to hold each of them liable as makers and endorsers and, should litigation be necessary to enforce this note, each maker and endorser waives trial by jury and consents to the personal jurisdiction and venue of a court of subject matter jurisdiction located in the State of Arizona, and County of Maricopa.
Each maker and endorser further agrees, jointly and severally, to pay all costs of collection, including a reasonable attorney's fee in case the principal of this note or any payment on the principal or any interest thereon is not paid at the respective maturity thereof, or in case it becomes necessary to protest the security hereof, whether suit be brought or not.
This note is to be construed and enforced according to the laws of the State of Arizona; upon default in the payment of principal and/or interest when due, the whole sum of principal and interest remaining unpaid shall, at the option of the holder, become immediately due and payable and it shall accrue interest at the highest rate allowable by law, or, if no highest rate is otherwise indicated, at ten (10%) percent, from the date of default.
Default shall include, but not be limited to non-payment within ten (10) days from the due date set out herein.
Unless specifically disallowed by law, should litigation arise hereunder, service of process therefore may be obtained through certified mail, return receipt requested; the parties hereto waiving and all rights they may have to object to the method by which service was perfected.
/s/MWS /s/TPS |
Taser International, Inc. herein acknowledges and agrees to the following, regarding the herein described Promissory Note.
A. The monies being borrowed are to secure tooling and equipment for that product as described in the enclosed attachment, marked "A" and listed as "Steman International Procurement, Quotation No: 98Q01-1-AT," Taser International, Inc. purchase order numbers: 021025-00, 021026-00, 021027-00, 021028-00, 021024-00 additionally known as "The Advanced Taser." Additional components as secured by Taser International, Inc. to complete the production of this product are included in the UCC filing and are described as electrical components, finished product or packaging.
B. Taser International, Inc. agrees to the tooling and components as purchased by the funds of this Promissory Note being subject to a UCC filing in favor of Malcolm W. Sherman i.e., lender. Said UCC filing to be valid for the full period of the listed payment schedule. Taser International, Inc. agrees to the UCC filing of this lien and its permission is granted for a "floating lien" to be issued to Malcolm W. Sherman.
C. Taser International, Inc. agrees and acknowledges that they have no right to sell, transfer, assign, sublease or encumber the equipment or this agreement or material covered under this agreement.
D. All cost relative to the filing of the above listed UCC filings are to be born by Taser International, Inc.
All matters pertinent to this Agreement (including its interpretation, application, validity, performance and breech), shall be governed by, construed and enforce in accordance with the laws of the State of Arizona. The parties herein waive trial by jury and agree to submit to the personal jurisdiction and venue of a court of subject matter jurisdiction located in Maricopa County, State of Arizona. In the event that litigation results from or arises out of this Agreement or the performance thereof, the parties agree to reimburse the prevailing party's reasonable attorney's fees, court costs, and all other expenses, whether or not taxable by the court as costs in addition to any other relief to which the prevailing party may be entitled. In such event, no action shall be entertained by said court or any court of competent jurisdiction if filed more than one year subsequent to the date of the cause(s) of action actually accrued regardless of whether damages were otherwise as of said time calculable.
Corporation /s/ Malcolm W. Sherman By: /s/ Patrick Smith ---------------------- --------------------- Payee - Signature President - Signature M. W. Sherman Patrick Smith --------------------- --------------------- Payee Name Printed President Corporate Seal Attest: /s/ Thomas P. Smith [Corporate Seal] --------------------------- Treasurer - Signature Thomas P. Smith --------------------------- Treasurer |
Exhibit 10.16
[TASER INTERNATIONAL LETTERHEAD]
May 26, 2000
Malcolm Sherman
9068 E. Hillery Dr.
Scottsdale, AZ 85260
Dear Malcolm,
This letter is to confirm our previous discussions regarding your pending retirement as a full time employee of TASER International.
- As we discussed, we would like you to work directly with Tom Smith to train him to maintain the current export customer base during the time between now and your formal retirement on June 30, 2000.
- The company will continue to pay your normal salary and car allowance up through June 30, although your work schedule between now and that time will be at your discretion in order to effectively train Tom and close any pending deals.
- After June 30, the company will pay your vacation time of 4 weeks in the month of July. These payments will be made on a biweekly basis concurrent with our normal payroll.
- Your outstanding balance of non-reimbursed expenses (approximately $30,000) will be repaid in full on a biweekly basis starting on August 15. These payments will be of the same amount as your current salary plus car allowance, paid on a biweekly basis concurrent with our payroll disbursements.
- You will be asked to continue to serve on the board of directors and as an active significant shareholder. As you are aware, we do not remunerate our board members with cash compensation. However, the company will extend your current stock options (20,000 shares) for an additional 5 years after your formal retirement (i.e. Expiration date of 7/1/2005). All of these options shall be considered vested as of June 30, 2000 if they have not already vested prior to that time.
- Further, the company shall work with you as an independent contractor (effective May 27th, 2000) in certain foreign countries. Specifically, you shall be considered the exclusive foreign agent for the countries of:
- India
- Nepal
- Sri Lanka
PAGE 1 PWS:/s/PWS MWS:/s/MWS --- --- |
- BANGLADESH - UKRAINE - JORDAN - ISRAEL |
For a period of 12 months (i.e. Through June 30, 2001), these countries shall be reserved for you, operating as an independent contractor, to close an exclusive distribution deal. You will be paid a 10% commission for all sales in these countries for the period of time that you remain the exclusive agent. This 10% commission shall not include the $20,000 deposit already received from Jordan, but shall include any additional sums received from the distributor in Jordan. Commissions will be paid to Sherman as payments are received by TASER International regardless of shipping dates as listed on purchase orders. Sales prices offered to Sherman during the course of his appointment as "exclusive agent" shall be equal to the best of prices offered to any other exclusive agreement granted by the company. In those instances which requires overages in billing, i.e. over the export selling price of TASER, these amount are to be forwarded to third parties for "commissions". TASER International, Inc, Agrees to forward via wire transfer or company check to such accounts as directed upon instructions from Sherman after these funds have been secured. Sherman's 10% commission is based on the net product prices as given to Sherman by TASER (less freight and miscellaneous charges). Once payment of commissions or overages has been remitted as instructed by Sherman, TASER shall be released of all liability associated with the specific transactions.
In order to maintain your exclusive agency for these areas, the following performance criteria must be met (the numbers in each column represent the number of ADVANCED TASERs sold within the territory):
---------------------------------------------------------------------------------------------------- Country 3/30 3/30 3/30 3/30 3/30 3/30 2001 2002 2003 2004 2005 2006 ---------------------------------------------------------------------------------------------------- India 500 600 720 864 1036 1244 ---------------------------------------------------------------------------------------------------- Ukraine 300 360 432 518 622 748 --------------------------------------------------------------------------------------------------- Sri Lanka 100 120 144 172 208 248 --------------------------------------------------------------------------------------------------- Bangladesh 200 240 288 346 414 498 --------------------------------------------------------------------------------------------------- Nepal 50 60 72 86 104 124 --------------------------------------------------------------------------------------------------- Jordan 200 240 288 346 414 498 --------------------------------------------------------------------------------------------------- Israel 200 240 288 346 414 498 --------------------------------------------------------------------------------------------------- |
The sales in each column represent sales in the 12 calendar months proceeding the date atop the column. Should sales not meet or exceed this number, the exclusivity will expire without notice and the company will have the option to pursue other sales opportunities in those markets without further compensation due.
All inquiries from these territories will be forwarded to Sherman directly, and no pricing information shall be given to inquiries without Sherman's prior consent.
- Under the terms of this representation, you will be responsible for all travel and other related expense for you to develop these markets. This shall include telephone
charges, cellular air time and all other related incidental expenses. We will, of course, support your efforts with reasonable collateral materials. Although you will remain on the payroll for the month of June as an employee, any sales in these territories (as listed above) beyond the $20,000 deposit already received from Jordan shall be treated as commissioned sales in your relationship as an independent contractor.
- For purposes of supporting your role as a sales agent in the above listed countries, you may continue to use the title of "Director of Sales and Marketing." But this exception is FOR THOSE TERRITORIES ONLY. Accordingly, you may use your existing business cards in conjunction with these countries.
- Any potential business outside the scope of countries listed in this agreement, including any initiated by distributors in the countries listed within this document (specifically: India, Nepal, Sri Lanka, Bangladesh, Ukraine, Jordan and Israel), must be approved by TASER International in advance. The company may accept or reject any offers for additional countries at its sole discretion. The company has current prospects in Egypt and other countries in the Middle East and shall pursue those prospects directly.
- Effective May 27th, you will be operating as an independent sales representative and independent contractor in relation to these foreign sales activities. You will also be responsible for ensuring that all distribution agreements in those countries comply with US export law and relevant laws concerning foreign commerce.
- Although you will remain a member of our board of directors, any commitments on behalf of the company subsequent to the date of this letter must be approved, and joint signed by either Tom or Rick Smith as active officers in the company.
- All foreign orders shall be prepaid prior to shipment.
- In the event the company is going to go public through an IPO, be acquired by another entity, or raise a significant amount of capital to fund operations, the company shall have the right to buy-out the exclusivity provisions outlined above by a single payment equivalent to 6 months' historical commissions.
- I trust that the above accurately memorializes our discussion of yesterday. Should a disagreement arise over any of the provisions relating to your retirement, or the subsequent sales representation outlined above, we shall first sit over a beer and work it out. If this is unsuccessful, both parties (TASER International and Malcolm Sherman) hereby agree that any disputes shall be settled in binding arbitration under the rules of the American Arbitration Association. Specifically, this agreement sets forth the entire understanding and agreement of the parties hereto with respect to the subject matter hereof and supersedes all other representations and understandings both written and oral. This agreement is drafted under the laws of the state of Arizona, and the venue for any legal recourse shall take place under laws as written in Arizona, and the venue for any legal recourse shall take place under these laws and be adjudicated within its jurisdiction. Further, the parties agree that any controversy or claim arising out of, or relating to, this contract, or the breach thereof, shall be settled by arbitration in accordance with the rules of the American Arbitration
Association in the state of Arizona, USA under their auspices and the parties agree to have any dispute heard and adjudicated under these rules in the state of Arizona USA and both parties agree to be bound by the decision of the arbitrator and to pay their proportionate fees as required under the rules of the association and judgment upon the award rendered by the arbitrator(s) may be entered into any court having jurisdiction thereof.
- This agreement may be amended or modified only in writing, signed in advance by the parties hereto or their designated representatives. This agreement shall inure to the benefit of and be binding upon the parties hereto, and their respective successors and assigns.
- This memorandum outlines all terms related to your pending retirement, and the parties agree that any and all documents and or agreements entered into or/of prior date to this agreement are herein cancelled and mutually abrogated by the parties.
- This memorandum outlines all terms related to your pending retirement, and the parties hereby mutually release each other from any and all claims and/or obligations related to your employment as Director of Sales and Marketing for TASER International other than those obligations outlined herein. Pre-existing financial obligations currently owed to you (such as your salary, vacation pay, notes payable and accrued expenses) shall survive this agreement in their current form.
- TASER agrees to pay Sherman all outstanding balances owed as outlined above regardless and excluded from the releases in the preceding paragraph. These expenses will carry an effective interest rate of 10% per annum, accrued monthly on the unpaid balance only, until the entire principal and accrued interest is paid in full. Such interest shall be calculated from the beginning date at which the expenses were outstanding (i.e. the average monthly balance). However, any prior financing charges will be applied as credits against the interest owed.
- Regarding office space, TASER will make temporary office space available through the end of July, 2000. After that time, the company will plan to redistribute the use of space within our offices. Further, TASER will make partial secretarial support available for preparation of formal letters and contracts in conjunction with TASER sales for those territories assigned to Sherman as a part of this contract only.
Malcolm, I've truly enjoyed the past 6 years together. I've grown tremendously working with you. I wish you nothing but the best and hope you find more time over the coming months and years to take some well-deserved personal time.
Sincerely, Understood and Agreed, /s/ Rick W. Smith 5/26/2000 /s/ Malcolm W. Sherman 5/26/2000 ----------------- --------- ---------------------- --------- Rick W. Smith date Malcolm W. Sherman date President, TASER International PAGE 4 PWS:/s/PWS MWS:/s/MWS --- --- |
[SILICON VALLEY BANK LETTERHEAD]
IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVB0IIS3615
DATE: APRIL 13, 2001
BENEFICIARY:
TASER INTERNATIONAL, INC.
7860 E. MCCLAIN DRIVE, SUITE 2
SCOTTSDALE, AZ 85260
ATTN: KATHY HANRAHAN, CONTROLLER
(480) 905-2012
APPLICANT:
BRUCE R. CULVER & DONNA T. CULVER
6592 E. OAK SPRING DRIVE
OAK PARK, CA 91377
(818) 991-9950
AMOUNT: US$500,000.00 (FIVE HUNDRED THOUSAND AND 00/100 U.S. DOLLARS)
EXPIRATION DATE: DECEMBER 31, 2001
LOCATION: AT OUR COUNTERS IN SANTA CLARA, CALIFORNIA
DEAR SIR/MADAM:
WE HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVB0IIS3615 IN YOUR FAVOR AVAILABLE BY YOUR DRAFTS DRAWN ON US AT SIGHT AND ACCOMPANIED BY THE FOLLOWING DOCUMENTS:
1. THE ORIGINAL OF THIS LETTER OF CREDIT AND ALL AMENDMENT(S), IF ANY.
PARTIAL DRAWS ARE ALLOWED. THIS LETTER OF CREDIT MUST ACCOMPANY ANY DRAWINGS HEREUNDER FOR ENDORSEMENT OF THE DRAWING AMOUNT AND WILL BE RETURNED TO THE BENEFICIARY UNLESS IT IS FULLY UTILIZED.
DRAFT(S) AND DOCUMENTS MUST INDICATE THE NUMBER AND DATE OF THIS LETTER OF CREDIT.
DOCUMENTS MUST BE FORWARDED TO US BY OVERNIGHT DELIVERY SERVICE TO:
SILICON VALLEY BANK, 3003 TASMAN DRIVE, SANTA CLARA CA 95054, ATTN:
INTERNATIONAL DIVISION.
WE HEREBY AGREE WITH THE DRAWERS, ENDORSERS AND BONAFIDE HOLDERS THAT THE DRAFTS DRAWN UNDER AND IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT SHALL BE DULY HONORED UPON PRESENTATION TO THE DRAWEE, IF NEGOTIATED ON OR BEFORE THE EXPIRATION DATE OF THIS CREDIT.
[SILICON VALLEY BANK LETTERHEAD]
IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVB011S3615
DATE: APRIL 13, 2001
EXCEPT AS EXPRESSLY STATED HEREIN THIS LETTER OF CREDIT IS SUBJECT TO THE UNIFORM CUSTOMS AND PRACTICE FOR DOCUMENTARY CREDITS (1993 REVISION), INTERNATIONAL CHAMBER OF COMMERCE, PUBLICATION NO. 500.
/s/ Danny J. Rowan /s/ Dawn Y. Shinsato -------------------- -------------------- AUTHORIZED SIGNATURE AUTHORIZED SIGNATURE DANNY J. ROWAN DAWN Y. SHINSATO |
March 30, 2001
Board of Directors
TASER, International, Inc.
7860 East McClain Drive, Suite 2
Scottsdale, Arizona 85260-1627
Letter of Support
Gentlemen:
The undersigned Phillips W. Smith and Bruce R. Culver are directors of TASER International, Inc., a Delaware corporation (the "Company"). Through loans, advances, provisions of guarantees, and other arrangements, we have from time-to-time supported financially and otherwise the business of the Company.
We agree, by this letter, to continue to support the Company by establishing an irrevocable, standby letter of credit issued by a bank of recognized standing in an amount not less than $500,000. The letter of credit is intended to provide additional financial resources on which the Company may rely in the event of its suffering a working capital deficit or otherwise. Such letter of credit may be drawn upon by the Company at any time prior to December 31, 2001 upon presentation to the bank of a resolution validly adopted by the Board of Directors of the Company confirming a determination by the Board of Directors of the Company's need for additional funds and electing to draw upon such letter of credit.
In consideration of this letter of support and the provision of the letter of credit, the Company shall pay each of us $10,000, and in the event of a draw upon the letter of credit, enter into commercially reasonable arrangements for the repayment to us of amounts so drawn.
If the foregoing accurately reflects our understanding, please so indicate by signing the enclosed copy of this letter and returning it to us.
Very truly yours,
/s/ Phillips W. Smith --------------------------------- Phillips W. Smith /s/ Bruce R. Culver --------------------------------- Bruce R. Culver Agreed and accepted this 30th day of March 2001. |
TASER International, Inc.
/s/ Patrick W. Smith --------------------------------- Patrick W. Smith Chief Executive Officer and Director |
Exhibit 10.18
[TASER INTERNATIONAL(R) LOGO]
7339 East Evans Road - Scottsdale, AZ - 85280 - USA - (480) 991-0791 -
Fax (480) 991-0791
AMENDMENT TO PROMISSORY NOTE(S)
Note Balance: __________
City/State: Scottsdale, Arizona
Date of Amendment: 3/30/01
This Amendment No. __ to the Original Loans and Security Agreement (this "Amendment") is made as of March 30, 2001 by and between TASER International Inc. ("Borrower") and _____________ ("Lender").
Borrower and Lender are parties to, among other documents, a Promissory Note agreement as of ______ (date of initial investment). Borrower and Lender desire to amend the Promissory Notes in accordance with the following terms.
NOW THEREFORE, Borrower and Lender agree as follows:
4. The Maturity Dates are hereby amended to July 1, 2002. With an additional provision that the company may at its discretion, extend the maturity date 2 consecutive terms of 12 months each to cover working capital shortfalls.
Unless otherwise defined, all other terms specified in the Promissory Notes shall remain in full force and effect.
IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date above written.
Borrower: Lender:
TASER International Inc.
By: /s/ Patrick W. Smith _____________________ ____________________ Name: Patrick W. Smith Name: |
Exhibit 23.2
[AA LETTERHEAD]
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the use of our report dated February 12, 2001 (and to all references to our firm) included in or made a part of Amendment #2 of the Registration Statement on Form SB-2.
Phoenix, Arizona
April 13, 2001